JP6024667B2 - Ink composition - Google Patents
Ink composition Download PDFInfo
- Publication number
- JP6024667B2 JP6024667B2 JP2013541772A JP2013541772A JP6024667B2 JP 6024667 B2 JP6024667 B2 JP 6024667B2 JP 2013541772 A JP2013541772 A JP 2013541772A JP 2013541772 A JP2013541772 A JP 2013541772A JP 6024667 B2 JP6024667 B2 JP 6024667B2
- Authority
- JP
- Japan
- Prior art keywords
- weight
- parts
- boiling point
- mpa
- resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims description 127
- 238000009835 boiling Methods 0.000 claims description 197
- 239000003094 microcapsule Substances 0.000 claims description 165
- 239000000976 ink Substances 0.000 claims description 113
- 239000007788 liquid Substances 0.000 claims description 95
- 125000004185 ester group Chemical group 0.000 claims description 63
- 125000001033 ether group Chemical group 0.000 claims description 40
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 40
- 239000002245 particle Substances 0.000 claims description 40
- 239000000126 substance Substances 0.000 claims description 40
- 125000001931 aliphatic group Chemical group 0.000 claims description 36
- 125000000468 ketone group Chemical group 0.000 claims description 35
- 125000000524 functional group Chemical group 0.000 claims description 29
- 239000007787 solid Substances 0.000 claims description 28
- 239000000049 pigment Substances 0.000 claims description 14
- 239000011344 liquid material Substances 0.000 claims description 6
- 239000006104 solid solution Substances 0.000 claims description 6
- 229920005989 resin Polymers 0.000 description 127
- 239000011347 resin Substances 0.000 description 127
- 239000000243 solution Substances 0.000 description 110
- 239000011162 core material Substances 0.000 description 84
- 229920001807 Urea-formaldehyde Polymers 0.000 description 83
- 239000007864 aqueous solution Substances 0.000 description 83
- 239000002775 capsule Substances 0.000 description 79
- 239000006185 dispersion Substances 0.000 description 78
- DTCCVIYSGXONHU-CJHDCQNGSA-N (z)-2-(2-phenylethenyl)but-2-enedioic acid Chemical compound OC(=O)\C=C(C(O)=O)\C=CC1=CC=CC=C1 DTCCVIYSGXONHU-CJHDCQNGSA-N 0.000 description 76
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 72
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 71
- 239000003795 chemical substances by application Substances 0.000 description 65
- -1 propylene glycol fatty acid ester Chemical class 0.000 description 64
- AOGQPLXWSUTHQB-UHFFFAOYSA-N hexyl acetate Chemical compound CCCCCCOC(C)=O AOGQPLXWSUTHQB-UHFFFAOYSA-N 0.000 description 56
- 239000000975 dye Substances 0.000 description 52
- 239000000839 emulsion Substances 0.000 description 51
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 49
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 49
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 49
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 42
- 239000012528 membrane Substances 0.000 description 41
- 238000000034 method Methods 0.000 description 36
- 238000011065 in-situ storage Methods 0.000 description 28
- 238000006116 polymerization reaction Methods 0.000 description 28
- 238000003756 stirring Methods 0.000 description 27
- 239000000463 material Substances 0.000 description 26
- 230000000379 polymerizing effect Effects 0.000 description 24
- 150000002576 ketones Chemical class 0.000 description 23
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 22
- IIEWJVIFRVWJOD-UHFFFAOYSA-N ethylcyclohexane Chemical compound CCC1CCCCC1 IIEWJVIFRVWJOD-UHFFFAOYSA-N 0.000 description 22
- WLJVXDMOQOGPHL-UHFFFAOYSA-N benzyl-alpha-carboxylic acid Natural products OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 21
- 239000003431 cross linking reagent Substances 0.000 description 20
- 239000002904 solvent Substances 0.000 description 19
- WOYWLLHHWAMFCB-UHFFFAOYSA-N 2-ethylhexyl acetate Chemical compound CCCCC(CC)COC(C)=O WOYWLLHHWAMFCB-UHFFFAOYSA-N 0.000 description 18
- HBGGXOJOCNVPFY-UHFFFAOYSA-N diisononyl phthalate Chemical compound CC(C)CCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCC(C)C HBGGXOJOCNVPFY-UHFFFAOYSA-N 0.000 description 18
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 16
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 16
- 229940049953 phenylacetate Drugs 0.000 description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 14
- GJRQTCIYDGXPES-UHFFFAOYSA-N iso-butyl acetate Natural products CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 description 14
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 description 14
- FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 description 14
- OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 description 14
- 229920000877 Melamine resin Polymers 0.000 description 12
- 239000002202 Polyethylene glycol Substances 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 12
- 235000014113 dietary fatty acids Nutrition 0.000 description 12
- 239000000194 fatty acid Substances 0.000 description 12
- 229930195729 fatty acid Natural products 0.000 description 12
- 229920001223 polyethylene glycol Polymers 0.000 description 12
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- 229920001228 polyisocyanate Polymers 0.000 description 11
- 239000005056 polyisocyanate Substances 0.000 description 11
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 10
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 10
- 239000004640 Melamine resin Substances 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 9
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 8
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 8
- 239000004372 Polyvinyl alcohol Substances 0.000 description 8
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 8
- QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 description 8
- 229920002451 polyvinyl alcohol Polymers 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 229940072049 amyl acetate Drugs 0.000 description 7
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 7
- 229920001577 copolymer Polymers 0.000 description 7
- 229960000735 docosanol Drugs 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 7
- 229940117955 isoamyl acetate Drugs 0.000 description 7
- OJEQSSJFSNLMLB-UHFFFAOYSA-N p-Tolyl phenylacetate Chemical compound C1=CC(C)=CC=C1OC(=O)CC1=CC=CC=C1 OJEQSSJFSNLMLB-UHFFFAOYSA-N 0.000 description 7
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000005215 alkyl ethers Chemical class 0.000 description 6
- 235000019445 benzyl alcohol Nutrition 0.000 description 6
- HHNHBFLGXIUXCM-GFCCVEGCSA-N cyclohexylbenzene Chemical compound [CH]1CCCC[C@@H]1C1=CC=CC=C1 HHNHBFLGXIUXCM-GFCCVEGCSA-N 0.000 description 6
- 239000003995 emulsifying agent Substances 0.000 description 6
- PGJQPLVEUVHSFQ-UHFFFAOYSA-N methyl-4-acetoxybenzoate Chemical compound COC(=O)C1=CC=C(OC(C)=O)C=C1 PGJQPLVEUVHSFQ-UHFFFAOYSA-N 0.000 description 6
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- LXEJRKJRKIFVNY-UHFFFAOYSA-N terephthaloyl chloride Chemical compound ClC(=O)C1=CC=C(C(Cl)=O)C=C1 LXEJRKJRKIFVNY-UHFFFAOYSA-N 0.000 description 6
- SWFHGTMLYIBPPA-UHFFFAOYSA-N (4-methoxyphenyl)-phenylmethanone Chemical compound C1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 SWFHGTMLYIBPPA-UHFFFAOYSA-N 0.000 description 5
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 5
- 239000004215 Carbon black (E152) Substances 0.000 description 5
- 238000012695 Interfacial polymerization Methods 0.000 description 5
- 229960000541 cetyl alcohol Drugs 0.000 description 5
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical compound C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 5
- 229940075507 glyceryl monostearate Drugs 0.000 description 5
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 5
- 229930195733 hydrocarbon Natural products 0.000 description 5
- 150000002430 hydrocarbons Chemical class 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- 229960003424 phenylacetic acid Drugs 0.000 description 5
- 239000003279 phenylacetic acid Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- YJWGKXIQTRYZSH-UHFFFAOYSA-N 2,4-diiodoaniline Chemical compound NC1=CC=C(I)C=C1I YJWGKXIQTRYZSH-UHFFFAOYSA-N 0.000 description 4
- HXVNBWAKAOHACI-UHFFFAOYSA-N 2,4-dimethyl-3-pentanone Chemical compound CC(C)C(=O)C(C)C HXVNBWAKAOHACI-UHFFFAOYSA-N 0.000 description 4
- QQZOPKMRPOGIEB-UHFFFAOYSA-N 2-Oxohexane Chemical compound CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 4
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 4
- CETWDUZRCINIHU-UHFFFAOYSA-N 2-heptanol Chemical compound CCCCCC(C)O CETWDUZRCINIHU-UHFFFAOYSA-N 0.000 description 4
- ICYDRUIZSPKQOH-UHFFFAOYSA-N 4-[1-(4-hydroxyphenyl)decyl]phenol Chemical compound C=1C=C(O)C=CC=1C(CCCCCCCCC)C1=CC=C(O)C=C1 ICYDRUIZSPKQOH-UHFFFAOYSA-N 0.000 description 4
- HCFAJYNVAYBARA-UHFFFAOYSA-N 4-heptanone Chemical compound CCCC(=O)CCC HCFAJYNVAYBARA-UHFFFAOYSA-N 0.000 description 4
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 4
- 239000004925 Acrylic resin Substances 0.000 description 4
- 229920000178 Acrylic resin Polymers 0.000 description 4
- NIQCNGHVCWTJSM-UHFFFAOYSA-N Dimethyl phthalate Chemical compound COC(=O)C1=CC=CC=C1C(=O)OC NIQCNGHVCWTJSM-UHFFFAOYSA-N 0.000 description 4
- RZKSECIXORKHQS-UHFFFAOYSA-N Heptan-3-ol Chemical compound CCCCC(O)CC RZKSECIXORKHQS-UHFFFAOYSA-N 0.000 description 4
- JKRZOJADNVOXPM-UHFFFAOYSA-N Oxalic acid dibutyl ester Chemical compound CCCCOC(=O)C(=O)OCCCC JKRZOJADNVOXPM-UHFFFAOYSA-N 0.000 description 4
- UEOFNBCUGJADBM-UHFFFAOYSA-N Trimethylaethergallussaeure-aethylester Natural products CCOC(=O)C1=CC(OC)=C(OC)C(OC)=C1 UEOFNBCUGJADBM-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- SBFLFRSXNYZPEH-YMKFFAQDSA-N [(2r)-3-[(2s)-3-[(2s)-2-butanoyloxy-3-[(2r)-2-hydroxy-3-[(2s)-3-[(2r)-3-hydroxy-2-pentanoyloxypropoxy]-2-propanoyloxypropoxy]propoxy]propoxy]-2-hydroxypropoxy]-2-hydroxypropyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)COC[C@H](O)COC[C@H](OC(=O)CCC)COC[C@H](O)COC[C@H](OC(=O)CC)COC[C@@H](CO)OC(=O)CCCC SBFLFRSXNYZPEH-YMKFFAQDSA-N 0.000 description 4
- 239000002518 antifoaming agent Substances 0.000 description 4
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 4
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 4
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 4
- NMJJFJNHVMGPGM-UHFFFAOYSA-N butyl formate Chemical compound CCCCOC=O NMJJFJNHVMGPGM-UHFFFAOYSA-N 0.000 description 4
- KBPLFHHGFOOTCA-UHFFFAOYSA-N caprylic alcohol Natural products CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 4
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 4
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 4
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 4
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 4
- 239000012738 dissolution medium Substances 0.000 description 4
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 4
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical group CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 4
- MVLVMROFTAUDAG-UHFFFAOYSA-N ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC MVLVMROFTAUDAG-UHFFFAOYSA-N 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 4
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 4
- XAOGXQMKWQFZEM-UHFFFAOYSA-N isoamyl propanoate Chemical compound CCC(=O)OCCC(C)C XAOGXQMKWQFZEM-UHFFFAOYSA-N 0.000 description 4
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 4
- KACHFMOHOPLTNX-UHFFFAOYSA-N methyl tri-O-methylgallate Natural products COC(=O)C1=CC(OC)=C(OC)C(OC)=C1 KACHFMOHOPLTNX-UHFFFAOYSA-N 0.000 description 4
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 4
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 4
- ZWRUINPWMLAQRD-UHFFFAOYSA-N nonan-1-ol Chemical compound CCCCCCCCCO ZWRUINPWMLAQRD-UHFFFAOYSA-N 0.000 description 4
- SJWFXCIHNDVPSH-UHFFFAOYSA-N octan-2-ol Chemical compound CCCCCCC(C)O SJWFXCIHNDVPSH-UHFFFAOYSA-N 0.000 description 4
- 229960005323 phenoxyethanol Drugs 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 125000003003 spiro group Chemical group 0.000 description 4
- MKSNYWIILLZWOY-UHFFFAOYSA-N 2-(4-phenylmethoxyphenyl)ethyl decanoate Chemical compound C1=CC(CCOC(=O)CCCCCCCCC)=CC=C1OCC1=CC=CC=C1 MKSNYWIILLZWOY-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QEQQAFXMPDXVSV-UHFFFAOYSA-N 4-[1,2,2,3,3,3-hexafluoro-1-(4-hydroxyphenyl)propyl]phenol Chemical compound C1=CC(O)=CC=C1C(F)(C(F)(F)C(F)(F)F)C1=CC=C(O)C=C1 QEQQAFXMPDXVSV-UHFFFAOYSA-N 0.000 description 3
- 108010053481 Antifreeze Proteins Proteins 0.000 description 3
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 3
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- 229920003082 Povidone K 90 Polymers 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- DMSMPAJRVJJAGA-UHFFFAOYSA-N benzo[d]isothiazol-3-one Chemical compound C1=CC=C2C(=O)NSC2=C1 DMSMPAJRVJJAGA-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000004927 clay Substances 0.000 description 3
- 239000006103 coloring component Substances 0.000 description 3
- 229940125904 compound 1 Drugs 0.000 description 3
- 229940125782 compound 2 Drugs 0.000 description 3
- 229940126214 compound 3 Drugs 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- YKFKEYKJGVSEIX-UHFFFAOYSA-N cyclohexanone, 4-(1,1-dimethylethyl)- Chemical compound CC(C)(C)C1CCC(=O)CC1 YKFKEYKJGVSEIX-UHFFFAOYSA-N 0.000 description 3
- 239000003712 decolorant Substances 0.000 description 3
- JBSLOWBPDRZSMB-FPLPWBNLSA-N dibutyl (z)-but-2-enedioate Chemical compound CCCCOC(=O)\C=C/C(=O)OCCCC JBSLOWBPDRZSMB-FPLPWBNLSA-N 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 229920000591 gum Polymers 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 3
- 150000002484 inorganic compounds Chemical class 0.000 description 3
- 229910010272 inorganic material Inorganic materials 0.000 description 3
- 150000002596 lactones Chemical group 0.000 description 3
- 239000005011 phenolic resin Substances 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 3
- 229920001187 thermosetting polymer Polymers 0.000 description 3
- XZZNDPSIHUTMOC-UHFFFAOYSA-N triphenyl phosphate Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)(=O)OC1=CC=CC=C1 XZZNDPSIHUTMOC-UHFFFAOYSA-N 0.000 description 3
- DCTMXCOHGKSXIZ-UHFFFAOYSA-N (R)-1,3-Octanediol Chemical compound CCCCCC(O)CCO DCTMXCOHGKSXIZ-UHFFFAOYSA-N 0.000 description 2
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 2
- RBACIKXCRWGCBB-UHFFFAOYSA-N 1,2-Epoxybutane Chemical compound CCC1CO1 RBACIKXCRWGCBB-UHFFFAOYSA-N 0.000 description 2
- QNLZIZAQLLYXTC-UHFFFAOYSA-N 1,2-dimethylnaphthalene Chemical compound C1=CC=CC2=C(C)C(C)=CC=C21 QNLZIZAQLLYXTC-UHFFFAOYSA-N 0.000 description 2
- LKUDPHPHKOZXCD-UHFFFAOYSA-N 1,3,5-trimethoxybenzene Chemical compound COC1=CC(OC)=CC(OC)=C1 LKUDPHPHKOZXCD-UHFFFAOYSA-N 0.000 description 2
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 2
- HFZLSTDPRQSZCQ-UHFFFAOYSA-N 1-pyrrolidin-3-ylpyrrolidine Chemical compound C1CCCN1C1CNCC1 HFZLSTDPRQSZCQ-UHFFFAOYSA-N 0.000 description 2
- PTTPXKJBFFKCEK-UHFFFAOYSA-N 2-Methyl-4-heptanone Chemical compound CC(C)CC(=O)CC(C)C PTTPXKJBFFKCEK-UHFFFAOYSA-N 0.000 description 2
- AFABGHUZZDYHJO-UHFFFAOYSA-N 2-Methylpentane Chemical compound CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 2
- TZYRSLHNPKPEFV-UHFFFAOYSA-N 2-ethyl-1-butanol Chemical compound CCC(CC)CO TZYRSLHNPKPEFV-UHFFFAOYSA-N 0.000 description 2
- UPGSWASWQBLSKZ-UHFFFAOYSA-N 2-hexoxyethanol Chemical compound CCCCCCOCCO UPGSWASWQBLSKZ-UHFFFAOYSA-N 0.000 description 2
- IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
- NDVWOBYBJYUSMF-UHFFFAOYSA-N 2-methylcyclohexan-1-ol Chemical compound CC1CCCCC1O NDVWOBYBJYUSMF-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- VAJVDSVGBWFCLW-UHFFFAOYSA-N 3-Phenyl-1-propanol Chemical compound OCCCC1=CC=CC=C1 VAJVDSVGBWFCLW-UHFFFAOYSA-N 0.000 description 2
- SVAPVDMWXJVISW-UHFFFAOYSA-N 3h-2-benzofuran-1-one;benzylbenzene Chemical class C1=CC=C2C(=O)OCC2=C1.C=1C=CC=CC=1CC1=CC=CC=C1 SVAPVDMWXJVISW-UHFFFAOYSA-N 0.000 description 2
- VGVHNLRUAMRIEW-UHFFFAOYSA-N 4-methylcyclohexan-1-one Chemical compound CC1CCC(=O)CC1 VGVHNLRUAMRIEW-UHFFFAOYSA-N 0.000 description 2
- GDWRKZLROIFUML-UHFFFAOYSA-N 4-phenylbutan-2-ol Chemical compound CC(O)CCC1=CC=CC=C1 GDWRKZLROIFUML-UHFFFAOYSA-N 0.000 description 2
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 2
- BQACOLQNOUYJCE-FYZZASKESA-N Abietic acid Natural products CC(C)C1=CC2=CC[C@]3(C)[C@](C)(CCC[C@@]3(C)C(=O)O)[C@H]2CC1 BQACOLQNOUYJCE-FYZZASKESA-N 0.000 description 2
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 2
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical group CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 2
- YYLLIJHXUHJATK-UHFFFAOYSA-N Cyclohexyl acetate Chemical compound CC(=O)OC1CCCCC1 YYLLIJHXUHJATK-UHFFFAOYSA-N 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Chemical group CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 2
- VIZORQUEIQEFRT-UHFFFAOYSA-N Diethyl adipate Chemical compound CCOC(=O)CCCCC(=O)OCC VIZORQUEIQEFRT-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- KBEBGUQPQBELIU-CMDGGOBGSA-N Ethyl cinnamate Chemical compound CCOC(=O)\C=C\C1=CC=CC=C1 KBEBGUQPQBELIU-CMDGGOBGSA-N 0.000 description 2
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- 229920004449 Halon® Polymers 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 2
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 2
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 2
- WRQNANDWMGAFTP-UHFFFAOYSA-N Methylacetoacetic acid Chemical compound COC(=O)CC(C)=O WRQNANDWMGAFTP-UHFFFAOYSA-N 0.000 description 2
- MODKMHXGCGKTLE-UHFFFAOYSA-N N-acetylphenylethylamine Chemical compound CC(=O)NCCC1=CC=CC=C1 MODKMHXGCGKTLE-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- PWATWSYOIIXYMA-UHFFFAOYSA-N Pentylbenzene Chemical compound CCCCCC1=CC=CC=C1 PWATWSYOIIXYMA-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- DCKVNWZUADLDEH-RXMQYKEDSA-N [(2r)-butan-2-yl] acetate Chemical compound CC[C@@H](C)OC(C)=O DCKVNWZUADLDEH-RXMQYKEDSA-N 0.000 description 2
- FVOVODNAQJCPAG-UHFFFAOYSA-N acetic acid hexyl acetate Chemical compound CC(O)=O.CCCCCCOC(C)=O FVOVODNAQJCPAG-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 2
- 239000012965 benzophenone Substances 0.000 description 2
- 229940007550 benzyl acetate Drugs 0.000 description 2
- 229960002903 benzyl benzoate Drugs 0.000 description 2
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 2
- ZFMQKOWCDKKBIF-UHFFFAOYSA-N bis(3,5-difluorophenyl)phosphane Chemical compound FC1=CC(F)=CC(PC=2C=C(F)C=C(F)C=2)=C1 ZFMQKOWCDKKBIF-UHFFFAOYSA-N 0.000 description 2
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- KBEBGUQPQBELIU-UHFFFAOYSA-N cinnamic acid ethyl ester Natural products CCOC(=O)C=CC1=CC=CC=C1 KBEBGUQPQBELIU-UHFFFAOYSA-N 0.000 description 2
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 description 2
- PCYQQSKDZQTOQG-NXEZZACHSA-N dibutyl (2r,3r)-2,3-dihydroxybutanedioate Chemical compound CCCCOC(=O)[C@H](O)[C@@H](O)C(=O)OCCCC PCYQQSKDZQTOQG-NXEZZACHSA-N 0.000 description 2
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 2
- YSAVZVORKRDODB-WDSKDSINSA-N diethyl tartrate Chemical compound CCOC(=O)[C@@H](O)[C@H](O)C(=O)OCC YSAVZVORKRDODB-WDSKDSINSA-N 0.000 description 2
- FBSAITBEAPNWJG-UHFFFAOYSA-N dimethyl phthalate Natural products CC(=O)OC1=CC=CC=C1OC(C)=O FBSAITBEAPNWJG-UHFFFAOYSA-N 0.000 description 2
- 229960001826 dimethylphthalate Drugs 0.000 description 2
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 2
- 239000001760 fusel oil Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 2
- 229940011051 isopropyl acetate Drugs 0.000 description 2
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- ONWPLBKWMAUFGZ-UHFFFAOYSA-N methyl 2-acetyloxybenzoate Chemical compound COC(=O)C1=CC=CC=C1OC(C)=O ONWPLBKWMAUFGZ-UHFFFAOYSA-N 0.000 description 2
- IMXBRVLCKXGWSS-UHFFFAOYSA-N methyl 2-cyclohexylacetate Chemical compound COC(=O)CC1CCCCC1 IMXBRVLCKXGWSS-UHFFFAOYSA-N 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 229940017219 methyl propionate Drugs 0.000 description 2
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methylcyclopentane Chemical compound CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 description 2
- VKCYHJWLYTUGCC-UHFFFAOYSA-N nonan-2-one Chemical compound CCCCCCCC(C)=O VKCYHJWLYTUGCC-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 2
- MOQRZWSWPNIGMP-UHFFFAOYSA-N pentyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCC MOQRZWSWPNIGMP-UHFFFAOYSA-N 0.000 description 2
- DLRJIFUOBPOJNS-UHFFFAOYSA-N phenetole Chemical compound CCOC1=CC=CC=C1 DLRJIFUOBPOJNS-UHFFFAOYSA-N 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 229940035044 sorbitan monolaurate Drugs 0.000 description 2
- 239000012749 thinning agent Substances 0.000 description 2
- 125000003944 tolyl group Chemical group 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- VARQGBHBYZTYLJ-UHFFFAOYSA-N tricosan-12-one Chemical compound CCCCCCCCCCCC(=O)CCCCCCCCCCC VARQGBHBYZTYLJ-UHFFFAOYSA-N 0.000 description 2
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 description 2
- HDDLVZWGOPWKFW-UHFFFAOYSA-N trimethyl 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound COC(=O)CC(O)(C(=O)OC)CC(=O)OC HDDLVZWGOPWKFW-UHFFFAOYSA-N 0.000 description 2
- KJIOQYGWTQBHNH-UHFFFAOYSA-N undecanol Chemical compound CCCCCCCCCCCO KJIOQYGWTQBHNH-UHFFFAOYSA-N 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- QODJHYBESCIPOG-UHFFFAOYSA-N (3-acetyl-5-acetyloxyphenyl) acetate Chemical compound CC(=O)OC1=CC(OC(C)=O)=CC(C(C)=O)=C1 QODJHYBESCIPOG-UHFFFAOYSA-N 0.000 description 1
- PAFJZWHXMSQJKV-UQZRNVAESA-N (3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol;octadecanoic acid Chemical compound OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O PAFJZWHXMSQJKV-UQZRNVAESA-N 0.000 description 1
- MISFQCBPASYYGV-UHFFFAOYSA-N (4-phenylphenyl) acetate Chemical group C1=CC(OC(=O)C)=CC=C1C1=CC=CC=C1 MISFQCBPASYYGV-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- HCNHNBLSNVSJTJ-UHFFFAOYSA-N 1,1-Bis(4-hydroxyphenyl)ethane Chemical compound C=1C=C(O)C=CC=1C(C)C1=CC=C(O)C=C1 HCNHNBLSNVSJTJ-UHFFFAOYSA-N 0.000 description 1
- MSAHTMIQULFMRG-UHFFFAOYSA-N 1,2-diphenyl-2-propan-2-yloxyethanone Chemical compound C=1C=CC=CC=1C(OC(C)C)C(=O)C1=CC=CC=C1 MSAHTMIQULFMRG-UHFFFAOYSA-N 0.000 description 1
- OTKCEEWUXHVZQI-UHFFFAOYSA-N 1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(=O)CC1=CC=CC=C1 OTKCEEWUXHVZQI-UHFFFAOYSA-N 0.000 description 1
- VWGNFIQXBYRDCH-UHFFFAOYSA-N 1,4-diethoxybenzene Chemical compound CCOC1=CC=C(OCC)C=C1 VWGNFIQXBYRDCH-UHFFFAOYSA-N 0.000 description 1
- WOFNMZNJGZJHJO-UHFFFAOYSA-N 1-(4-phenylphenyl)butan-1-one Chemical group C1=CC(C(=O)CCC)=CC=C1C1=CC=CC=C1 WOFNMZNJGZJHJO-UHFFFAOYSA-N 0.000 description 1
- MODAACUAXYPNJH-UHFFFAOYSA-N 1-(methoxymethyl)-4-[4-(methoxymethyl)phenyl]benzene Chemical group C1=CC(COC)=CC=C1C1=CC=C(COC)C=C1 MODAACUAXYPNJH-UHFFFAOYSA-N 0.000 description 1
- RMSGQZDGSZOJMU-UHFFFAOYSA-N 1-butyl-2-phenylbenzene Chemical group CCCCC1=CC=CC=C1C1=CC=CC=C1 RMSGQZDGSZOJMU-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- IBLKWZIFZMJLFL-UHFFFAOYSA-N 1-phenoxypropan-2-ol Chemical compound CC(O)COC1=CC=CC=C1 IBLKWZIFZMJLFL-UHFFFAOYSA-N 0.000 description 1
- LXUIUVLDNRQBQJ-UHFFFAOYSA-N 1-phenyltetradecan-1-one Chemical compound CCCCCCCCCCCCCC(=O)C1=CC=CC=C1 LXUIUVLDNRQBQJ-UHFFFAOYSA-N 0.000 description 1
- LRZBIPQJHILPJI-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-(2,3-dihydroxypropyl)octadecanoate Chemical compound CCCCCCCCCCCCCCCCC(CC(O)CO)C(=O)OCC(O)CO LRZBIPQJHILPJI-UHFFFAOYSA-N 0.000 description 1
- DINAZWYMBSZRQF-UHFFFAOYSA-N 2,3-dihydroxypropyl octadecanoate propane-1,2-diol Chemical compound CC(O)CO.CC(O)CO.CC(O)CO.CC(O)CO.CC(O)CO.CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO.CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO.CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO.CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO.CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO DINAZWYMBSZRQF-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- PWVUXRBUUYZMKM-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCO PWVUXRBUUYZMKM-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- ZUAURMBNZUCEAF-UHFFFAOYSA-N 2-(2-phenoxyethoxy)ethanol Chemical compound OCCOCCOC1=CC=CC=C1 ZUAURMBNZUCEAF-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- XSAYZAUNJMRRIR-UHFFFAOYSA-N 2-acetylnaphthalene Chemical compound C1=CC=CC2=CC(C(=O)C)=CC=C21 XSAYZAUNJMRRIR-UHFFFAOYSA-N 0.000 description 1
- XFDQLDNQZFOAFK-UHFFFAOYSA-N 2-benzoyloxyethyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCCOC(=O)C1=CC=CC=C1 XFDQLDNQZFOAFK-UHFFFAOYSA-N 0.000 description 1
- POYYYXPQBFPUKS-UHFFFAOYSA-N 2-butylcyclohexan-1-one Chemical compound CCCCC1CCCCC1=O POYYYXPQBFPUKS-UHFFFAOYSA-N 0.000 description 1
- KMNCBSZOIQAUFX-UHFFFAOYSA-N 2-ethoxy-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(OCC)C(=O)C1=CC=CC=C1 KMNCBSZOIQAUFX-UHFFFAOYSA-N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- ZPVFWPFBNIEHGJ-UHFFFAOYSA-N 2-octanone Chemical compound CCCCCCC(C)=O ZPVFWPFBNIEHGJ-UHFFFAOYSA-N 0.000 description 1
- CUZKCNWZBXLAJX-UHFFFAOYSA-N 2-phenylmethoxyethanol Chemical compound OCCOCC1=CC=CC=C1 CUZKCNWZBXLAJX-UHFFFAOYSA-N 0.000 description 1
- XZXFZILEZWXEND-UHFFFAOYSA-N 3',6'-bis(diethylamino)-2-(4-nitrophenyl)spiro[isoindole-3,9'-xanthene]-1-one Chemical compound C=1C(N(CC)CC)=CC=C2C=1OC1=CC(N(CC)CC)=CC=C1C2(C1=CC=CC=C1C1=O)N1C1=CC=C([N+]([O-])=O)C=C1 XZXFZILEZWXEND-UHFFFAOYSA-N 0.000 description 1
- GYWGQAIDMYGOLU-UHFFFAOYSA-N 3',6'-dihydroxy-5-nitrospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C2=CC=C([N+]([O-])=O)C=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GYWGQAIDMYGOLU-UHFFFAOYSA-N 0.000 description 1
- YMTYZTXUZLQUSF-UHFFFAOYSA-N 3,3'-Dimethylbisphenol A Chemical compound C1=C(O)C(C)=CC(C(C)(C)C=2C=C(C)C(O)=CC=2)=C1 YMTYZTXUZLQUSF-UHFFFAOYSA-N 0.000 description 1
- JZEPXWWZAJGALH-UHFFFAOYSA-N 3,3-bis(1-butyl-2-methylindol-3-yl)-2-benzofuran-1-one Chemical compound C1=CC=C2C(C3(C4=CC=CC=C4C(=O)O3)C3=C(C)N(C4=CC=CC=C43)CCCC)=C(C)N(CCCC)C2=C1 JZEPXWWZAJGALH-UHFFFAOYSA-N 0.000 description 1
- XBCTUDRVBSOUQD-UHFFFAOYSA-N 3-(1h-indol-2-yl)-3-phenyl-2-benzofuran-1-one Chemical class C12=CC=CC=C2C(=O)OC1(C=1NC2=CC=CC=C2C=1)C1=CC=CC=C1 XBCTUDRVBSOUQD-UHFFFAOYSA-N 0.000 description 1
- UYMBCDOGDVGEFA-UHFFFAOYSA-N 3-(1h-indol-2-yl)-3h-2-benzofuran-1-one Chemical compound C12=CC=CC=C2C(=O)OC1C1=CC2=CC=CC=C2N1 UYMBCDOGDVGEFA-UHFFFAOYSA-N 0.000 description 1
- WCFJUSRQHZPVKY-UHFFFAOYSA-N 3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)NCCC(O)=O WCFJUSRQHZPVKY-UHFFFAOYSA-N 0.000 description 1
- BJEMXPVDXFSROA-UHFFFAOYSA-N 3-butylbenzene-1,2-diol Chemical group CCCCC1=CC=CC(O)=C1O BJEMXPVDXFSROA-UHFFFAOYSA-N 0.000 description 1
- MKASXAGBWHIGCF-UHFFFAOYSA-N 3-methoxy-n-phenylaniline Chemical compound COC1=CC=CC(NC=2C=CC=CC=2)=C1 MKASXAGBWHIGCF-UHFFFAOYSA-N 0.000 description 1
- ZGZVGZCIFZBNCN-UHFFFAOYSA-N 4,4'-(2-Methylpropylidene)bisphenol Chemical compound C=1C=C(O)C=CC=1C(C(C)C)C1=CC=C(O)C=C1 ZGZVGZCIFZBNCN-UHFFFAOYSA-N 0.000 description 1
- VPWNQTHUCYMVMZ-UHFFFAOYSA-N 4,4'-sulfonyldiphenol Chemical compound C1=CC(O)=CC=C1S(=O)(=O)C1=CC=C(O)C=C1 VPWNQTHUCYMVMZ-UHFFFAOYSA-N 0.000 description 1
- VWGKEVWFBOUAND-UHFFFAOYSA-N 4,4'-thiodiphenol Chemical compound C1=CC(O)=CC=C1SC1=CC=C(O)C=C1 VWGKEVWFBOUAND-UHFFFAOYSA-N 0.000 description 1
- NYMQRLJHQHVCAD-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3,3-bis[2-[4-(dimethylamino)phenyl]-2-(4-methoxyphenyl)ethenyl]-2-benzofuran-1-one Chemical compound C1=CC(OC)=CC=C1C(C=1C=CC(=CC=1)N(C)C)=CC1(C=C(C=2C=CC(OC)=CC=2)C=2C=CC(=CC=2)N(C)C)C(C(Cl)=C(Cl)C(Cl)=C2Cl)=C2C(=O)O1 NYMQRLJHQHVCAD-UHFFFAOYSA-N 0.000 description 1
- GQHVWDKJTDUZRP-UHFFFAOYSA-N 4-(2-nitrobutyl)morpholine Chemical compound CCC([N+]([O-])=O)CN1CCOCC1 GQHVWDKJTDUZRP-UHFFFAOYSA-N 0.000 description 1
- OQIDYCVWAFZRTR-UHFFFAOYSA-N 4-(4-oxocyclohexyl)cyclohexan-1-one Chemical compound C1CC(=O)CCC1C1CCC(=O)CC1 OQIDYCVWAFZRTR-UHFFFAOYSA-N 0.000 description 1
- SRFHDEQOIMRMHH-UHFFFAOYSA-N 4-[1-(4-hydroxyphenyl)-3-methylbutyl]phenol Chemical compound C=1C=C(O)C=CC=1C(CC(C)C)C1=CC=C(O)C=C1 SRFHDEQOIMRMHH-UHFFFAOYSA-N 0.000 description 1
- YMZDMPPYBDUSMI-UHFFFAOYSA-N 4-[1-(4-hydroxyphenyl)dodecyl]phenol Chemical compound C=1C=C(O)C=CC=1C(CCCCCCCCCCC)C1=CC=C(O)C=C1 YMZDMPPYBDUSMI-UHFFFAOYSA-N 0.000 description 1
- CZCLTCVIZZPPBW-UHFFFAOYSA-N 4-[1-(4-hydroxyphenyl)heptyl]phenol Chemical compound C=1C=C(O)C=CC=1C(CCCCCC)C1=CC=C(O)C=C1 CZCLTCVIZZPPBW-UHFFFAOYSA-N 0.000 description 1
- WKGVDZYQWLBSQC-UHFFFAOYSA-N 4-[1-(4-hydroxyphenyl)hexyl]phenol Chemical compound C=1C=C(O)C=CC=1C(CCCCC)C1=CC=C(O)C=C1 WKGVDZYQWLBSQC-UHFFFAOYSA-N 0.000 description 1
- OUKOUEHLRVEKCJ-UHFFFAOYSA-N 4-[1-(4-hydroxyphenyl)nonyl]phenol Chemical compound C=1C=C(O)C=CC=1C(CCCCCCCC)C1=CC=C(O)C=C1 OUKOUEHLRVEKCJ-UHFFFAOYSA-N 0.000 description 1
- NBKVULRGDSYCGP-UHFFFAOYSA-N 4-[1-(4-hydroxyphenyl)octyl]phenol Chemical compound C=1C=C(O)C=CC=1C(CCCCCCC)C1=CC=C(O)C=C1 NBKVULRGDSYCGP-UHFFFAOYSA-N 0.000 description 1
- VHLLJTHDWPAQEM-UHFFFAOYSA-N 4-[2-(4-hydroxyphenyl)-4-methylpentan-2-yl]phenol Chemical compound C=1C=C(O)C=CC=1C(C)(CC(C)C)C1=CC=C(O)C=C1 VHLLJTHDWPAQEM-UHFFFAOYSA-N 0.000 description 1
- KBWOAGGPYKQCAO-UHFFFAOYSA-N 4-[2-(4-hydroxyphenyl)nonan-2-yl]phenol Chemical compound C=1C=C(O)C=CC=1C(C)(CCCCCCC)C1=CC=C(O)C=C1 KBWOAGGPYKQCAO-UHFFFAOYSA-N 0.000 description 1
- SMIOEQSLJNNKQF-UHFFFAOYSA-N 4-acetoxy acetophenone Chemical compound CC(=O)OC1=CC=C(C(C)=O)C=C1 SMIOEQSLJNNKQF-UHFFFAOYSA-N 0.000 description 1
- CYMPUOGZUXAIMY-UHFFFAOYSA-N 4-methoxy-2-methyl-n-phenylaniline Chemical compound CC1=CC(OC)=CC=C1NC1=CC=CC=C1 CYMPUOGZUXAIMY-UHFFFAOYSA-N 0.000 description 1
- KNDDEFBFJLKPFE-UHFFFAOYSA-N 4-n-Heptylphenol Chemical compound CCCCCCCC1=CC=C(O)C=C1 KNDDEFBFJLKPFE-UHFFFAOYSA-N 0.000 description 1
- YOAWSYSKQHLFPM-UHFFFAOYSA-N 5-amino-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(N)C=C21 YOAWSYSKQHLFPM-UHFFFAOYSA-N 0.000 description 1
- GZAJOEGTZDUSKS-UHFFFAOYSA-N 5-aminofluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C21OC(=O)C1=CC(N)=CC=C21 GZAJOEGTZDUSKS-UHFFFAOYSA-N 0.000 description 1
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- MNALUTYMBUBKNX-UHFFFAOYSA-N 6-methoxy-3,4-dihydro-2h-naphthalen-1-one Chemical compound O=C1CCCC2=CC(OC)=CC=C21 MNALUTYMBUBKNX-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- IRYRPJDQYKZBOL-UHFFFAOYSA-N 7-[4-(diethylamino)-2-methylphenyl]-7-(1-ethylindol-3-yl)furo[3,4-b]pyridin-5-one Chemical compound O=C1OC(C2=C1C=CC=N2)(C=1C2=CC=CC=C2N(C=1)CC)C1=CC=C(N(CC)CC)C=C1C IRYRPJDQYKZBOL-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- VOWWYDCFAISREI-UHFFFAOYSA-N Bisphenol AP Chemical compound C=1C=C(O)C=CC=1C(C=1C=CC(O)=CC=1)(C)C1=CC=CC=C1 VOWWYDCFAISREI-UHFFFAOYSA-N 0.000 description 1
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 1
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 1
- OQQFDTRYSFLKQY-UHFFFAOYSA-N C(C)(=O)OCC(CCCC)CC.P(=O)(OCC)(OCC)OCC Chemical compound C(C)(=O)OCC(CCCC)CC.P(=O)(OCC)(OCC)OCC OQQFDTRYSFLKQY-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- IPAJDLMMTVZVPP-UHFFFAOYSA-N Crystal violet lactone Chemical compound C1=CC(N(C)C)=CC=C1C1(C=2C=CC(=CC=2)N(C)C)C2=CC=C(N(C)C)C=C2C(=O)O1 IPAJDLMMTVZVPP-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- VOWAEIGWURALJQ-UHFFFAOYSA-N Dicyclohexyl phthalate Chemical compound C=1C=CC=C(C(=O)OC2CCCCC2)C=1C(=O)OC1CCCCC1 VOWAEIGWURALJQ-UHFFFAOYSA-N 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- NQSMEZJWJJVYOI-UHFFFAOYSA-N Methyl 2-benzoylbenzoate Chemical compound COC(=O)C1=CC=CC=C1C(=O)C1=CC=CC=C1 NQSMEZJWJJVYOI-UHFFFAOYSA-N 0.000 description 1
- HMGAHRPPRPQDAS-UHFFFAOYSA-N Methyl-n-heneikosyl-keton Natural products CCCCCCCCCCCCCCCCCCCCCC(C)=O HMGAHRPPRPQDAS-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229940126902 Phlorizin Drugs 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- CDJJKTLOZJAGIZ-UHFFFAOYSA-N Tolylacetate Chemical compound CC(=O)OC1=CC=C(C)C=C1 CDJJKTLOZJAGIZ-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical class CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 229920002310 Welan gum Polymers 0.000 description 1
- KYCAEIXHUXBNTQ-UHFFFAOYSA-N [2-(4-methoxyphenyl)acetyl] 2-(4-methoxyphenyl)acetate Chemical compound C1=CC(OC)=CC=C1CC(=O)OC(=O)CC1=CC=C(OC)C=C1 KYCAEIXHUXBNTQ-UHFFFAOYSA-N 0.000 description 1
- OCKWAZCWKSMKNC-UHFFFAOYSA-N [3-octadecanoyloxy-2,2-bis(octadecanoyloxymethyl)propyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC OCKWAZCWKSMKNC-UHFFFAOYSA-N 0.000 description 1
- NSNHONPMCQYMNT-UHFFFAOYSA-N [4-[2-(4-acetyloxyphenyl)propan-2-yl]phenyl] acetate Chemical compound C1=CC(OC(=O)C)=CC=C1C(C)(C)C1=CC=C(OC(C)=O)C=C1 NSNHONPMCQYMNT-UHFFFAOYSA-N 0.000 description 1
- XDILZEPJCPEDLT-UHFFFAOYSA-N [Na].[O-][N+]1=CC=CC=C1S Chemical compound [Na].[O-][N+]1=CC=CC=C1S XDILZEPJCPEDLT-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DYRDKSSFIWVSNM-UHFFFAOYSA-N acetoacetanilide Chemical compound CC(=O)CC(=O)NC1=CC=CC=C1 DYRDKSSFIWVSNM-UHFFFAOYSA-N 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 229920000180 alkyd Polymers 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000012874 anionic emulsifier Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- MJSHDCCLFGOEIK-UHFFFAOYSA-N benzyl (2,5-dioxopyrrolidin-1-yl) carbonate Chemical compound O=C1CCC(=O)N1OC(=O)OCC1=CC=CC=C1 MJSHDCCLFGOEIK-UHFFFAOYSA-N 0.000 description 1
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 1
- ZFVMWEVVKGLCIJ-UHFFFAOYSA-N bisphenol AF Chemical compound C1=CC(O)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(O)C=C1 ZFVMWEVVKGLCIJ-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- VXIVSQZSERGHQP-UHFFFAOYSA-N chloroacetamide Chemical compound NC(=O)CCl VXIVSQZSERGHQP-UHFFFAOYSA-N 0.000 description 1
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 1
- 229920006026 co-polymeric resin Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- BMFYCFSWWDXEPB-UHFFFAOYSA-N cyclohexyl(phenyl)methanone Chemical compound C=1C=CC=CC=1C(=O)C1CCCCC1 BMFYCFSWWDXEPB-UHFFFAOYSA-N 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- GDVKFRBCXAPAQJ-UHFFFAOYSA-A dialuminum;hexamagnesium;carbonate;hexadecahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-]C([O-])=O GDVKFRBCXAPAQJ-UHFFFAOYSA-A 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- ROORDVPLFPIABK-UHFFFAOYSA-N diphenyl carbonate Chemical compound C=1C=CC=CC=1OC(=O)OC1=CC=CC=C1 ROORDVPLFPIABK-UHFFFAOYSA-N 0.000 description 1
- DWNAQMUDCDVSLT-UHFFFAOYSA-N diphenyl phthalate Chemical compound C=1C=CC=C(C(=O)OC=2C=CC=CC=2)C=1C(=O)OC1=CC=CC=C1 DWNAQMUDCDVSLT-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- KWKXNDCHNDYVRT-UHFFFAOYSA-N dodecylbenzene Chemical compound CCCCCCCCCCCCC1=CC=CC=C1 KWKXNDCHNDYVRT-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- VRHAQNTWKSVEEC-UHFFFAOYSA-N ethyl 1,3-dioxoisoindole-2-carboxylate Chemical compound C1=CC=C2C(=O)N(C(=O)OCC)C(=O)C2=C1 VRHAQNTWKSVEEC-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- HKTSLDUAGCAISP-UHFFFAOYSA-N ethyl n,n-diphenylcarbamate Chemical compound C=1C=CC=CC=1N(C(=O)OCC)C1=CC=CC=C1 HKTSLDUAGCAISP-UHFFFAOYSA-N 0.000 description 1
- 229940105994 ethylhexyl acetate Drugs 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- RPOCFUQMSVZQLH-UHFFFAOYSA-N furan-2,5-dione;2-methylprop-1-ene Chemical compound CC(C)=C.O=C1OC(=O)C=C1 RPOCFUQMSVZQLH-UHFFFAOYSA-N 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010985 glycerol esters of wood rosin Nutrition 0.000 description 1
- 229940074045 glyceryl distearate Drugs 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 229940100242 glycol stearate Drugs 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229910001701 hydrotalcite Inorganic materials 0.000 description 1
- 229960001545 hydrotalcite Drugs 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- IUSBVFZKQJGVEP-SNAWJCMRSA-N isoeugenol acetate Chemical compound COC1=CC(\C=C\C)=CC=C1OC(C)=O IUSBVFZKQJGVEP-SNAWJCMRSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- AORIUCNKPVHMTN-UHFFFAOYSA-N methyl 2,2-diphenylacetate Chemical compound C=1C=CC=CC=1C(C(=O)OC)C1=CC=CC=C1 AORIUCNKPVHMTN-UHFFFAOYSA-N 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- SQRTWLGWCOJOTO-UHFFFAOYSA-N n-(2-ethoxyphenyl)acetamide Chemical compound CCOC1=CC=CC=C1NC(C)=O SQRTWLGWCOJOTO-UHFFFAOYSA-N 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- LYSJUAWWUBVYCB-UHFFFAOYSA-N n-phenyltetradecanamide Chemical compound CCCCCCCCCCCCCC(=O)NC1=CC=CC=C1 LYSJUAWWUBVYCB-UHFFFAOYSA-N 0.000 description 1
- 239000012875 nonionic emulsifier Substances 0.000 description 1
- 229920003986 novolac Polymers 0.000 description 1
- 239000010680 novolac-type phenolic resin Substances 0.000 description 1
- RIKCMEDSBFQFAL-UHFFFAOYSA-N octyl 4-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=C(O)C=C1 RIKCMEDSBFQFAL-UHFFFAOYSA-N 0.000 description 1
- 235000010292 orthophenyl phenol Nutrition 0.000 description 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- FCJSHPDYVMKCHI-UHFFFAOYSA-N phenyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OC1=CC=CC=C1 FCJSHPDYVMKCHI-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- IOUVKUPGCMBWBT-UHFFFAOYSA-N phloridzosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-UHFFFAOYSA-N 0.000 description 1
- IOUVKUPGCMBWBT-GHRYLNIYSA-N phlorizin Chemical compound O[C@@H]1[C@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-GHRYLNIYSA-N 0.000 description 1
- 235000019139 phlorizin Nutrition 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920006122 polyamide resin Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229940051841 polyoxyethylene ether Drugs 0.000 description 1
- 229920000056 polyoxyethylene ether Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- FKRCODPIKNYEAC-UHFFFAOYSA-N propionic acid ethyl ester Natural products CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- DCBSHORRWZKAKO-UHFFFAOYSA-N rac-1-monomyristoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(O)CO DCBSHORRWZKAKO-UHFFFAOYSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229960000414 sodium fluoride Drugs 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 1
- 229920005992 thermoplastic resin Polymers 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- 229920006337 unsaturated polyester resin Polymers 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D11/00—Inks
- C09D11/16—Writing inks
- C09D11/17—Writing inks characterised by colouring agents
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D11/00—Inks
- C09D11/16—Writing inks
- C09D11/18—Writing inks specially adapted for ball-point writing instruments
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
Description
本発明は、ロイコ染料の顕色性能及び消色性能を応用した消色又は変色するインキ組成物に関する。 The present invention relates to an ink composition that is decolored or discolored by applying the color developing performance and decoloring performance of a leuco dye.
従来、ロイコ染料の顕色性能、消色性能を応用した感熱性の消色性インキ組成物が知られている。
これは電子供与体であるロイコ染料と、電子受容体である顕色剤と、消色剤とよりなり、これらの相互作用によって発色、消色することを利用したものである。ロイコ染料に顕色剤が作用することにより発色する。
特許文献1には、擦過等の熱で融解してロイコ染料や顕色剤を溶解する溶解媒体を消色剤とし、この消色剤をロイコ染料と顕色剤と共にカプセル内に内包しマイクロカプセル顔料として使用する消去性インキが開示されている。この消色性インキは、筆跡に擦過の摩擦熱などを付与してマイクロカプセル顔料に熱を加えると消色剤が融解してロイコ染料や顕色剤を溶解させ、溶解媒体が顕色剤に作用することにより、顕色剤のロイコ染料に対する顕色効果がなくなり、筆跡が消色状態となるものである。
また、特許文献1には、消色時の溶解状態の消色剤と顕色剤との溶液の凝固点を比較的低いものとして融解状態の幅(熱的ヒステリシス)を調整し、擦過による熱(64℃)で消色した筆跡が再発色する温度を−18℃以下の温度とし、それ以上の温度環境では再発色しないようにした事も記載されている。2. Description of the Related Art Conventionally, heat-sensitive decolorizable ink compositions using the leuco dye developing and decoloring performances are known.
This is made up of a leuco dye as an electron donor, a developer as an electron acceptor, and a decoloring agent, and utilizes color development and decoloring by their interaction. Color develops when the developer acts on the leuco dye.
In Patent Document 1, a dissolution medium that melts by heat such as rubbing to dissolve a leuco dye or a developer is used as a decolorizer, and the decolorizer is encapsulated in a capsule together with the leuco dye and the developer. An erasable ink for use as a pigment is disclosed. In this decolorizable ink, when friction is applied to the handwriting and heat is applied to the microcapsule pigment, the decolorizer melts and dissolves the leuco dye or developer, and the dissolution medium becomes the developer. By acting, the color developing effect of the developer on the leuco dye is lost, and the handwriting is in a decolored state.
Patent Document 1 discloses that the melting point width (thermal hysteresis) is adjusted by setting the freezing point of the solution of the decoloring agent and the developer in the dissolved state at the time of decoloring to be relatively low, and heat generated by rubbing ( It is also described that the temperature at which the handwritten color erased at 64 ° C. is recolored is set to a temperature of −18 ° C. or lower and the color is not regenerated in a temperature environment higher than that.
特許文献1に記載の消去性インキ組成物は、ロイコ染料と顕色剤の溶解媒体である消色剤の熱的ヒステリシス幅によって発色、消色状態をコントロールしている。熱的ヒステリシスを持たせるためには、分子量の高い無置換芳香族環を含むカルボン酸と炭素数10以上の脂肪族アルコールのエステルや、炭素数9以上の奇数脂肪族一価アルコールと炭素数が偶数の脂肪族カルボン酸から得られる脂肪族エステルなどを使用する必要がある。一般的に溶媒の分子量が高くなると溶解性能が低下する傾向があり、顕色剤を溶解させるためには多量の溶媒が必要となる。
具体的には、ジフェニルメタンフタリド類やフェニルインドリルフタリド類などが使用されており、構成成分の好ましい割合として、ロイコ染料:顕色剤:溶解媒体=1:0.5〜20:5〜200の比率にすることで上記性能を出している。結果として、相対的にロイコ染料濃度を高くすることができなく、着色成分の割合が少ないインキにならざるを得ない。更に、マイクロカプセル顔料としていることから、ロイコ染料の発色はマイクロカプセル皮膜を通して見えるため、マイクロカプセル顔料としての発色は弱くなり、その筆跡は必然的に薄くなってしまうという問題があった。The erasable ink composition described in Patent Document 1 controls the color development and color erasure state by the thermal hysteresis width of the color erasing agent that is a dissolution medium of the leuco dye and the developer. In order to have thermal hysteresis, a carboxylic acid containing an unsubstituted aromatic ring having a high molecular weight and an ester of an aliphatic alcohol having 10 or more carbon atoms, an odd aliphatic monohydric alcohol having 9 or more carbon atoms and a carbon number are used. It is necessary to use aliphatic esters obtained from even-numbered aliphatic carboxylic acids. Generally, as the molecular weight of the solvent increases, the dissolution performance tends to decrease, and a large amount of solvent is required to dissolve the developer.
Specifically, diphenylmethane phthalides, phenyl indolyl phthalides, and the like are used, and a preferable ratio of the constituent components is leuco dye: developer: dissolution medium = 1: 0.5 to 20: 5. The above performance is achieved by setting the ratio to 200. As a result, the leuco dye concentration cannot be relatively increased, and the ink has to have a small proportion of coloring components. Furthermore, since the color of the leuco dye can be seen through the microcapsule film because it is a microcapsule pigment, the color development as a microcapsule pigment becomes weak and the handwriting is inevitably thinned.
本発明は、エステル基、ケトン基、エーテル基及び脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を少なくとも有する物質の液状物を少なくとも内包するマイクロカプセルと、ロイコ染料と、顕色剤と、インキ液媒体とを少なくとも含有する消去可能なインキ組成物を第1の要旨とする。
前記液状物の沸点が250℃以上である消去可能なインキ組成物を第2の要旨とする。
前記液状物が、エステル基、ケトン基、エーテル基及び脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を有する固体の溶解液である消去可能なインキ組成物を第3の要旨とする。
前記エステル基、ケトン基、エーテル基及び脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を有する固体が非晶質である消去可能なインキ組成物を第4の要旨とする。
前記マイクロカプセルの平均粒子径が1〜10μmである消去可能なインキ組成物を第5の要旨とする。The present invention relates to a microcapsule that contains at least a liquid material of a substance having at least one or two or more functional groups selected from an ester group, a ketone group, an ether group, and an aliphatic hydroxyl group, a leuco dye, and a developer. And an erasable ink composition containing at least an ink liquid medium.
The second gist is an erasable ink composition having a boiling point of 250 ° C. or higher.
A third gist is an erasable ink composition in which the liquid is a solid solution having one or more functional groups selected from an ester group, a ketone group, an ether group and an aliphatic hydroxyl group. .
A fourth gist is an erasable ink composition in which a solid having one or more functional groups selected from the ester group, ketone group, ether group and aliphatic hydroxyl group is amorphous.
A erasable ink composition having an average particle diameter of 1 to 10 μm of the microcapsules is a fifth gist.
本発明の消去可能なインキ組成物にて書いた筆跡などに、マイクロカプセルの強度以上の力が加わるとマイクロカプセルが破壊され、内包された消色液剤であるエステル基、ケトン基、エーテル基及び脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を少なくとも有する液状物がしみ出す。エステル基、ケトン基、エーテル基、脂肪族水酸基は、いずれも電子密度が高くなった酸素原子を有し、顕色剤からの電子空孔を有するH+を引きつける。その結果顕色剤の電子受容効果がなくなり、ロイコ染料のラクトン環、ピリジン環、キナゾリン環、ビスキナゾリン環等が閉環し消色状態となる。
本発明のインキ組成物は、消色液剤を、マイクロカプセルに内包させてロイコ染料や顕色剤と隔離することで、ロイコ染料と顕色剤を直接にインキの液媒体に溶解、またはロイコ染料と顕色剤を顔料化させたものを液媒体に分散できるので、着色成分を高濃度に配合でき発色が良い筆跡を形成できる。The handwriting written with the erasable ink composition of the present invention, when a force greater than the strength of the microcapsule is applied, the microcapsule is destroyed, and the ester group, ketone group, ether group, A liquid material having at least one or two or more functional groups selected from aliphatic hydroxyl groups exudes. Each of the ester group, ketone group, ether group and aliphatic hydroxyl group has an oxygen atom with an increased electron density, and attracts H + having electron vacancies from the developer. As a result, the electron acceptor effect of the developer is lost, and the lactone ring, pyridine ring, quinazoline ring, bisquinazoline ring, etc. of the leuco dye are closed and decolored.
In the ink composition of the present invention, the decolorizing liquid is encapsulated in a microcapsule and separated from the leuco dye or developer, so that the leuco dye and the developer are directly dissolved in the ink liquid medium, or the leuco dye. Since the developer obtained by pigmentizing the developer can be dispersed in the liquid medium, the coloring component can be blended at a high concentration, and a handwriting with good color can be formed.
また、マイクロカプセルに内包される、エステル基、ケトン基、エーテル基、脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を少なくとも有する液状物の沸点が250℃以上である場合、すぐには揮発せずに筆跡上に留まるので顕色剤に作用し続け消色状態が維持される。 In addition, when the boiling point of the liquid substance having at least one or two or more functional groups selected from an ester group, a ketone group, an ether group and an aliphatic hydroxyl group included in the microcapsule is 250 ° C. or higher, immediately Since it does not volatilize and remains on the handwriting, it continues to act on the developer and the decolored state is maintained.
また、マイクロカプセルに内包される、エステル基、ケトン基、エーテル基、脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を少なくとも有する液状物が、エステル基、ケトン基、エーテル基、脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を有する固体の溶解液であると、この固体の溶媒が蒸発すると、溶質であるエステル基、ケトン基、エーテル基、脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を有する固体が分子レベルで顕色剤からのH+を引きつけた状態を維持したままに固化するため、再発色しにくく、確実に消色状態が維持される。In addition, a liquid substance having at least one or two or more functional groups selected from an ester group, a ketone group, an ether group, and an aliphatic hydroxyl group included in the microcapsule is an ester group, a ketone group, an ether group, a fatty acid. In the case of a solid solution having one or more functional groups selected from an aromatic group, when the solid solvent evaporates, the solvent is selected from an ester group, a ketone group, an ether group, and an aliphatic hydroxyl group. Since the solid having one or more functional groups is solidified while maintaining the state attracting H + from the developer at the molecular level, it is difficult to recolor, and the decolored state is reliably maintained. .
この時、エステル基、ケトン基、エーテル基、脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を有する固体が結晶質の場合は、原子・分子などの配列に規則性があり、溶解していたものが再び固化する時規則性のある配列に戻るが、H+等の不純物が混ざったものが固化すると規則的な配列が取れず非晶質となり、H+を引きつけたまま固化するので消色状態が維持されるものと推察される。但し、一部はH+を放し、規則性のある配列に戻ってしまう。この固体が非晶質の場合は、原子・分子などの配列に規則性がなく、溶解時に結びついたH+を分子内に閉じこめたまま固化するので、H+を再放出せず、より確実に消色状態が維持される。At this time, when the solid having one or more functional groups selected from an ester group, a ketone group, an ether group, and an aliphatic hydroxyl group is crystalline, the arrangement of atoms and molecules is regular and dissolved. When it solidifies again, it returns to a regular arrangement, but when a mixture of impurities such as H + is solidified, it does not take a regular arrangement and becomes amorphous and solidifies while attracting H +. Therefore, it is assumed that the decolored state is maintained. However, some release H + and return to a regular array. When this solid is amorphous, the arrangement of atoms and molecules is not regular, and H + that is bound at the time of dissolution is solidified while confined in the molecule, so that H + is not released again and more reliably. The decolored state is maintained.
また、マイクロカプセルの平均粒子径1〜10μmとすることで、マイクロカプセルが紙の繊維中に埋没したり適度な力で破壊させ、内包物を放出させることができ、ボールペンに使用した場合などの筆圧では消去されない筆跡を形成することができる。 In addition, by setting the average particle diameter of the microcapsules to 1 to 10 μm, the microcapsules can be embedded in paper fibers or destroyed with an appropriate force to release the inclusions. Handwriting that cannot be erased by writing pressure can be formed.
本発明の消去性インキ組成物は、電子供与体であるロイコ染料と、電子受容体である顕色剤の双方が溶解状態であることで作用し発色する。
また、消色のためには、顕色剤からのH+をエステル基、ケトン基、エーテル基、脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を少なくとも有する液状物が引きつける必要があり、そのためには顕色剤と、エステル基、ケトン基、エーテル基、脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を少なくとも有する物質との双方が溶液状態で作用しなければならないので、インキ組成物の液媒体を、顕色剤を溶解するものを採用するか、またはマイクロカプセル内包されている液体のいずれか、即ち、エステル基、ケトン基、エーテル基、脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を少なくとも有する有機溶剤、又は、エステル基、ケトン基、エーテル基、脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を少なくとも有する固体を溶解する液体、又は、エステル基、ケトン基、エーテル基、脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を少なくとも有する固体の溶解液、又は、マイクロカプセルに内包され得るその他の液体のいずれかに、顕色剤を溶解する液体を採用する必要がある。The erasable ink composition of the present invention acts and develops color when both the leuco dye as the electron donor and the developer as the electron acceptor are in a dissolved state.
For decoloring, it is necessary to attract H + from the developer to a liquid material having at least one or more functional groups selected from an ester group, a ketone group, an ether group, and an aliphatic hydroxyl group. For this purpose, both the developer and the substance having at least one or two or more functional groups selected from an ester group, a ketone group, an ether group and an aliphatic hydroxyl group must act in a solution state. Therefore, the liquid medium of the ink composition is either selected from those that dissolve the developer or the liquid encapsulated in the microcapsules, that is, an ester group, a ketone group, an ether group, and an aliphatic hydroxyl group. Organic solvent having at least one or two or more functional groups, or one or more selected from ester groups, ketone groups, ether groups and aliphatic hydroxyl groups A liquid that dissolves a solid having at least one functional group, or a solid solution having at least one or two or more functional groups selected from an ester group, a ketone group, an ether group, and an aliphatic hydroxyl group, or a microcapsule It is necessary to employ a liquid that dissolves the developer in any of the other liquids that can be encapsulated.
マイクロカプセルは芯物質(マイクロカプセルに内包する液体)をホモジナイザー、高圧ホモジナイザー、マグネチックスターラーなどで乳化させエマルション状態にし、その後マグネチックスターラーやスリーワンモーターを使用し皮膜を形成して得られる。多くはほぼ球形となるが、円盤状または不整形状のものであっても良い。
芯物質の乳化には、従来知られている乳化剤が使用できる。具体的には、非イオン性乳化剤として、プロピレングリコール脂肪酸エステル、グリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンソルビット脂肪酸エステル、ポリオキシエチレンアルキルフェニル脂肪酸エステル、ポリオキシエチレンヒマシ油、ポリオキシエチレンステロール、ポリエチレングリコール脂肪酸エステル、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンポリオキシプロピレンアルキルエーテル、ポリビニルアルコールなどが挙げられる。陰イオン性乳化剤として、ポリオキシエチレンアルキルエーテルリン酸塩、ソルビタンモノラウレート、ソルビタンモノラウレートポリオキシエチレンエーテル、アクリル樹脂、スチレンマレイン酸樹脂、イソブチレン無水マレイン酸樹脂などが挙げられる。陽イオン性の乳化剤として、ポリオキシエチレンアルキルアミン、ポリオキシエチレン脂肪酸アミドなどが挙げられる。尚、マイクロカプセルの外郭を形成する材料として、後述するメラミン樹脂や尿素樹脂を使用する際は、少なくともカルボキシル基を有するアクリル樹脂やスチレン−マレイン酸樹脂などの乳化剤を使用する。これは油滴化した消色液表面にメチロール化されたメラミンや尿素が乳化剤のカルボキシル基に酸アミド結合によりマイクロカプセル皮膜を形成していくためである。
マイクロカプセルの外郭を形成する材料としては、熱硬化性樹脂としてウレタン樹脂、メラミン樹脂、ユリア樹脂、エポキシ樹脂、フェノール樹脂、不飽和ポリエステル樹脂、熱可塑性樹脂としてポリイミド、ポリアミドなどが挙げられる。熱硬化性樹脂は硬いが脆いという性質があり、マイクロカプセルの強度以上の力が掛かると直ちに壊れ、内包物を放出させることができるので、筆跡を確実に消去できる。
筆跡の消去したい部分を消去具などで力を加えマイクロカプセルを破壊して使用するので、マイクロカプセルの平均粒子径は1〜10μmが好ましい。これは、1μm未満ではマイクロカプセルが紙の繊維の中に埋没して、消去時に破壊しにくくなってしまったり、10μmを超えると跡を指などで擦っただけで壊れて筆跡が消去されてしまう懸念があるためである。
また、水中で製造されるマイクロカプセルをベンジルアルコールやエチレングリコールモノフェニルエーテルを主溶剤とする油性ボールペンなどに使用する場合、マイクロカプセルを乾燥させこれらの溶剤に分散させる必要がある。その際、水とベンジルアルコールやフェニルグリコールなどのインキの溶剤双方に可溶なポリビニルピロリドン(PVP)やグリセリンなどの高沸点溶剤をマイクロカプセル分散液に添加し乾燥させることにより、ポリビニルピロリドンやグリセリンでコートされたマイクロカプセルができる。これは乾燥したマイクロカプセルの塊をベンジルアルコールやエチレングリコールモノフェニルエーテルなどの溶剤に弱い力でほぐすことができ、皮膜強度の弱いマイクロカプセルでも壊れずにインキ中に分散できるので好ましい。
更に、本発明の消去性インキ組成物をボールペンに使用した場合は、平均粒子径は1〜10μmで、且つ、粒子径15μm以上の粒子がインキ組成物中に配合されるマイクロカプセル全個数の10個数%未満であることが好ましい。これは、ボールペン内でのインキ組成物の通路には数十ミクロンの隙間があり、十分に吐出させることができる。また、紙の繊維には数ミクロン〜十ミクロン程度の凹凸があり、筆記時にマイクロカプセルはここに入り込むため、筆記時に筆圧などの力がかかってもマイクロカプセルには大きな力が掛かり難く破壊されにくい。しかし、15μm以上の粒子は筆記時に紙とボールペンのボールとの間で壊れ、筆跡が薄くなってしまう懸念があるためである。A microcapsule is obtained by emulsifying a core material (liquid contained in a microcapsule) with a homogenizer, a high-pressure homogenizer, a magnetic stirrer, etc., and then forming a film using a magnetic stirrer or a three-one motor. Many are substantially spherical, but may be disk-shaped or irregularly shaped.
A conventionally known emulsifier can be used for emulsification of the core substance. Specifically, as a nonionic emulsifier, propylene glycol fatty acid ester, glycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene sorbit fatty acid ester, polyoxyethylene alkylphenyl Examples include fatty acid ester, polyoxyethylene castor oil, polyoxyethylene sterol, polyethylene glycol fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene polyoxypropylene alkyl ether, and polyvinyl alcohol. Examples of the anionic emulsifier include polyoxyethylene alkyl ether phosphate, sorbitan monolaurate, sorbitan monolaurate polyoxyethylene ether, acrylic resin, styrene maleic acid resin, and isobutylene maleic anhydride resin. Examples of the cationic emulsifier include polyoxyethylene alkylamine and polyoxyethylene fatty acid amide. In addition, when using the melamine resin and urea resin mentioned later as a material which forms the outline of a microcapsule, emulsifiers, such as an acrylic resin and styrene-maleic acid resin which have at least a carboxyl group, are used. This is because melamine or urea methylated on the surface of the decolored liquid that has become oil droplets forms a microcapsule film by an acid amide bond to the carboxyl group of the emulsifier.
Examples of the material forming the outline of the microcapsule include urethane resin, melamine resin, urea resin, epoxy resin, phenol resin, unsaturated polyester resin as thermosetting resin, and polyimide, polyamide and the like as thermoplastic resin. The thermosetting resin has a property of being hard but brittle. When a force exceeding the strength of the microcapsules is applied, the thermosetting resin can be immediately broken and the inclusions can be released, so that the handwriting can be erased reliably.
Since the portion to be erased of the handwriting is used by applying force with an erasing tool to destroy the microcapsule, the average particle diameter of the microcapsule is preferably 1 to 10 μm. This is because if it is less than 1 μm, the microcapsule is buried in the fiber of the paper, making it difficult to destroy at the time of erasing, and if it exceeds 10 μm, it is broken just by rubbing the mark with a finger and the handwriting is erased. This is because there are concerns.
In addition, when microcapsules produced in water are used for oil-based ballpoint pens containing benzyl alcohol or ethylene glycol monophenyl ether as a main solvent, the microcapsules must be dried and dispersed in these solvents. At that time, polyvinyl pyrrolidone or glycerin can be obtained by adding a high boiling point solvent such as polyvinyl pyrrolidone (PVP) or glycerin that is soluble in both water and an ink solvent such as benzyl alcohol or phenyl glycol to the microcapsule dispersion and drying it. Coated microcapsules are made. This is preferable because the dried microcapsule mass can be loosened with a solvent such as benzyl alcohol or ethylene glycol monophenyl ether with a weak force, and even a microcapsule with a low film strength can be dispersed in the ink without breaking.
Further, when the erasable ink composition of the present invention is used in a ballpoint pen, the average particle diameter is 1 to 10 μm, and 10 particles of the total number of microcapsules in which particles having a particle diameter of 15 μm or more are blended in the ink composition. It is preferable that it is less than number%. This has a gap of several tens of microns in the passage of the ink composition in the ballpoint pen and can be sufficiently discharged. Also, paper fibers have irregularities of several microns to 10 microns, and the microcapsules enter here when writing, so even if a force such as writing pressure is applied during writing, the microcapsules are difficult to break and are destroyed. Hateful. However, there is a concern that particles of 15 μm or more are broken between paper and a ball-point pen ball at the time of writing and the handwriting becomes thin.
ロイコ染料と顕色剤との発色した色剤に対して消去液剤として働き、マイクロカプセルに内包されるエステル基、ケトン基、エーテル基、脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を少なくとも有する液状物は、これら官能基を構造内に有する液体か、これらの官能基を有する固体の溶解液及び両者の混合物を指す。尚、マイクロカプセル内に上記官能基を構造内に有する液体以外の液体や、他の溶質物、固形物などが存在していてもかまわない。
このエステル基、ケトン基、エーテル基、脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を少なくとも有する液状物の沸点が250℃以上であれば、筆跡上ですぐには揮発せずに筆跡上に留まるので顕色剤に作用し続け消色状態が維持され好ましいと言えるが、そのためには、エステル基、ケトン基、エーテル基、脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を有する液体そのものの沸点が250℃以上である場合の他に、前記液状物が、エステル基、ケトン基、エーテル基、脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を有する固体の溶解液である場合には、この溶解液の沸点が250℃以上であるか、この溶解液の溶媒の沸点が250℃以上であればよい。
マイクロカプセルに内包する、エステル基、ケトン基、エーテル基、脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を少なくとも有する液体の具体例は、エステル基を有する液体として、安息香酸エチル(沸点213.2℃、粘度2.0mPa・s)、酢酸ベンジル(沸点215.5℃、粘度1.4mPa・s)、シュウ酸ジブチル(沸点240℃、粘度3.4mPa・s)、プロピオン酸イソアミル(沸点160.7℃、粘度1.4mPa・s)、プロピオン酸ブチル(沸点146.8℃、粘度0.7mPa・s)、プロピオン酸メチル(沸点79.8℃、粘度0.5mPa・s)、アセト酢酸メチル(沸点171℃、粘度1.7mPa・s)、ギ酸エチル(沸点53℃、粘度0.4mPa・s)、ギ酸ブチル(沸点106.8℃、粘度0.7mPa・s)、ギ酸プロピル(沸点81℃、粘度0.5mPa・s)、酢酸アミル(沸点149.2℃、粘度0.9mPa・s)、酢酸イソアミル(沸点142.1℃、粘度0.9mPa・s)、酢酸イソブチル(沸点116.6℃、粘度0.7mPa・s)、酢酸イソプロピル(沸点88.6℃、粘度0.6mPa・s)、酢酸2−エチルヘキシル(沸点198.6℃、粘度1.5mPa・s)、酢酸シクロヘキシル(粘度0.9mPa・s)、酢酸n−ブチル(粘度0.7mPa・s)、酢酸s−ブチル(沸点177℃、粘度0.7mPa・s)、酢酸メチルシクロヘキシル(沸点181.5℃、粘度2.3mPa・s)、酪酸エチル(沸点121.4℃、粘度0.6mPa・s)、アジピン酸ジエチル(沸点251℃、粘度3.6mPa・s)、アジピン酸ジオクチル(沸点214℃(5mmHg)、粘度1.2mPa・s)、アセチルクエン酸トリエチル(沸点131℃(1mmHg)、粘度53.7mPa・s)、アセチルクエン酸トリブチル(沸点172℃(1mmHg)、粘度42.7mPa・s)、アビエチン酸メチル(沸点360℃、粘度3.4mPa・s)、安息香酸ベンジル(沸点323℃、粘度9.7mPa・s)、ケイ皮酸エチル(沸点271℃、粘度8.7mPa・s)、酒石酸ジエチル(沸点280℃)、酒石酸ジブチル(沸点128℃(12mmHg)、粘度10.6mPa・s)、ステアリン酸アミル(沸点192℃(2mmHg))、ステアリン酸エチル(沸点199℃(10mmHg))、ステアリン酸ブチル(沸点343℃、粘度8.3mPa・s)、セバシン酸ビス(2−エチルヘキシル)(沸点312℃、粘度19.9mPa・s)、フタル酸ジエチル(沸点296.1℃、粘度10.0mPa・s)、フタル酸ジオクチル(沸点361℃、粘度81.4mPa・s)、フタル酸ジブチル(沸点340.7℃、粘度20.0mPa・s)、フタル酸ジイソノニル(沸点296.1℃、粘度78.0mPa・s)、フタル酸ジメチル(沸点282℃、粘度17.2mPa・s)、マレイン酸ジブチル(沸点280.6℃、粘度4.7mPa・s)などが挙げられる。
エーテル基を有する液体として、1,2−エポキシブタン(沸点63℃、粘度0.4mPa・s)、ジイソプロピルエーテル(沸点68.5℃、粘度0.3mPa・s)、ジエチルエーテル(沸点34.6℃、粘度0.2mPa・s)、ジブチルエーテル(沸点142℃、粘度0.7mPa・s)、ビニルエチルエーテル(沸点35.8℃、粘度0.2mPa・s)、フェネトール(沸点170.3℃、粘度1.1mPa・s)、ジフェニルエーテル(沸点259℃、粘度3.7mPa・s)などが挙げられる。
ケトン基を有する液体として、アセトフェノン(沸点201.7℃、粘度1.6mPa・s)、メチル−n−ブチルケトン(沸点127℃、粘度0.63mPa・s)、ジイソブチルケトン(沸点163℃、粘度0.9mPa・s)、ジイソプロピルケトン(沸点124.4℃、粘度0.6mPa・s)、ジ−n−プロピルケトン(沸点143.7℃、粘度0.7mPa・s)、メチル−n−アミルケトン(沸点151.5℃、粘度0.8mPa・s)、メチルイソブチルケトン(沸点116.2℃、粘度0.5mPa・s)、メチルシクロヘキサノン(沸点169℃、粘度1.8mPa・s)、メチル−n−ヘキシルケトン(沸点172.9℃)、メチル−n−ヘプチルケトン(沸点195.3℃)などが挙げられる。
脂肪族水酸基を有する液体として、ウンデカノール(沸点243℃、粘度17.2mPa・s)、2−オクタノール(沸点178℃、粘度8.2mPa・s)、n−デカノール(沸点231℃、粘度1.38mPa・s)、α−テルピオネール(沸点219℃)、1−ノナノール(沸点214℃、粘度14.3mPa・s)、エチレングリコールモノヘキシルエーテル(沸点208.3℃、粘度5.2mPa・s)、1,3−オクチレングリコール(沸点244.2℃、粘度323mPa・s)、2−エチルブタノール(沸点147℃、粘度5.6mPa・s)、2−エチルヘキサノール(沸点184.7℃、粘度9.8mPa・s)、n−オクタノール(沸点195℃、粘度8.2mPa・s)、フーゼル油(沸点110〜130℃)、n−ヘキサノール(沸点157.1℃、粘度5.2mPa・s)、2−ヘプタノール(沸点160.4℃、粘度6.5mPa・s)、3−ヘプタノール(沸点156.4℃、粘度7.1mPa・s)、n−ヘプタノール(沸点176.3℃、粘度7.0mPa・s)、2−メチルシクロヘキサノール(沸点167.6℃)などが挙げられる。これらは混合して使用することも出来る。
尚、沸点の記載に気圧表示のないものは、常圧(760mmHg)での沸点を示す。One or more functional groups selected from an ester group, a ketone group, an ether group, and an aliphatic hydroxyl group that act as an erasing agent for a colorant developed with a leuco dye and a developer. The liquid substance having at least the above refers to a liquid having these functional groups in the structure, a solid solution having these functional groups, or a mixture of both. In addition, liquid other than the liquid having the functional group in the structure, other solutes, solids, etc. may be present in the microcapsules.
If the boiling point of the liquid substance having at least one or two or more functional groups selected from an ester group, a ketone group, an ether group, and an aliphatic hydroxyl group is 250 ° C. or higher, it will not volatilize immediately on the handwriting. Therefore, it can be said that the decolored state continues to act on the developer and is preferable, but for that purpose, one or more functional groups selected from an ester group, a ketone group, an ether group and an aliphatic hydroxyl group are used. In addition to the case where the boiling point of the liquid itself has a boiling point of 250 ° C. or higher, dissolution of a solid in which the liquid material has one or more functional groups selected from an ester group, a ketone group, an ether group, and an aliphatic hydroxyl group In the case of a liquid, the boiling point of the solution may be 250 ° C. or higher, or the boiling point of the solvent of the solution may be 250 ° C. or higher.
A specific example of a liquid having at least one or two or more functional groups selected from an ester group, a ketone group, an ether group, and an aliphatic hydroxyl group encapsulated in a microcapsule is ethyl benzoate ( Boiling point 213.2 ° C., viscosity 2.0 mPa · s), benzyl acetate (boiling point 215.5 ° C., viscosity 1.4 mPa · s), dibutyl oxalate (boiling point 240 ° C., viscosity 3.4 mPa · s), isoamyl propionate (Boiling point 160.7 ° C., viscosity 1.4 mPa · s), butyl propionate (boiling point 146.8 ° C., viscosity 0.7 mPa · s), methyl propionate (boiling point 79.8 ° C., viscosity 0.5 mPa · s) Methyl acetoacetate (boiling point 171 ° C., viscosity 1.7 mPa · s), ethyl formate (boiling point 53 ° C., viscosity 0.4 mPa · s), butyl formate (boiling point 106.8) , Viscosity 0.7 mPa · s), propyl formate (boiling point 81 ° C., viscosity 0.5 mPa · s), amyl acetate (boiling point 149.2 ° C., viscosity 0.9 mPa · s), isoamyl acetate (boiling point 142.1 ° C., (Viscosity 0.9 mPa · s), isobutyl acetate (boiling point 116.6 ° C., viscosity 0.7 mPa · s), isopropyl acetate (boiling point 88.6 ° C., viscosity 0.6 mPa · s), 2-ethylhexyl acetate (boiling point 198. 6 ° C., viscosity 1.5 mPa · s), cyclohexyl acetate (viscosity 0.9 mPa · s), n-butyl acetate (viscosity 0.7 mPa · s), s-butyl acetate (boiling point 177 ° C., viscosity 0.7 mPa · s) ), Methyl cyclohexyl acetate (boiling point 181.5 ° C., viscosity 2.3 mPa · s), ethyl butyrate (boiling point 121.4 ° C., viscosity 0.6 mPa · s), diethyl adipate (boiling point 251 ° C., 3.6 mPa · s), dioctyl adipate (boiling point 214 ° C. (5 mmHg), viscosity 1.2 mPa · s), triethyl acetylcitrate (boiling point 131 ° C. (1 mmHg), viscosity 53.7 mPa · s), acetylcitric acid Tributyl (boiling point 172 ° C. (1 mmHg), viscosity 42.7 mPa · s), methyl abietic acid (boiling point 360 ° C., viscosity 3.4 mPa · s), benzyl benzoate (boiling point 323 ° C., viscosity 9.7 mPa · s), silica Ethyl cinnamate (boiling point 271 ° C., viscosity 8.7 mPa · s), diethyl tartrate (boiling point 280 ° C.), dibutyl tartrate (boiling point 128 ° C. (12 mmHg), viscosity 10.6 mPa · s), amyl stearate (boiling point 192 ° C. ( 2 mmHg)), ethyl stearate (boiling point 199 ° C. (10 mmHg)), butyl stearate (boiling point 343 ° C. , Viscosity 8.3 mPa · s), bis (2-ethylhexyl) sebacate (boiling point 312 ° C., viscosity 19.9 mPa · s), diethyl phthalate (boiling point 296.1 ° C., viscosity 10.0 mPa · s), phthalic acid Dioctyl (boiling point 361 ° C., viscosity 81.4 mPa · s), dibutyl phthalate (boiling point 340.7 ° C., viscosity 20.0 mPa · s), diisononyl phthalate (boiling point 296.1 ° C., viscosity 78.0 mPa · s), Examples thereof include dimethyl phthalate (boiling point 282 ° C., viscosity 17.2 mPa · s) and dibutyl maleate (boiling point 280.6 ° C., viscosity 4.7 mPa · s).
As liquids having an ether group, 1,2-epoxybutane (boiling point 63 ° C., viscosity 0.4 mPa · s), diisopropyl ether (boiling point 68.5 ° C., viscosity 0.3 mPa · s), diethyl ether (boiling point 34.6). ° C, viscosity 0.2 mPa · s), dibutyl ether (boiling point 142 ° C, viscosity 0.7 mPa · s), vinyl ethyl ether (boiling point 35.8 ° C, viscosity 0.2 mPa · s), phenetole (boiling point 170.3 ° C) , Viscosity 1.1 mPa · s), diphenyl ether (boiling point 259 ° C., viscosity 3.7 mPa · s), and the like.
As a liquid having a ketone group, acetophenone (boiling point 201.7 ° C., viscosity 1.6 mPa · s), methyl-n-butyl ketone (boiling point 127 ° C., viscosity 0.63 mPa · s), diisobutyl ketone (boiling point 163 ° C., viscosity 0) .9 mPa · s), diisopropyl ketone (boiling point 124.4 ° C., viscosity 0.6 mPa · s), di-n-propyl ketone (boiling point 143.7 ° C., viscosity 0.7 mPa · s), methyl-n-amyl ketone ( Boiling point 151.5 ° C., viscosity 0.8 mPa · s), methyl isobutyl ketone (boiling point 116.2 ° C., viscosity 0.5 mPa · s), methylcyclohexanone (boiling point 169 ° C., viscosity 1.8 mPa · s), methyl-n -Hexyl ketone (boiling point 172.9 ° C.), methyl-n-heptyl ketone (boiling point 195.3 ° C.) and the like.
As a liquid having an aliphatic hydroxyl group, undecanol (boiling point 243 ° C., viscosity 17.2 mPa · s), 2-octanol (boiling point 178 ° C., viscosity 8.2 mPa · s), n-decanol (boiling point 231 ° C., viscosity 1.38 mPa) S), α-terpioneel (boiling point 219 ° C.), 1-nonanol (boiling point 214 ° C., viscosity 14.3 mPa · s), ethylene glycol monohexyl ether (boiling point 208.3 ° C., viscosity 5.2 mPa · s), 1,3-octylene glycol (boiling point: 244.2 ° C., viscosity: 323 mPa · s), 2-ethylbutanol (boiling point: 147 ° C., viscosity: 5.6 mPa · s), 2-ethylhexanol (boiling point: 184.7 ° C., viscosity: 9) .8 mPa · s), n-octanol (boiling point 195 ° C., viscosity 8.2 mPa · s), fusel oil (boiling point 110 to 130 ° C.), n Hexanol (boiling point 157.1 ° C., viscosity 5.2 mPa · s), 2-heptanol (boiling point 160.4 ° C., viscosity 6.5 mPa · s), 3-heptanol (boiling point 156.4 ° C., viscosity 7.1 mPa · s) ), N-heptanol (boiling point: 176.3 ° C., viscosity: 7.0 mPa · s), 2-methylcyclohexanol (boiling point: 167.6 ° C.), and the like. These can also be mixed and used.
In addition, the thing without an atmospheric pressure display in the description of a boiling point shows the boiling point in a normal pressure (760 mmHg).
エステル基、ケトン基、エーテル基、脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を少なくとも有する液状物がこれらの官能基を有する固体の溶液である場合、その固体は、液体に溶解した状態で使用する。溶解状態であることで、顕色剤からの電子空孔を有するH+を引きつけて消色させ、溶媒が蒸発し固化した後も、H+を引きつけ続け消色状態を維持するものである。
具体的には、エステル基を有する結晶質のものとして、ジフェニルウレタン、N−(tert−ブトキシカルボニル)−β−アラニン、1−アセトキシ−2−メトキシ−4−(1−プロペニル)ベンゼン、3’,5’−ジアセトキシアセトフェノン、フタル酸ジフェニル、フタル酸ジシクロヘキシル、2−ベンゾイル安息香酸メチル、安息香酸フェニル、炭酸ジフェニル、2,2−ビス(4−アセトキシフェニル)プロパン、4−アセトキシビフェニル、フェニル酢酸p−トリル、ジフェニル酢酸メチル、エチレングリコールジベンゾアート、ペンタエリトリトールテトラステアラート、クエン酸トリメチル、4’−アセトキシアセトフェノン、4−メトキシフェニル酢酸無水物、3,4,5−トリメトキシ安息香酸メチル、サリチル酸4−オクチルフェニルなどが挙げられる。
エステル基を有する非晶質として、パルミチン酸セチル、モノミリスチン酸グリセリル、モノステアリン酸グリセリル、ジステアリン酸グリセリル、モノステアリン酸ポリオキシエチレングリセリル、モノステアリン酸ジグリセリル、モノステアリン酸テトラグリセリル、トリステアリン酸テトラグリセリル、ペンタステアリン酸テトラグリセリル、モノステアリン酸ヘキサグリセリル、トリステアリン酸ヘキサグリセリル、ペンタステアリン酸ヘキサグリセリル、モノステアリン酸デカグリセリル、ジステアリン酸デカグリセリル、トリステアリン酸デカグリセリル、ペンタステアリン酸デカグリセリル、デカステアリン酸デカグリセリル、モノパルミチン酸ソルビタン、モノステアリン酸ソルビタン、セスキスステアリン酸ソルビタン、モノステアリン酸ポリエチレングリコール、モノステアリン酸エチレングリコール、ジステアリン酸エチレングリコール、ステアリン酸ジエチレングリコール、ジステアリン酸ポリエチレングリコール、アクリル樹脂、アルキッド樹脂、エステルガムなどが挙げられる。
エーテル基を有する結晶として、4−メトキシ−2−メチルジフェニルアミン、3−メトキシジフェニルアミン、ベンゾインイソプロピルエーテル、1,3,5−トリメトキシベンゼン、1,4−ジエトキシベンゼン、りん酸トリフェニル、4−アセトキシ安息香酸メチルなどが挙げられる。
エーテル基を有する非晶質として、ポリオキシエチレンセチルエーテル、ポリオキシエチレンステアリルエーテル、ポリオキシエチレンベヘニルエーテル、ポリオキシエチレンポリオキシプロピレンデシルテトラデシルエーテル、ポリオキシエチレンラノリンアルコール、ポリオキシエチレンソルビットミツロウ,キシレン樹脂などが挙げられる。
ケトン基を有する結晶として、N−(2−フェニルエチル)アセトアミド、アセトアセトアニリド、リドカイン、ミリスチン酸アニリド、N−アセチル−o−フェネチジン、N−カルボエトキシフタルイミド、N−カルボベンゾキシオキシスクシンイミド、テトラデカノフェノン、2’−アセトナフトン、4−ブチリルビフェニル、4−メトキシベンゾフェノン、ベンゾフェノン、シクロヘキシルフェニルケトン、1,3−ジフェニル−1,3−プロパンジオン、ベンゾインエチルエーテル、2,2−ジメトキシ−2−フェニルアセトフェノン、4,4’−ビシクロヘキサノン、4−tert−ブチルシクロヘキサノン、4,4’−ビス(メトキシメチル)ビフェニル、12−トリコサノン、6−メトキシ−1−テトラロンなどが挙げられる。
ケトン基を有する非晶質として、ケトン樹脂が挙げられる。
脂肪族水酸基を有する結晶として、セタノール、ステアリルアルコール、1−ドコサノールなどが挙げられる。
脂肪族水酸基を有する非晶質として、ベヘニルアルコールなどが挙げられる。
これらエステル基、ケトン基、エーテル基及び脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を有する固体は、1種または2種以上混合して使用可能である。好ましい添加量はインキ組成物に使用される顕色剤の総重量に対し、0.1〜10重量%である。0.1重量%未満ではマイクロカプセルに内包される液体が揮散後、再発色してしまう可能性があり、種類により異なるが概ね10重量%を超えて使用しても顕著な効果の向上は得られない。When the liquid substance having at least one or more functional groups selected from an ester group, a ketone group, an ether group and an aliphatic hydroxyl group is a solid solution having these functional groups, the solid is dissolved in the liquid Use it in the condition. By being in a dissolved state, H + having electron vacancies from the developer is attracted and decolored, and even after the solvent evaporates and solidifies, H + is continuously attracted and the decolored state is maintained.
Specifically, as crystalline ones having an ester group, diphenylurethane, N- (tert-butoxycarbonyl) -β-alanine, 1-acetoxy-2-methoxy-4- (1-propenyl) benzene, 3 ′ , 5'-diacetoxyacetophenone, diphenyl phthalate, dicyclohexyl phthalate, methyl 2-benzoylbenzoate, phenyl benzoate, diphenyl carbonate, 2,2-bis (4-acetoxyphenyl) propane, 4-acetoxybiphenyl, phenylacetic acid p-tolyl, methyl diphenylacetate, ethylene glycol dibenzoate, pentaerythritol tetrastearate, trimethyl citrate, 4'-acetoxyacetophenone, 4-methoxyphenylacetic anhydride, methyl 3,4,5-trimethoxybenzoate, salicylic acid 4 -Ok Butylphenyl and the like.
As an amorphous substance having an ester group, cetyl palmitate, glyceryl monomyristate, glyceryl monostearate, glyceryl distearate, polyoxyethylene glyceryl monostearate, diglyceryl monostearate, tetraglyceryl monostearate, tristearic acid Tetraglyceryl, tetraglyceryl pentastearate, hexaglyceryl monostearate, hexaglyceryl tristearate, hexaglyceryl pentastearate, decaglyceryl monostearate, decaglyceryl distearate, decaglyceryl tristearate, decaglyceryl pentastearate, Decastearate decaglyceryl, sorbitan monopalmitate, sorbitan monostearate, sorbitan sesquistearate, Nosutearin acid polyethylene glycol, ethylene glycol monostearate, ethylene glycol distearate, diethylene glycol stearate, polyethylene glycol distearate, acrylic resins, alkyd resins, and ester gum and the like.
Crystals having an ether group include 4-methoxy-2-methyldiphenylamine, 3-methoxydiphenylamine, benzoin isopropyl ether, 1,3,5-trimethoxybenzene, 1,4-diethoxybenzene, triphenyl phosphate, 4- And methyl acetoxybenzoate.
As an amorphous substance having an ether group, polyoxyethylene cetyl ether, polyoxyethylene stearyl ether, polyoxyethylene behenyl ether, polyoxyethylene polyoxypropylene decyl tetradecyl ether, polyoxyethylene lanolin alcohol, polyoxyethylene sorbit beeswax, Examples include xylene resins.
As crystals having a ketone group, N- (2-phenylethyl) acetamide, acetoacetanilide, lidocaine, myristic acid anilide, N-acetyl-o-phenetidine, N-carboethoxyphthalimide, N-carbobenzoxyoxysuccinimide, tetradeca Nophenone, 2′-acetonaphthone, 4-butyrylbiphenyl, 4-methoxybenzophenone, benzophenone, cyclohexylphenylketone, 1,3-diphenyl-1,3-propanedione, benzoin ethyl ether, 2,2-dimethoxy-2- Examples include phenylacetophenone, 4,4′-bicyclohexanone, 4-tert-butylcyclohexanone, 4,4′-bis (methoxymethyl) biphenyl, 12-tricosanone, 6-methoxy-1-tetralone, and the like.
Examples of the amorphous substance having a ketone group include a ketone resin.
Examples of the crystal having an aliphatic hydroxyl group include cetanol, stearyl alcohol, 1-docosanol and the like.
Examples of the amorphous having an aliphatic hydroxyl group include behenyl alcohol.
These solids having one or more functional groups selected from ester groups, ketone groups, ether groups and aliphatic hydroxyl groups can be used alone or in combination. A preferred addition amount is 0.1 to 10% by weight based on the total weight of the developer used in the ink composition. If it is less than 0.1% by weight, the liquid encapsulated in the microcapsule may be recolored after volatilization. Depending on the type, even if it exceeds approximately 10% by weight, a significant improvement in the effect is obtained. I can't.
これらの固体を消色剤として作用させるために、これを溶解する液体の具体例は、以下のものが挙げられる。
エステル基を有する液体として、安息香酸エチル(沸点213.2℃、粘度2.0mPa・s)、酢酸ベンジル(沸点215.5℃、粘度1.4mPa・s)、シュウ酸ジブチル(沸点240℃、粘度3.4mPa・s)、プロピオン酸イソアミル(沸点160.7℃、粘度1.4mPa・s)、プロピオン酸ブチル(沸点146.8℃、粘度0.7mPa・s)、プロピオン酸メチル(沸点79.8℃、粘度0.5mPa・s)、アセト酢酸メチル(沸点171℃、粘度1.7mPa・s)、ギ酸エチル(沸点53℃、粘度0.4mPa・s)、ギ酸ブチル(沸点106.8℃、粘度0.7mPa・s)、ギ酸プロピル(沸点81℃、粘度0.5mPa・s)、酢酸アミル(沸点149.2℃、粘度0.9mPa・s)、酢酸イソアミル(沸点142.1℃、粘度0.9mPa・s)、酢酸イソブチル(沸点116.6℃、粘度0.7mPa・s)、酢酸イソプロピル(沸点88.6℃、粘度0.6mPa・s)、酢酸2−エチルヘキシル(沸点198.6℃、1.5mPa・s)、酢酸シクロヘキシル(粘度0.9mPa・s)、酢酸n−ブチル(粘度0.7mPa・s)、酢酸s−ブチル(沸点177℃、粘度0.7mPa・s)、酢酸メチルシクロヘキシル(沸点181.5℃、粘度2.3mPa・s)、酪酸エチル(沸点121.4℃、粘度0.6mPa・s)、アジピン酸ジエチル(沸点251℃、粘度3.6mPa・s)、アジピン酸ジオクチル(沸点214℃(5mmHg)、粘度1.2mPa・s)、アセチルクエン酸トリエチル(沸点131℃(1mmHg)、粘度53.7mPa・s)、アセチルクエン酸トリブチル(沸点172℃(1mmHg)、粘度42.7mPa・s)、アビエチン酸メチル(沸点360℃、粘度3.4mPa・s)、安息香酸ベンジル(沸点323℃、粘度9.7mPa・s)、ケイ皮酸エチル(沸点271℃、粘度8.7mPa・s)、酒石酸ジエチル(沸点280℃)、酒石酸ジブチル(沸点128℃(12mmHg)、粘度10.6mPa・s)、ステアリン酸アミル(沸点192℃(2mmHg))、ステアリン酸エチル(沸点199℃(10mmHg))、ステアリン酸ブチル(沸点343℃、粘度8.3mPa・s)、セバシン酸ビス(2−エチルヘキシル)(沸点312℃、粘度19.9mPa・s)、フタル酸ジエチル(沸点296.1℃、粘度10.0mPa・s)、フタル酸ジオクチル(沸点361℃、粘度81.4mPa・s)、フタル酸ジブチル(沸点340.7℃、粘度20.0mPa・s)、フタル酸ジイソノニル(沸点296.1℃、粘度78.0mPa・s)、フタル酸ジメチル(沸点282℃、粘度17.2mPa・s)、マレイン酸ジブチル(沸点280.6℃、粘度4.7mPa・s)などが挙げられる。
エーテル基を有する液体として、1,2−エポキシブタン(沸点63℃、粘度0.4mPa・s)、ジイソプロピルエーテル(沸点68.5℃、粘度0.3mPa・s)、ジエチルエーテル(沸点34.6℃、粘度0.2mPa・s)、ジブチルエーテル(沸点142℃、粘度0.7mPa・s)、ビニルエチルエーテル(沸点35.8℃、粘度0.2mPa・s)、フェネトール(沸点170.3℃、粘度1.1mPa・s)、ジフェニルエーテル(沸点259℃、粘度3.7mPa・s)などが挙げられる。
ケトン基を有する液体として、アセトフェノン(沸点201.7℃、粘度1.6mPa・s)、メチル−n−ブチルケトン(沸点127℃、0.63mPa・s)、ジイソブチルケトン(沸点163℃、粘度0.9mPa・s)、ジイソプロピルケトン(沸点124.4℃、粘度0.6mPa・s)、ジ−n−プロピルケトン(沸点143.7℃、粘度0.7mPa・s)、メチル−n−アミルケトン(沸点151.5℃、粘度0.8mPa・s)、メチルイソブチルケトン(沸点116.2℃、0.5mPa・s)、メチルシクロヘキサノン(沸点169℃、粘度1.8mPa・s)、メチル−n−ヘキシルケトン(沸点172.9℃)、メチル−n−ヘプチルケトン(沸点195.3℃)などが挙げられる。
脂肪族水酸基を有する液体として、ウンデカノール(沸点243℃、粘度17.2mPa・s)、2−オクタノール(沸点178℃、粘度8.2mPa・s)、n−デカノール(沸点231℃、粘度1.38mPa・s)、α−テルピオネール(沸点219℃)、1−ノナノール(沸点214℃、粘度14.3mPa・s)、エチレングリコールモノヘキシルエーテル(沸点208.3℃、粘度5.2mPa・s)、1,3−オクチレングリコール(沸点244.2℃、粘度323mPa・s)、2−エチルブタノール(沸点147℃、粘度5.6mPa・s)、2−エチルヘキサノール(沸点184.7℃、粘度9.8mPa・s)、n−オクタノール(沸点195℃、粘度8.2mPa・s)、フーゼル油(沸点110〜130℃)、n−ヘキサノール(沸点157.1℃、粘度5.2mPa・s)、2−ヘプタノール(沸点160.4℃、粘度6.5mPa・s)、3−ヘプタノール(沸点156.4℃、粘度7.1mPa・s)、n−ヘプタノール(沸点176.3℃、粘度7.0mPa・s)、2−メチルシクロヘキサノール(沸点167.6℃)などが挙げられる。
炭化水素系の液体として、アミルベンゼン(沸点202℃)、イソプロピルベンゼン(沸点152℃)、エチルベンゼン(沸点136℃)、オクタン(沸点125℃)、キシレン(沸点138〜144℃)、1,2−エチルベンゼン(沸点183℃)、シクロヘキシルベンゼン(沸点239℃)、ジペンテン(沸点177℃)、ジメチルナフタレン(沸点262.1〜286.6℃)、p−シメン(沸点177℃)、デカン(沸点174℃)、テトラリン(沸点207℃)、ドデシルベンゼン(沸点270〜331℃)、ナフタレン(沸点218℃)、ヘプタン(沸点98.4℃)、メチルシクロヘキサン(沸点101℃)、流動パラフィン(沸点300℃以上)などが挙げられる。
これらは混合して使用することも出来る。
尚、沸点の記載に気圧表示のないものは、常圧(760mmHg)での沸点を示す。In order to make these solids act as a color erasing agent, specific examples of liquids for dissolving them include the following.
As the liquid having an ester group, ethyl benzoate (boiling point 213.2 ° C., viscosity 2.0 mPa · s), benzyl acetate (boiling point 215.5 ° C., viscosity 1.4 mPa · s), dibutyl oxalate (boiling point 240 ° C., Viscosity 3.4 mPa · s), isoamyl propionate (boiling point 160.7 ° C., viscosity 1.4 mPa · s), butyl propionate (boiling point 146.8 ° C., viscosity 0.7 mPa · s), methyl propionate (boiling point 79 0.8 ° C., viscosity 0.5 mPa · s), methyl acetoacetate (boiling point 171 ° C., viscosity 1.7 mPa · s), ethyl formate (boiling point 53 ° C., viscosity 0.4 mPa · s), butyl formate (boiling point 106.8) ° C, viscosity 0.7 mPa · s), propyl formate (boiling point 81 ° C, viscosity 0.5 mPa · s), amyl acetate (boiling point 149.2 ° C, viscosity 0.9 mPa · s), isoamyl acetate ( 142.1 ° C, viscosity 0.9 mPa · s), isobutyl acetate (boiling point 116.6 ° C, viscosity 0.7 mPa · s), isopropyl acetate (boiling point 88.6 ° C, viscosity 0.6 mPa · s), acetic acid 2 -Ethylhexyl (boiling point 198.6 ° C., 1.5 mPa · s), cyclohexyl acetate (viscosity 0.9 mPa · s), n-butyl acetate (viscosity 0.7 mPa · s), s-butyl acetate (boiling point 177 ° C., viscosity) 0.7 mPa · s), methyl cyclohexyl acetate (boiling point 181.5 ° C., viscosity 2.3 mPa · s), ethyl butyrate (boiling point 121.4 ° C., viscosity 0.6 mPa · s), diethyl adipate (boiling point 251 ° C., Viscosity 3.6 mPa · s), Dioctyl adipate (boiling point 214 ° C. (5 mmHg), viscosity 1.2 mPa · s), triethyl acetyl citrate (boiling point 131 ° C. (1 mmHg)) Viscosity 53.7 mPa · s), tributyl acetylcitrate (boiling point 172 ° C. (1 mmHg), viscosity 42.7 mPa · s), methyl abietic acid (boiling point 360 ° C., viscosity 3.4 mPa · s), benzyl benzoate (boiling point 323) ° C, viscosity 9.7 mPa · s), ethyl cinnamate (boiling point 271 ° C, viscosity 8.7 mPa · s), diethyl tartrate (boiling point 280 ° C), dibutyl tartrate (boiling point 128 ° C (12 mmHg), viscosity 10.6 mPa · s) s), amyl stearate (boiling point 192 ° C. (2 mmHg)), ethyl stearate (boiling point 199 ° C. (10 mmHg)), butyl stearate (boiling point 343 ° C., viscosity 8.3 mPa · s), bis (2-ethylhexyl) sebacate ) (Boiling point 312 ° C., viscosity 19.9 mPa · s), diethyl phthalate (boiling point 296.1 ° C., viscosity 10.0) mPa · s), dioctyl phthalate (boiling point 361 ° C., viscosity 81.4 mPa · s), dibutyl phthalate (boiling point 340.7 ° C., viscosity 20.0 mPa · s), diisononyl phthalate (boiling point 296.1 ° C., viscosity) 78.0 mPa · s), dimethyl phthalate (boiling point 282 ° C., viscosity 17.2 mPa · s), dibutyl maleate (boiling point 280.6 ° C., viscosity 4.7 mPa · s), and the like.
As liquids having an ether group, 1,2-epoxybutane (boiling point 63 ° C., viscosity 0.4 mPa · s), diisopropyl ether (boiling point 68.5 ° C., viscosity 0.3 mPa · s), diethyl ether (boiling point 34.6). ° C, viscosity 0.2 mPa · s), dibutyl ether (boiling point 142 ° C, viscosity 0.7 mPa · s), vinyl ethyl ether (boiling point 35.8 ° C, viscosity 0.2 mPa · s), phenetole (boiling point 170.3 ° C) , Viscosity 1.1 mPa · s), diphenyl ether (boiling point 259 ° C., viscosity 3.7 mPa · s), and the like.
As a liquid having a ketone group, acetophenone (boiling point 201.7 ° C., viscosity 1.6 mPa · s), methyl-n-butyl ketone (boiling points 127 ° C., 0.63 mPa · s), diisobutyl ketone (boiling point 163 ° C., viscosity 0. 9 mPa · s), diisopropyl ketone (boiling point 124.4 ° C., viscosity 0.6 mPa · s), di-n-propyl ketone (boiling point 143.7 ° C., viscosity 0.7 mPa · s), methyl-n-amyl ketone (boiling point) 151.5 ° C., viscosity 0.8 mPa · s), methyl isobutyl ketone (boiling point 116.2 ° C., 0.5 mPa · s), methylcyclohexanone (boiling point 169 ° C., viscosity 1.8 mPa · s), methyl-n-hexyl Examples include ketones (boiling point 172.9 ° C.) and methyl-n-heptyl ketone (boiling point 195.3 ° C.).
As a liquid having an aliphatic hydroxyl group, undecanol (boiling point 243 ° C., viscosity 17.2 mPa · s), 2-octanol (boiling point 178 ° C., viscosity 8.2 mPa · s), n-decanol (boiling point 231 ° C., viscosity 1.38 mPa) S), α-terpioneel (boiling point 219 ° C.), 1-nonanol (boiling point 214 ° C., viscosity 14.3 mPa · s), ethylene glycol monohexyl ether (boiling point 208.3 ° C., viscosity 5.2 mPa · s), 1,3-octylene glycol (boiling point: 244.2 ° C., viscosity: 323 mPa · s), 2-ethylbutanol (boiling point: 147 ° C., viscosity: 5.6 mPa · s), 2-ethylhexanol (boiling point: 184.7 ° C., viscosity: 9) .8 mPa · s), n-octanol (boiling point 195 ° C., viscosity 8.2 mPa · s), fusel oil (boiling point 110 to 130 ° C.), n Hexanol (boiling point 157.1 ° C., viscosity 5.2 mPa · s), 2-heptanol (boiling point 160.4 ° C., viscosity 6.5 mPa · s), 3-heptanol (boiling point 156.4 ° C., viscosity 7.1 mPa · s) ), N-heptanol (boiling point: 176.3 ° C., viscosity: 7.0 mPa · s), 2-methylcyclohexanol (boiling point: 167.6 ° C.), and the like.
As hydrocarbon liquids, amylbenzene (boiling point 202 ° C), isopropylbenzene (boiling point 152 ° C), ethylbenzene (boiling point 136 ° C), octane (boiling point 125 ° C), xylene (boiling point 138 to 144 ° C), 1,2- Ethylbenzene (boiling point 183 ° C), cyclohexylbenzene (boiling point 239 ° C), dipentene (boiling point 177 ° C), dimethylnaphthalene (boiling point 262.1-286.6 ° C), p-cymene (boiling point 177 ° C), decane (boiling point 174 ° C) ), Tetralin (boiling point 207 ° C), dodecylbenzene (boiling point 270-331 ° C), naphthalene (boiling point 218 ° C), heptane (boiling point 98.4 ° C), methylcyclohexane (boiling point 101 ° C), liquid paraffin (boiling point 300 ° C or higher) ) And the like.
These can also be mixed and used.
In addition, the thing without an atmospheric pressure display in the description of a boiling point shows the boiling point in a normal pressure (760 mmHg).
ロイコ染料は電子供与性染料で、電子受容体である顕色剤と反応、即ち、電子空孔を有するH+により、ラクトン環等が開環し共鳴構造をとることで発色を発現するものである。ロイコ染料としては、ジフェニルメタンフタリド系色素、フルオラン系色素、インドリルフタリド系色素、スピロピラン系色素、ローダミンラクタム系色素、アザフタリド系色素等がある。以下に具体的なものを例示するが、これらに限定されるものではない。
例えば、3,3−ビス(p−ジメチルアミノフェニル)−6−ジメチルアミノフタリド、2’−アニリロ−6’−(N−エチル−N−イソペンチルアミノ)−3’−メチルスピロ[フタリド−3,9’−(9H)キサンテン]−3−オン、2’−メチル−6’−(N−p−トリル−Nエチルアミノ)スピロ[イソベンゾフラン−1(3H),9’−(9H)キサンテン]−3−オン、2−メチル−6−(N−エチル−N−p−トリルアミノ)フルオラン、3,3−ビス(1−n−ブチル−2−メチルインドール−3−イル)フタリド、3−(4−ジエチルアミノ−2−メチルフェニル)−3−(1−エチル−1H−インドール−3−イル)−4−アザフタリド、9−(ジエチルアミノ)スピロ[12H−ベンゾ(a)キサンテン−12,1’(3’H)−イソベンゾフラン]−3’−オン、2−メチル−6−(N−エチル−N−p−トリルアミノ)フルオラン、5−アミノ−3’,6’−ジヒドロキシスピロ[イソベンゾフラン−1(3H),9’−(9H)キサンテン]−3−オン、6’−(ジエチルアミノ)−1’,2’−ベンゾフルオラン、6−アミノ−3’,6’−ジヒドロキシスピロ[イソベンゾフラン−1(3H),9’−(9H)キサンテン]−3−オン、3’,6’−ビス(ジエチルアミノ)−2−(4−ニトロフェニル)スピロ[イソインドール−1,9’−キサンテン]−3−オン、2’−アニリノ−6’−ジブチルアミノ−3’−メチルスピロ[フタリド−3,9’−(9H)キサンテン]−3−オン、2’−(フェニルアミノ)−3−メチル−6−[エチル(p−トリル)アミン]スピロ[9H−キサンテン]−9オン、1’−[3’H−イソベンゾフラン]−3−オン、6−(ジエチルアミン)−2−[3−(トリフルオロメチル)アニリノ]スピロ[9H−キサンテン−9,3’(1’H)−イソベンゾフラン]−1’−オン、3,3−ビス[2−(4−ジメチルアミノフェニル)−2−(4−メトキシフェニル)エテニル]4,5,6,7−テトラクロロイソベンゾフラン−1(3H)−オン、2’−(N−フェニル−N−メチルアミン)−6’,6(N−p−トリル−N−エチルアミノ)スピロ[イソベンゾフラン−1(3H)]−3−オン、6−ニトロ−3’,6’−ジヒドロキシスピロ[イソベンゾフラン−1(3H),9’−(9H)キサンテン]−3−オン、3−メトキシ−4−ドデコキシスチリノキノリンなどが挙げられ、これらは、1種又は2種以上を混合して用いることができる。
インキ組成物全量に対するロイコ染料の添加量は1〜30重量%が好ましい。1重量%未満では筆跡濃度が薄く、30重量%を超えるとインキ組成物の粘度が上がり吐出性が低下することが懸念される。
ロイコ染料はエステル基、ケトン基、エーテル基、脂肪族水酸基から選ばれる1種もしくは2種以上の官能基を少なくとも有する物質の液状物に溶解する必要はない。A leuco dye is an electron-donating dye that reacts with a developer that is an electron acceptor, that is, develops color by opening a lactone ring or the like and taking a resonance structure by H + having electron vacancies. is there. Examples of leuco dyes include diphenylmethane phthalide dyes, fluorane dyes, indolyl phthalide dyes, spiropyran dyes, rhodamine lactam dyes, azaphthalide dyes, and the like. Specific examples are given below, but the present invention is not limited to these.
For example, 3,3-bis (p-dimethylaminophenyl) -6-dimethylaminophthalide, 2'-anilo-6-6- (N-ethyl-N-isopentylamino) -3'-methylspiro [phthalide-3 , 9 ′-(9H) xanthene] -3-one, 2′-methyl-6 ′-(Np-tolyl-Nethylamino) spiro [isobenzofuran-1 (3H), 9 ′-(9H) xanthene ] -3-one, 2-methyl-6- (N-ethyl-Np-tolylamino) fluorane, 3,3-bis (1-n-butyl-2-methylindol-3-yl) phthalide, 3- (4-Diethylamino-2-methylphenyl) -3- (1-ethyl-1H-indol-3-yl) -4-azaphthalide, 9- (diethylamino) spiro [12H-benzo (a) xanthene-12,1 ′ (3'H)- Sobenzofuran] -3′-one, 2-methyl-6- (N-ethyl-Np-tolylamino) fluorane, 5-amino-3 ′, 6′-dihydroxyspiro [isobenzofuran-1 (3H), 9 '-(9H) xanthen] -3-one, 6'-(diethylamino) -1 ', 2'-benzofluorane, 6-amino-3', 6'-dihydroxyspiro [isobenzofuran-1 (3H), 9 ′-(9H) xanthen] -3-one, 3 ′, 6′-bis (diethylamino) -2- (4-nitrophenyl) spiro [isoindole-1,9′-xanthene] -3-one, 2 '-Anilino-6'-dibutylamino-3'-methylspiro [phthalide-3,9'-(9H) xanthen] -3-one, 2 '-(phenylamino) -3-methyl-6- [ethyl (p -Tolyl) amine] spiro [9H Xanthene] -9one, 1 '-[3'H-isobenzofuran] -3-one, 6- (diethylamine) -2- [3- (trifluoromethyl) anilino] spiro [9H-xanthene-9,3' (1′H) -Isobenzofuran] -1′-one, 3,3-bis [2- (4-dimethylaminophenyl) -2- (4-methoxyphenyl) ethenyl] 4,5,6,7-tetra Chloroisobenzofuran-1 (3H) -one, 2 ′-(N-phenyl-N-methylamine) -6 ′, 6 (Np-tolyl-N-ethylamino) spiro [isobenzofuran-1 (3H) ] -3-one, 6-nitro-3 ′, 6′-dihydroxyspiro [isobenzofuran-1 (3H), 9 ′-(9H) xanthen] -3-one, 3-methoxy-4-dedecoxyst Such as linoquinoline. It may be used alone or in combination.
The amount of leuco dye added to the total amount of the ink composition is preferably 1 to 30% by weight. If it is less than 1% by weight, the handwriting density is thin, and if it exceeds 30% by weight, there is a concern that the viscosity of the ink composition is increased and the dischargeability is lowered.
The leuco dye does not need to be dissolved in a liquid substance having at least one or more functional groups selected from an ester group, a ketone group, an ether group, and an aliphatic hydroxyl group.
顕色剤は、前述のロイコ染料を発色させるものであり、顕色剤とロイコ染料を溶解した状態で作用させることで発色する。
具体的に用いることができる顕色剤としては、置換性水素を有する無機化合物やフェノール性水酸基を有する化合物が挙げられる。
置換性水素を有する無機化合物は化学的に酸性を呈しH+を放出し、ロイコ染料を発色させる。置換性水素を有する無機化合物としては、酸性白土、活性白土モンモリロナイト、ハイドロタルサイト、ヒドロキシアパタイト、フロリジン、ケイ酸アルミニウム、ケイ酸マグネシウム、ゼオライト酸、硫酸マグネシウム、硫酸カルシウムなどが挙げられる。
フェノール性水酸基は、ベンゼン環のI効果により、水酸基の酸素原子の電子密度が低くなり、その結果水素原子が活性プロトンH+として遊離しやすくなる。これがロイコ染料のラクトン環を開環させ発色する。
フェノール性水酸基を有する化合物の具体例としては、ターシャリーブチルカテコール、n−ステアリルフェノール、o−フェニルフェノール、ヘキサフルオロビスフェノール、p−ヒドロキシ安息香酸n−ブチル、p−ヒドロキシ安息香酸n−オクチル、没食子酸ドデシル、2,2−ビス(4−ヒドロキシフェニル)プロパン、4,4’−ジヒドロキシジフェニルスルホン、1,1−ビス(4−ヒドロキシフェニル)エタン、2,2−ビス(4−ヒドロキシ−3−メチルフェニル)プロパン、ビス(4−ヒドロキシフェニル)スルフィド、1−フェニル−1,1−ビス(4−ヒドロキシフェニル)エタン、1,1−ビス(4−ヒドロキシフェニル)−3−メチルブタン、1,1−ビス(4−ヒドロキシフェニル)−2−メチルプロパン、1,1−ビス(4−ヒドロキシフェニル)n−ヘキサン、1,1−ビス(4−ヒドロキシフェニル)n−ヘプタン、1,1−ビス(4−ヒドロキシフェニル)n−オクタン、1,1−ビス(4−ヒドロキシフェニル)n−ノナン、1,1−ビス(4−ヒドロキシフェニル)n−デカン、1,1−ビス(4−ヒドロキシフェニル)n−ドデカン、2,2−ビス(4−ヒドロキシフェニル)ブタン、2,2−ビス(4−ヒドロキシフェニル)エチルプロピオネート、2,2−ビス(4−ヒドロキシフェニル)−4−メチルペンタン、2,2−ビス(4−ヒドロキシフェニル)ヘキサフルオロプロパン、2,2−ビス(4−ヒドロキシフェニル)n−ヘプタン、2,2−ビス(4’−ヒドロキシフェニル)n−ノナン、ノボラック型フェノール樹脂などが挙げられる。
これらの顕色剤は、1種、または2種類以上混合して用いることができ、その使用量は、種類により異なるが、概ねロイコ染料1に対し1〜10が好ましい。The developer develops the aforementioned leuco dye, and develops color by acting in a state where the developer and leuco dye are dissolved.
Specific examples of the developer that can be used include inorganic compounds having a substitutable hydrogen and compounds having a phenolic hydroxyl group.
An inorganic compound having a substitutable hydrogen is chemically acidic, releases H + , and develops a leuco dye. Examples of the inorganic compound having substitutable hydrogen include acidic clay, activated clay montmorillonite, hydrotalcite, hydroxyapatite, phlorizin, aluminum silicate, magnesium silicate, zeolitic acid, magnesium sulfate, and calcium sulfate.
The phenolic hydroxyl group has a low electron density of the oxygen atom of the hydroxyl group due to the I effect of the benzene ring, and as a result, the hydrogen atom is easily released as the active proton H + . This opens the lactone ring of the leuco dye and develops color.
Specific examples of the compound having a phenolic hydroxyl group include tertiary butylcatechol, n-stearylphenol, o-phenylphenol, hexafluorobisphenol, n-butyl p-hydroxybenzoate, n-octyl p-hydroxybenzoate, and gallic acid. Acid dodecyl, 2,2-bis (4-hydroxyphenyl) propane, 4,4'-dihydroxydiphenylsulfone, 1,1-bis (4-hydroxyphenyl) ethane, 2,2-bis (4-hydroxy-3- Methylphenyl) propane, bis (4-hydroxyphenyl) sulfide, 1-phenyl-1,1-bis (4-hydroxyphenyl) ethane, 1,1-bis (4-hydroxyphenyl) -3-methylbutane, 1,1 -Bis (4-hydroxyphenyl) -2-methylpropane, 1, 1-bis (4-hydroxyphenyl) n-hexane, 1,1-bis (4-hydroxyphenyl) n-heptane, 1,1-bis (4-hydroxyphenyl) n-octane, 1,1-bis (4 -Hydroxyphenyl) n-nonane, 1,1-bis (4-hydroxyphenyl) n-decane, 1,1-bis (4-hydroxyphenyl) n-dodecane, 2,2-bis (4-hydroxyphenyl) butane 2,2-bis (4-hydroxyphenyl) ethyl propionate, 2,2-bis (4-hydroxyphenyl) -4-methylpentane, 2,2-bis (4-hydroxyphenyl) hexafluoropropane, 2, , 2-bis (4-hydroxyphenyl) n-heptane, 2,2-bis (4′-hydroxyphenyl) n-nonane, novolac type phenol resin, etc. Can be mentioned.
These developers can be used alone or in combination of two or more, and the amount used varies depending on the type, but is generally preferably 1 to 10 relative to leuco dye 1.
また、ロイコ染料および顕色剤が、使用するインキ液媒体に溶解しない場合には、予めアセトンやメチルエチルケトンなどにロイコ染料と顕色剤を溶解させ、発色した状態で、乾燥、粉砕し顔料化したものを使用する。
その平均粒子径は、ボールペンペン先からの吐出性を考慮すると、10μm以下が好ましい。好ましい添加量は2〜30重量%である。In addition, when the leuco dye and the developer are not dissolved in the ink liquid medium to be used, the leuco dye and the developer are dissolved in acetone, methyl ethyl ketone, etc. in advance and dried, pulverized, and pigmented. Use things.
The average particle diameter is preferably 10 μm or less in consideration of dischargeability from the ballpoint pen tip. A preferable addition amount is 2 to 30% by weight.
本発明に用いるインキ液媒体は、顕色剤により発色したロイコ染料を消色しにくい、ベンゼン環と水酸基の間の(CH2)nによりI効果が遮断された芳香族アルコール、エステル基、ケトン基、エーテル基、水酸基を有さない炭化水素系溶剤及び/又は水を使用する。芳香族アルコールの具体例として、ベンジルアルコール、フェネチルアルコール、3−フェニル−1−プロパノール、4−フェニル−2−ブタノール、芳香族系グリコールエーテルの具体例として、エチレングリコールモノフェニルエーテル、ジエチレングリコールモノフェニルエーテル、プロピレングリコールモノフェニルエーテル、エチレングリコールモノベンジルエーテル、炭化水素系溶剤の具体例として、ノルマルペンタン、シクロペンタン、メチルシクロペンタン、ノルマルヘキサン、イソヘキサン、ノルマルヘプタン、ノルマルオクタンなど脂肪族炭化水素系溶剤、シクロヘキサン、メチルシクロヘキサン、エチルシクロヘキサン、デカン、ドデカン等の他、エクソールDSP 100/140(以上、エクソン化学(株)製)等の脂肪族炭化水素系溶剤の混合品などが挙げられる。その使用量は40〜70重量%が好ましい。The ink liquid medium used in the present invention is an aromatic alcohol, ester group, or ketone in which the I effect is blocked by (CH 2 ) n between the benzene ring and the hydroxyl group, which is difficult to erase the leuco dye developed by the developer. A hydrocarbon solvent and / or water having no group, ether group or hydroxyl group is used. Specific examples of the aromatic alcohol include benzyl alcohol, phenethyl alcohol, 3-phenyl-1-propanol, 4-phenyl-2-butanol, and specific examples of the aromatic glycol ether include ethylene glycol monophenyl ether and diethylene glycol monophenyl ether. Specific examples of propylene glycol monophenyl ether, ethylene glycol monobenzyl ether, hydrocarbon solvents include aliphatic hydrocarbon solvents such as normal pentane, cyclopentane, methylcyclopentane, normal hexane, isohexane, normal heptane, normal octane, In addition to cyclohexane, methylcyclohexane, ethylcyclohexane, decane, dodecane, etc., Exol DSP 100/140 (above, manufactured by Exxon Chemical Co., Ltd.), etc. And a mixture of these aliphatic hydrocarbon solvents. The amount used is preferably 40 to 70% by weight.
また、筆記具用インキ組成物と成すため、マイクロカプセルの沈降防止やペン先からのインキ漏れ防止や適切な吐出量等のため剪断減粘性付与剤、色素化合物や、樹脂の分散乳化剤や定着剤、ボール受座の摩耗防止のための潤滑剤、防腐・防黴剤、防錆剤、消泡剤、染料、顔料などを適宜含有することができる。染料、顔料などの着色成分が添加された場合には、顕色時に混色された状態から消色インキ成分が消色して筆跡は変色した状態となる。
剪断減粘性付与剤としては、インキ液媒体が芳香族アルコールの場合には、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ポリビニルピロリドン、ポリビニルブチラールなどが、インキ液媒体が炭化水素系溶剤の場合には、脂肪酸アマイド、酸化ポリオレフィン、水添ひまし油、乾式シリカ、ベントナイトなどが、インキ液媒体が水の場合には、水溶性高分子化合物を用いることができる。水溶性高分子化合物としては、例えば、アラビアガム、トラガカントガム、グァーガム、ローカストビーンガム、アルギン酸、カラギーナン、ゼラチン、カゼイン、キサンテンガム、デキストラン、ウェランガム、ラムザンガム、アルカシーガム、メチルセルロース、エチルセルロース、ヒドロキシエチルセルロース、カルボキシメチルセルロース、デンプングリコール酸ナリウム、アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル、ヒドロキシプロピル化グァーガム、メチルセルロース、エチルセルロース、ポリビニルピロリドン、ポリビニルメチルエーテル、ポリアクリル酸、カルボキシビニルポリマー、ポリエチレンオキサイド、酢酸ビニルとポリビニルピロリドンの共重合体、アクリル樹脂塩、アクリル酸とアルキルメタクリレートの共重合体又はそれらの塩を1種または2種以上を併用して使用できる。In addition, since it is formed with an ink composition for writing instruments, shear thinning imparting agent, dye compound, resin dispersion emulsifier and fixing agent for preventing sedimentation of microcapsules, preventing ink leakage from the pen tip, and an appropriate discharge amount, etc. Lubricants, antiseptic / antifungal agents, rust preventives, antifoaming agents, dyes, pigments and the like for preventing wear of the ball seats can be appropriately contained. When a coloring component such as a dye or a pigment is added, the decoloring ink component is decolored from the mixed state at the time of color development and the handwriting is in a discolored state.
Examples of the shear thinning agent include hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl pyrrolidone, and polyvinyl butyral when the ink liquid medium is an aromatic alcohol, and fatty acid amide when the ink liquid medium is a hydrocarbon solvent. In the case where the ink liquid medium is water, such as oxidized polyolefin, hydrogenated castor oil, dry silica, bentonite, etc., a water-soluble polymer compound can be used. Examples of the water-soluble polymer compound include gum arabic, gum tragacanth, guar gum, locust bean gum, alginic acid, carrageenan, gelatin, casein, xanthene gum, dextran, welan gum, lambzan gum, alkasy gum, methylcellulose, ethylcellulose, hydroxyethylcellulose, carboxymethylcellulose, Sodium starch glycolate, sodium alginate, propylene glycol ester alginate, hydroxypropylated guar gum, methylcellulose, ethylcellulose, polyvinylpyrrolidone, polyvinylmethylether, polyacrylic acid, carboxyvinyl polymer, polyethylene oxide, copolymer of vinyl acetate and polyvinylpyrrolidone, Acrylic resin salt, acrylic acid and alkyl Copolymers of methacrylates or their salts in combination with one or more types may be used.
分散乳化剤としては、高級アルコール硫酸エステル類、液体脂肪酸硫酸エステル類、アルキルアリルスルホン酸類などのアニオン系界面活性剤や、ポリビニルアルコール、ポリオキシエチレンアルキルエーテル類、ソルビタンアルキルエステル類、ポリオキシエチレンソルビタンアルキルエステル類などの非イオン系界面活性剤や、カチオン系界面活性剤や両性界面活性剤などである。 Dispersing emulsifiers include anionic surfactants such as higher alcohol sulfates, liquid fatty acid sulfates, alkylallyl sulfonic acids, polyvinyl alcohol, polyoxyethylene alkyl ethers, sorbitan alkyl esters, polyoxyethylene sorbitan alkyls. Nonionic surfactants such as esters, cationic surfactants and amphoteric surfactants.
インキ液媒体に水を使用した場合には防腐・防黴剤としては、クロロアセトアミド、1,2−ベンゾイソチアゾリン−3−オン、5−クロロ−2−メチル−4−イソチアゾリン−3−オン、2−メチル−4−イソチアゾリン−3−オン、2−ピリジンチオール−1−オキサイド・ナトリウム塩、デヒドロ酢酸ナトリウム、安息香酸ナトリウム、ソルビン酸ナトリウム、ソルビン酸カリウム、チアベンダゾール、フェノキシエタノール、フッ化ナトリウム、4−(2−ニトロブチル)モルホリン、1,3−ジモルホリノ−2−エチル−2−ニトリプロパン、2−ブロモ−2−ニトロプロパン−1,3−ジオールなどである。
表面張力調整や消泡剤としては、シリコン系界面活性剤、フッ素系界面活性剤等を挙げることができる。When water is used as the ink medium, antiseptic / antifungal agents include chloroacetamide, 1,2-benzisothiazolin-3-one, 5-chloro-2-methyl-4-isothiazolin-3-one, 2 -Methyl-4-isothiazolin-3-one, 2-pyridinethiol-1-oxide sodium salt, sodium dehydroacetate, sodium benzoate, sodium sorbate, potassium sorbate, thiabendazole, phenoxyethanol, sodium fluoride, 4- ( 2-nitrobutyl) morpholine, 1,3-dimorpholino-2-ethyl-2-nitripropane, 2-bromo-2-nitropropane-1,3-diol and the like.
Examples of the surface tension adjustment and antifoaming agent include silicon surfactants and fluorine surfactants.
インキ化する時は、溶剤に芳香族アルコールを使用し、ロイコ染料、顕色剤を溶解して使用する場合は、マグネチックスターラーやスリーワンモーターなどでロイコ染料と顕色剤を溶解させた後、マイクロカプセルを添加し、ロールミル、ボールミル、サンドグラインダー、アトライター、ホモジナイザーなどで分散し得られる。
また、溶剤に炭化水素系溶剤や水を使用し、ロイコ染料と顕色剤を微粒子化して使用する場合には、ロイコ染料と顕色剤の微粒子、マイクロカプセルをロールミル、ボールミル、サンドグラインダー、アトライターなどで分散し得られる。その粒径は概ね1〜10μmが好ましい。When making an ink, use an aromatic alcohol as the solvent, and dissolve and use the leuco dye and developer, after dissolving the leuco dye and developer with a magnetic stirrer or three-one motor, Microcapsules can be added and dispersed using a roll mill, ball mill, sand grinder, attritor, homogenizer or the like.
When a hydrocarbon solvent or water is used as the solvent and the leuco dye and developer are finely divided, the fine particles of the leuco dye and developer and the microcapsules are roll mill, ball mill, sand grinder, atomizer. Can be dispersed with a lighter. The particle size is preferably about 1 to 10 μm.
次に、実施例及び比較例により本発明を更に詳細に説明するが、本発明は下記実施例等に限定されるものではない。 EXAMPLES Next, although an Example and a comparative example demonstrate this invention further in detail, this invention is not limited to the following Example etc.
マイクロカプセルを作成する方法として、in situ重合法や界面重合法などが知られている。in situ重合法は、カプセルの芯物質となる物質の溶液(油層)を水中に乳化した後、これにカプセル膜剤を加えて、油滴上で皮膜を重合させる方法である。界面重合法は、カプセル膜剤を溶解させた疎水性有機溶剤を水中に乳化させた後、カプセル膜剤の硬化剤を添加し、油滴界面で皮膜を生成させる方法である。 As a method for producing a microcapsule, an in situ polymerization method or an interfacial polymerization method is known. The in situ polymerization method is a method of emulsifying a solution (oil layer) of a substance serving as a core substance of a capsule in water, adding a capsule film agent thereto, and polymerizing the film on oil droplets. The interfacial polymerization method is a method in which a hydrophobic organic solvent in which a capsule film agent is dissolved is emulsified in water, and then a hardener for the capsule film agent is added to form a film at the oil droplet interface.
マイクロカプセル1(in situ重合法)
(芯物質乳化液の作成)
水 20.0重量部
BL−25(ポリオキシエチレンラウリルエーテル、日光ケミカルズ(株)製)
2.2重量部
上記各成分をマグネチックスターラーで1時間攪拌して、溶解させポリオキシエチレンラウリルエーテル水溶液を得た。
上記ポリオキシエチレンラウリルエーテル水溶液に、同量の酢酸−2−エチルヘキシル(エステル基を有する液体、沸点198.6℃)を添加し、ホモジナイザーにて9500rpmで1時間乳化させ、酢酸−2−エチルヘキシルを液滴とした水分散液を得た。
(カプセル膜剤の調整)
メラミンモノマー(東京化成工業(株)製)10.0重量部とホルムアルデヒド(37%水溶液、東京化成工業(株)製)20.0重量部とを混合し、25%水酸化ナトリウム水溶液でpH9に調整してマグネチックスターラーで80℃にて1時間撹拌し、カプセル膜剤を得た。
(マイクロカプセル化)
アラスター703S(スチレン−マレイン酸共重合体30±1%水溶液、荒川化学(株)製)
6.7重量部
水 15.5重量部
上記各成分を混合して酢酸でpH4.5に調整した後、マグネチックスターラーで1時間撹拌しスチレン−マレイン酸共重合体水溶液を得た。
上記ポリオキシエチレンラウリルエーテル水溶液と同量の上記スチレン−マレイン酸共重合体水溶液を混合し、マグネチックスターラーで1時間撹拌して、酢酸−2−エチルヘキシルの水分散液の液滴の表面にスチレン−マレイン酸共重合体を吸着させた。
上記芯物質乳化液66.6重量部に、上記カプセル膜剤33.4重量部を添加し、マグネチックスターラーで2時間撹拌して、酢酸−2−エチルヘキシルの芯物質液滴表面上にてメラミン樹脂を重合させたマイクロカプセル分散液を得た。これを自然乾燥し、平均粒径18.0μmで皮膜材質がメラミン樹脂のマイクロカプセル1を得た。Microcapsule 1 (in situ polymerization method)
(Creation of core material emulsion)
Water 20.0 parts by weight BL-25 (polyoxyethylene lauryl ether, manufactured by Nikko Chemicals Co., Ltd.)
2.2 parts by weight The above components were stirred for 1 hour with a magnetic stirrer and dissolved to obtain a polyoxyethylene lauryl ether aqueous solution.
To the above polyoxyethylene lauryl ether aqueous solution, the same amount of 2-ethylhexyl acetate (liquid having an ester group, boiling point 198.6 ° C.) is added and emulsified with a homogenizer at 9500 rpm for 1 hour, and 2-ethylhexyl acetate is added. An aqueous dispersion was obtained as droplets.
(Adjustment of capsule film)
Melamine monomer (Tokyo Chemical Industry Co., Ltd.) 10.0 parts by weight and formaldehyde (37% aqueous solution, Tokyo Chemical Industry Co., Ltd.) 20.0 parts by weight are mixed and adjusted to pH 9 with 25% aqueous sodium hydroxide solution. The mixture was adjusted and stirred with a magnetic stirrer at 80 ° C. for 1 hour to obtain a capsule membrane agent.
(Microencapsulation)
Alastar 703S (styrene-maleic acid copolymer 30 ± 1% aqueous solution, manufactured by Arakawa Chemical Co., Ltd.)
6.7 parts by weight water 15.5 parts by weight The above components were mixed and adjusted to pH 4.5 with acetic acid, and then stirred with a magnetic stirrer for 1 hour to obtain a styrene-maleic acid copolymer aqueous solution.
The same amount of the above styrene-maleic acid copolymer aqueous solution as the above polyoxyethylene lauryl ether aqueous solution is mixed and stirred with a magnetic stirrer for 1 hour. -A maleic acid copolymer was adsorbed.
Add 33.4 parts by weight of the capsule membrane agent to 66.6 parts by weight of the core material emulsion and stir with a magnetic stirrer for 2 hours to melamine on the surface of the core material droplet of 2-ethylhexyl acetate. A microcapsule dispersion obtained by polymerizing the resin was obtained. This was naturally dried to obtain microcapsules 1 having an average particle diameter of 18.0 μm and a film material of melamine resin.
マイクロカプセル2(in situ重合法)
上記マイクロカプセル1の製法において、酢酸−2−エチルヘキシルをマレイン酸ジブチル(エステル基を有する液体、沸点280.6℃)に置き換えた以外は、マイクロカプセル1の場合と同様にして、マレイン酸ジブチルの芯物質をメラミン樹脂で被覆したマイクロカプセル2を得た。Microcapsule 2 (in situ polymerization method)
In the production method of the microcapsule 1, the same procedure as in the case of the microcapsule 1 except that 2-ethylhexyl acetate was replaced with dibutyl maleate (liquid having an ester group, boiling point 280.6 ° C.). Microcapsules 2 in which the core material was coated with melamine resin were obtained.
マイクロカプセル3(in situ重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.0重量部
水 32.0重量部
上記各成分をマグネチックスターラーで1時間攪拌してスチレン−マレイン酸樹脂水溶解を得た。
上記スチレン−マレイン酸樹脂水溶液にジイソノニルフタレート(エステル基を有する沸点403℃の液体)20.0重量部を添加し、マグネチックスターラーで20分撹拌し、ジイソノニルフタレートを液滴とした水分散液を得た。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)22.5重量部とレソルシノール(尿素樹脂の架橋剤)2.0重量部と水16.0重量部とを混合し、マグネチックスターラーで攪拌し、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液60.0重量部を酢酸でpH4.2に調整し、上記カプセル膜剤40.5重量部を添加して、液温60℃でマグネチックスターラーにて2時間撹拌して、ジイソノニルフタレートの芯物質液滴表面上にて尿素樹脂を重合させたマイクロカプセル分散液を得た。これを自然乾燥し、平均粒径12.0μmで皮膜材質がメラミン樹脂のマイクロカプセル3を得た。Microcapsule 3 (in situ polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.0 parts by weight of water 32.0 parts by weight The above components were stirred with a magnetic stirrer for 1 hour to obtain a styrene-maleic acid resin water solution.
20.0 parts by weight of diisononyl phthalate (liquid having an ester group and a boiling point of 403 ° C.) is added to the styrene-maleic acid resin aqueous solution, and the mixture is stirred with a magnetic stirrer for 20 minutes to prepare an aqueous dispersion containing diisononyl phthalate as droplets. Obtained.
(Adjustment of capsule film)
22.5 parts by weight of becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation), 2.0 parts by weight of resorcinol (urea resin cross-linking agent) and 16.0 parts by weight of water were mixed, The capsule film agent was obtained by stirring with a magnetic stirrer.
(Microencapsulation)
60.0 parts by weight of the core material emulsion is adjusted to pH 4.2 with acetic acid, 40.5 parts by weight of the capsule membrane agent is added, and the mixture is stirred at a liquid temperature of 60 ° C. with a magnetic stirrer for 2 hours. A microcapsule dispersion in which urea resin was polymerized on the surface of the core material droplet of diisononyl phthalate was obtained. This was naturally dried to obtain microcapsules 3 having an average particle diameter of 12.0 μm and a film material of melamine resin.
マイクロカプセル4(in situ重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.0重量部
水 32.0重量部
上記各成分をマグネチックスターラーで1時間攪拌して、溶解させたスチレンマレイン酸樹脂水溶液を得た。
エチルシクロヘキサン(沸点132℃) 18.0重量部
フェニル酢酸p−トリル(エステル基を有する固体(結晶質))
2.0重量部
上記各成分をマグネチックスターラーで1時間攪拌して、フェニル酢酸p−トリルのエチルシクロヘキサン溶液を得た。
上記スチレンマレイン酸樹脂水溶液とフェニル酢酸p−トリルのエチルシクロヘキサン溶液とをマグネチックスターラーで20分間撹拌し、フェニル酢酸p−トリルのエチルシクロヘキサン溶液を液滴とした水分散液を得た。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)18.0重量部とレソルシノール(尿素樹脂の架橋剤)1.6重量部と水16.0重量部とを混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液60.0重量部を酢酸でpH4.2に調整し、上記カプセル膜剤35.6重量部を添加後、液温60℃に調整しマグネチックスターラーにて3時間撹拌して、フェニル酢酸p−トリルのエチルシクロヘキサン溶液の芯物質液滴表面上にて尿素樹脂を重合させた平均粒径12.0μmのマイクロカプセル分散液を得た。この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質が尿素樹脂であるマイクロカプセル4を得た。Microcapsule 4 (in situ polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.0 parts by weight of water 32.0 parts by weight Each of the above components was stirred with a magnetic stirrer for 1 hour to obtain a dissolved styrene maleic acid resin aqueous solution.
Ethylcyclohexane (boiling point 132 ° C.) 18.0 parts by weight p-tolyl phenylacetate (solid having an ester group (crystalline))
2.0 parts by weight The above components were stirred with a magnetic stirrer for 1 hour to obtain an ethylcyclohexane solution of p-tolyl phenylacetate.
The aqueous styrene maleic acid resin solution and the ethylcyclohexane solution of phenylacetic acid p-tolyl were stirred with a magnetic stirrer for 20 minutes to obtain an aqueous dispersion in which the ethylcyclohexane solution of phenylacetic acid p-tolyl was used as droplets.
(Adjustment of capsule film)
Becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation) 18.0 parts by weight, resorcinol (urea resin cross-linking agent) 1.6 parts by weight and water 16.0 parts by weight were mixed, The capsule membrane agent was obtained by stirring with a tic stirrer.
(Microencapsulation)
Adjust 60.0 parts by weight of the core material emulsion to pH 4.2 with acetic acid, add 35.6 parts by weight of the capsule membrane agent, adjust the liquid temperature to 60 ° C., and stir for 3 hours with a magnetic stirrer. A microcapsule dispersion having an average particle size of 12.0 μm was obtained by polymerizing urea resin on the surface of the core material droplet of ethylcyclohexane solution of p-tolyl phenylacetate. After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 4 whose film material was urea resin.
マイクロカプセル5(in situ重合法)
上記マイクロカプセル4の製法において、エチルシクロヘキサンと18.0重量部とフェニル酢酸p−トリル2.0重量部とを、酢酸ヘキシル(エステル基を有する液体、沸点170℃)18.0重量部とフェニル酢酸p−トリル(エステル基を有する固体(結晶質))2.0重量部とに置き換えた以外は、マイクロカプセル4の場合と同様にして、フェニル酢酸p−トリルの酢酸ヘキシル溶液の芯物質を尿素樹脂で被覆した平均粒径12.0μmのマイクロカプセル5を得た。Microcapsule 5 (in situ polymerization method)
In the production method of the above microcapsule 4, ethylcyclohexane, 18.0 parts by weight and 2.0 parts by weight of phenylacetate p-tolyl are mixed with 18.0 parts by weight of hexyl acetate (liquid having an ester group, boiling point 170 ° C.) and phenyl. The core substance of the hexyl acetate solution of p-tolyl phenylacetate was the same as in the case of the microcapsule 4 except that it was replaced with 2.0 parts by weight of p-tolyl acetate (solid (crystalline) having an ester group). Microcapsules 5 having an average particle diameter of 12.0 μm coated with urea resin were obtained.
マイクロカプセル6(in situ重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.0重量部
水 32.0重量部
上記各成分をマグネチックスターラーで1時間攪拌して、溶解させたスチレン−マレイン酸樹脂水溶液を得た。
シクロヘキシルベンゼン 5.0重量部
酢酸2−エチルヘキシル(エステル基を有する液体、沸点200℃)
15.0重量部
上記各成分をマグネチックスターラーで1時間攪拌して、シクロヘキシルベンゼンと酢酸2−エチルヘキシルの溶液を得た。
上記スチレンマレイン酸樹脂水溶液と、シクロヘキシルベンゼンと酢酸2−エチルヘキシルとの溶液とを、ホモジナイザーにて6500rpmで10分間撹拌し、シクロヘキシルベンゼンと酢酸2−エチルヘキシルとの溶液を液滴とした水分散液を得た。
(カプセル膜剤の調整)
ベッカミン M−3(メラミン樹脂プレポリマー、不揮発分80%、DIC(株)製)22.5重量部と水15.0重量部とを混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液60.0重量部を酢酸でpH4.8に調整し、上記カプセル膜剤37.5重量部を添加後、液温60℃に調整しマグネチックスターラーにて3時間撹拌して、シクロヘキシルベンゼンと酢酸2−エチルヘキシルとの溶液の芯物質液滴表面上にてメラミン樹脂を重合させた平均粒径9.0μmのマイクロカプセル分散液を得た。この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質がメラミン樹脂であるマイクロカプセル6を得た。Microcapsule 6 (in situ polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.0 parts by weight of water 32.0 parts by weight The above components were stirred with a magnetic stirrer for 1 hour to obtain a dissolved styrene-maleic acid resin aqueous solution.
Cyclohexylbenzene 5.0 parts by weight 2-ethylhexyl acetate (liquid having an ester group, boiling point 200 ° C.)
15.0 parts by weight Each of the above components was stirred with a magnetic stirrer for 1 hour to obtain a solution of cyclohexylbenzene and 2-ethylhexyl acetate.
The aqueous styrene maleic acid resin solution and a solution of cyclohexylbenzene and 2-ethylhexyl acetate were stirred at 6500 rpm for 10 minutes with a homogenizer, and an aqueous dispersion in which a solution of cyclohexylbenzene and 2-ethylhexyl acetate was used as droplets was obtained. Obtained.
(Adjustment of capsule film)
Becamine M-3 (melamine resin prepolymer, non-volatile content 80%, manufactured by DIC Corporation) 22.5 parts by weight and 15.0 parts by weight of water were mixed and stirred with a magnetic stirrer to obtain a capsule film agent It was.
(Microencapsulation)
60.0 parts by weight of the core material emulsion is adjusted to pH 4.8 with acetic acid, 37.5 parts by weight of the capsule membrane agent is added, the liquid temperature is adjusted to 60 ° C., and the mixture is stirred with a magnetic stirrer for 3 hours. A microcapsule dispersion having an average particle size of 9.0 μm was obtained by polymerizing a melamine resin on the surface of the core material droplet of a solution of cyclohexylbenzene and 2-ethylhexyl acetate. After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 6 whose film material was melamine resin.
マイクロカプセル7(in situ重合法)
上記マイクロカプセル3の製法において、ジイソノニルフタレート(エステル基を有する沸点403℃の液体)20.0重量部をジイソノニルフタレート(エステル基を有する沸点403℃の液体)18.0重量部とフェニル酢酸p−トリル(エステル基を有する固体(結晶質))2.0重量部とに置き換えた以外は、マイクロカプセル3の場合と同様にして、フェニル酢酸p−トリルのジイソノニルフタレート溶液の芯物質を尿素樹脂で被覆した平均粒径12.0μmのマイクロカプセル7を得た。Microcapsule 7 (in situ polymerization method)
In the production method of the microcapsule 3, 20.0 parts by weight of diisononyl phthalate (liquid having an ester group and a boiling point of 403 ° C.) is mixed with 18.0 parts by weight of diisononyl phthalate (liquid having an ester group and a boiling point of 403 ° C.) and phenylacetic acid p- The core substance of the diisononyl phthalate solution of p-tolyl phenylacetate was replaced with urea resin in the same manner as in the microcapsule 3 except that it was replaced with 2.0 parts by weight of tolyl (solid having an ester group (crystalline)). A coated microcapsule 7 having an average particle diameter of 12.0 μm was obtained.
マイクロカプセル8(in situ重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.0重量部
水 32.0重量部
上記各成分をマグネチックスターラーで1時間攪拌して、溶解させたスチレン−マレイン酸樹脂水溶液を得た。
上記スチレン−マレイン酸樹脂水溶液とジイソノニルフタレート(エステル基を有する沸点403℃の液体)20.0重量部とをホモジナイザーにて9500rpmで10分間撹拌し、ジイソノニルフタレートを液滴とした水分散液を得た。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)22.5重量部とレソルシノール(尿素樹脂の架橋剤)2.0重量部と水16.0重量部とを混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液60.0重量部を酢酸でpH4.2に調整し、上記カプセル膜剤40.5重量部を添加後、液温60℃に調整しマグネチックスターラーにて3時間撹拌してジイソノニルフタレートの芯物質液滴表面上にて尿素樹脂を重合させた平均粒径4.0μmのマイクロカプセル分散液を得た。この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質が尿素樹脂であるマイクロカプセル8を得た。Microcapsule 8 (in situ polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.0 parts by weight of water 32.0 parts by weight The above components were stirred with a magnetic stirrer for 1 hour to obtain a dissolved styrene-maleic acid resin aqueous solution.
The aqueous styrene-maleic acid resin solution and 20.0 parts by weight of diisononyl phthalate (liquid having an ester group and a boiling point of 403 ° C.) are stirred with a homogenizer at 9500 rpm for 10 minutes to obtain an aqueous dispersion having diisononyl phthalate as droplets. It was.
(Adjustment of capsule film)
22.5 parts by weight of becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation), 2.0 parts by weight of resorcinol (urea resin cross-linking agent) and 16.0 parts by weight of water were mixed. The capsule membrane agent was obtained by stirring with a tic stirrer.
(Microencapsulation)
Adjust 60.0 parts by weight of the core material emulsion to pH 4.2 with acetic acid, add 40.5 parts by weight of the capsule membrane agent, adjust the liquid temperature to 60 ° C., and stir for 3 hours with a magnetic stirrer. A microcapsule dispersion having an average particle size of 4.0 μm was obtained by polymerizing urea resin on the surface of the core material droplet of diisononyl phthalate. After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 8 whose film material was urea resin.
マイクロカプセル9(in situ重合法)
(芯物質乳化液の作成)
NIKKOL MYS−55V(モノステアリン酸ポリエチレングリコール、日光ケミカルズ(株)製)
0.4重量部
水 20.0重量部
上記各成分をマグネチックスターラーで1時間攪拌して、溶解させモノステアリン酸ポリエチレングリコール水溶液を得た。
ジブチルエーテル(エーテル基を有する液体) 18.0重量部
ハイラック111(ケトン樹脂(非晶質)、日立化成工業(株)製)
2.0重量部
上記各成分をマグネチックスターラーで1時間溶解し、ケトン樹脂のジブチルエーテル溶液を得た。
上記ステアリン酸ポリエチレングリコール水溶液20.4重量部に、ケトン樹脂のジブチルエーテル溶液20.0重量部を添加し、ホモジナイザー(Star Burst Mini、スギノマシン(株)製)にて圧力80MPaで、1パスし、ケトン樹脂のジブチルエーテル溶液を液滴とした水分散液を得た。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)22.5重量部とレソルシノール(尿素樹脂の架橋剤)2.0重量部と水16.0重量部を混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
6.5重量部
水 15.0重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸樹脂水溶液を得た。
上記ケトン樹脂のジブチルエーテル溶液を液滴とした水分散液にスチレン−マレイン酸樹脂水溶液を混合しホモジナイザーにて13500rpmで10分間撹拌して、ケトン樹脂のジブチルエーテル溶液の液滴の表面にスチレン−マレイン酸樹脂を吸着させた。
上記スチレン−マレイン酸樹脂を吸着させた芯物質乳化液61.9重量部を酢酸でpH4.2調整、上記カプセル膜剤40.5重量部を添加し、液温60℃にてマグネチックスターラーで2時間撹拌して、ケトン樹脂のジブチルエーテル溶液の芯物質液滴表面上にて尿素樹脂を重合させた平均粒径0.5μmのマイクロカプセル分散液を得た。この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質が尿素樹脂であるマイクロカプセル9を得た。Microcapsule 9 (in situ polymerization method)
(Creation of core material emulsion)
NIKKOL MYS-55V (polyethylene glycol monostearate, manufactured by Nikko Chemicals Corporation)
0.4 parts by weight of water 20.0 parts by weight The above components were stirred for 1 hour with a magnetic stirrer and dissolved to obtain a polyethylene glycol monostearate aqueous solution.
Dibutyl ether (liquid having an ether group) 18.0 parts by weight Hilac 111 (ketone resin (amorphous), manufactured by Hitachi Chemical Co., Ltd.)
2.0 parts by weight Each of the above components was dissolved with a magnetic stirrer for 1 hour to obtain a dibutyl ether solution of a ketone resin.
20.0 parts by weight of a dibutyl ether solution of a ketone resin is added to 20.4 parts by weight of the aqueous polyethylene glycol stearate solution, and one pass is performed with a homogenizer (Star Burst Mini, manufactured by Sugino Machine Co., Ltd.) at a pressure of 80 MPa. Then, an aqueous dispersion having droplets of a dibutyl ether solution of a ketone resin was obtained.
(Adjustment of capsule film)
Becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation) 22.5 parts by weight, resorcinol (urea resin crosslinking agent) 2.0 parts by weight and water 16.0 parts by weight, magnetic The capsule membrane agent was obtained by stirring with a stirrer.
(Microencapsulation)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
6.5 weight part water 15.0 weight part The said each component was mixed and it stirred with the magnetic stirrer for 1 hour, and obtained styrene- maleic acid resin aqueous solution.
A styrene-maleic acid resin aqueous solution is mixed with an aqueous dispersion of the above-mentioned ketone resin dibutyl ether solution as droplets and stirred at 13500 rpm for 10 minutes with a homogenizer. Maleic acid resin was adsorbed.
61.9 parts by weight of the core material emulsified liquid adsorbed with the styrene-maleic acid resin was adjusted to pH 4.2 with acetic acid, and 40.5 parts by weight of the capsule film agent was added. The mixture was stirred for 2 hours to obtain a microcapsule dispersion having an average particle size of 0.5 μm in which urea resin was polymerized on the surface of the core material droplet of a dibutyl ether solution of ketone resin. After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 9 whose film material was urea resin.
マイクロカプセル10(in situ重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.0重量部
水 32.0重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸樹脂水溶液を得た。
酢酸ヘキシル(エステル基を有する液体、沸点170℃) 18.0重量部
ハイラック111(ケトン樹脂(非晶質)、日立化成工業(株)製)
2.0重量部
上記各成分をマグネチックスターラーで1時間溶解し、ケトン樹脂の酢酸ヘキシル溶液を得た。
上記スチレン−マレイン酸樹脂水溶液40.0重量部に、ケトン樹脂の酢酸ヘキシル溶液20.0重量部を添加し、マグネチックスターラーで20分間撹拌し、ケトン樹脂酢酸ヘキシル溶液を液滴とした水分散液を得た。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)22.5重量部とレソルシノール(尿素樹脂の架橋剤)2.0重量部と水16.0重量部とを混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液60.0重量部を酢酸でpH4.2に調整し、上記カプセル膜剤40.5重量部を添加し、液温60℃にてマグネチックスターラーで2時間撹拌して、ケトン樹脂の酢酸ヘキシル溶液の芯物質液滴表面上にて尿素樹脂を重合させた平均粒径12.0μmのマイクロカプセル分散液を得た。この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質が尿素樹脂であるマイクロカプセル10を得た。Microcapsule 10 (in situ polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.0 parts by weight of water 32.0 parts by weight The above components were mixed and stirred with a magnetic stirrer for 1 hour to obtain a styrene-maleic acid resin aqueous solution.
Hexyl acetate (liquid having ester group, boiling point 170 ° C.) 18.0 parts by weight Hilac 111 (ketone resin (amorphous), manufactured by Hitachi Chemical Co., Ltd.)
2.0 parts by weight Each of the above components was dissolved with a magnetic stirrer for 1 hour to obtain a hexyl acetate solution of a ketone resin.
20.0 parts by weight of a ketone resin hexyl acetate solution is added to 40.0 parts by weight of the styrene-maleic acid resin aqueous solution, and the mixture is stirred with a magnetic stirrer for 20 minutes. A liquid was obtained.
(Adjustment of capsule film)
22.5 parts by weight of becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation), 2.0 parts by weight of resorcinol (urea resin cross-linking agent) and 16.0 parts by weight of water were mixed. The capsule membrane agent was obtained by stirring with a tic stirrer.
(Microencapsulation)
60.0 parts by weight of the above core substance emulsion is adjusted to pH 4.2 with acetic acid, 40.5 parts by weight of the above capsule membrane agent is added, and stirred at a liquid temperature of 60 ° C. with a magnetic stirrer for 2 hours. A microcapsule dispersion having an average particle diameter of 12.0 μm was obtained by polymerizing urea resin on the surface of the core material droplet of a hexyl acetate solution of the resin. After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 10 whose film material was urea resin.
マイクロカプセル11(in situ重合法)
(芯物質乳化液の作成)
水 20.0重量部
BL−25(ポリオキシエチレンラウリルエーテル、日光ケミカルズ(株)製)
2.2重量部
上記各成分をマグネチックスターラーで1時間攪拌して、溶解させポリオキシエチレンラウリルエーテル水溶液を得た。
アラスター703S(スチレン−マレイン酸30±1%水溶液、荒川化学(株)製)
13.3重量部
水 31.1重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸樹脂水溶液を得た。
酢酸イソブチル(エステル基を有する液体、沸点116.6℃)
20.0重量部
BS−2(ポリオキシエチレンステアリルエーテル、日光ケミカルズ(株))
2.2重量部
上記各成分をマグネチックスターラーで1時間溶解し、ポリオキシエチレンステアリルエーテルの酢酸イソブチル溶液を得た。
上記ポリオキシエチレンラウリルエーテル水溶液22.2重量部に、ポリオキシエチレンステアリルエーテルの酢酸イソブチル溶液22.2重量部を添加し、ホモジナイザー(Star Burst Mini、スギノマシン(株)製)にて圧力80MPaで、2パスする。ここにスチレン−マレイン酸樹脂水溶液44.4重量部を添加し、更にマグネチックスターラーで1時間撹拌させ、ポリオキシエチレンステアリルエーテルの酢酸イソブチル溶液を液滴とした水分散液を得た。
(カプセル膜剤の調整)
メラミンモノマー(東京化成工業(株)製)10.0重量部とホルムアルデヒド(37%水溶液、東京化成工業(株)製)20.0重量部とを混合し、25%水酸化ナトリウム水溶液でpH9に調整してマグネチックスターラーで80℃にて1時間撹拌し、カプセル膜剤を得た。
(マイクロカプセル化)
アラスター703S(スチレン−マレイン酸共重合体30±1%水溶液、荒川化学(株)製)
13.3重量部
水 31.1重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸共重合体(樹脂)水溶液を得た。
ポリオキシエチレンステアリルエーテルの酢酸イソブチル溶液を液滴とした水分散液にスチレン−マレイン酸樹脂水溶液を混合し、マグネチックスターラーで1時間撹拌して、ポリオキシエチレンステアリルエーテルの酢酸イソブチル溶液の液滴の表面にスチレン−マレイン酸樹脂を吸着させた。
上記スチレン−マレイン酸樹脂を吸着させた芯物質乳化液88.8重量部を酢酸でpH4.8に調整し、上記カプセル膜剤30.0重量部を添加し、マグネチックスターラーで2時間撹拌して、ポリオキシエチレンステアリルエーテルの酢酸イソブチル溶液の芯物質液滴表面上にてメラミン樹脂を重合させた平均粒径0.08μmのマイクロカプセル分散液を得た。これを自然乾燥し、皮膜材質がメラミン樹脂であるマイクロカプセル11を得た。Microcapsule 11 (in situ polymerization method)
(Creation of core material emulsion)
Water 20.0 parts by weight BL-25 (polyoxyethylene lauryl ether, manufactured by Nikko Chemicals Co., Ltd.)
2.2 parts by weight The above components were stirred for 1 hour with a magnetic stirrer and dissolved to obtain a polyoxyethylene lauryl ether aqueous solution.
ALASTAR 703S (styrene-maleic acid 30 ± 1% aqueous solution, manufactured by Arakawa Chemical Co., Ltd.)
13.3 parts by weight of water 31.1 parts by weight The above components were mixed and stirred with a magnetic stirrer for 1 hour to obtain a styrene-maleic acid resin aqueous solution.
Isobutyl acetate (liquid with ester group, boiling point 116.6 ° C)
20.0 parts by weight BS-2 (polyoxyethylene stearyl ether, Nikko Chemicals Corporation)
2.2 parts by weight The above components were dissolved with a magnetic stirrer for 1 hour to obtain an isobutyl acetate solution of polyoxyethylene stearyl ether.
22.2 parts by weight of an isobutyl acetate solution of polyoxyethylene stearyl ether is added to 22.2 parts by weight of the above polyoxyethylene lauryl ether aqueous solution, and the pressure is 80 MPa with a homogenizer (Star Burst Mini, manufactured by Sugino Machine Co., Ltd.). 2 passes. 44.4 parts by weight of a styrene-maleic acid resin aqueous solution was added thereto, and the mixture was further stirred with a magnetic stirrer for 1 hour to obtain an aqueous dispersion in which an isobutyl acetate solution of polyoxyethylene stearyl ether was used as droplets.
(Adjustment of capsule film)
Melamine monomer (Tokyo Chemical Industry Co., Ltd.) 10.0 parts by weight and formaldehyde (37% aqueous solution, Tokyo Chemical Industry Co., Ltd.) 20.0 parts by weight are mixed and adjusted to pH 9 with 25% aqueous sodium hydroxide solution. The mixture was adjusted and stirred with a magnetic stirrer at 80 ° C. for 1 hour to obtain a capsule membrane agent.
(Microencapsulation)
Alastar 703S (styrene-maleic acid copolymer 30 ± 1% aqueous solution, manufactured by Arakawa Chemical Co., Ltd.)
13.3 parts by weight of water 31.1 parts by weight The above components were mixed and stirred with a magnetic stirrer for 1 hour to obtain a styrene-maleic acid copolymer (resin) aqueous solution.
A water dispersion of polyoxyethylene stearyl ether in isobutyl acetate is mixed with an aqueous dispersion of styrene-maleic acid resin and stirred with a magnetic stirrer for 1 hour to form droplets of polyoxyethylene stearyl ether in isobutyl acetate. A styrene-maleic acid resin was adsorbed on the surface of the film.
The core material emulsion 88.8 parts by weight of the styrene-maleic acid resin adsorbed is adjusted to pH 4.8 with acetic acid, 30.0 parts by weight of the capsule film agent is added, and the mixture is stirred with a magnetic stirrer for 2 hours. Thus, a microcapsule dispersion having an average particle size of 0.08 μm was obtained by polymerizing a melamine resin on the surface of the core material droplet of an isobutyl acetate solution of polyoxyethylene stearyl ether. This was naturally dried to obtain microcapsules 11 whose film material was melamine resin.
マイクロカプセル12(in situ重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.0重量部
水 32.0重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸樹脂水溶液を得た。
酢酸ヘキシル(エステル基を有する液体、沸点170℃) 18.0重量部
1,3−ジフェニル−1,3プロパンジオン(ケトン基を有する固体(結晶質))
2.0重量部
上記各成分をマグネチックスターラーで1時間溶解し、1,3−ジフェニル−1,3プロパンジオンの酢酸ヘキシル溶液を得た。
上記スチレン−マレイン酸樹脂水溶液40.0重量部に、1,3−ジフェニル−1,3プロパンジオンの酢酸ヘキシル溶液20.0重量部を添加し、ホモジナイザーにて13500rpmで10分間撹拌し、1,3−ジフェニル−1,3プロパンジオンの酢酸ヘキシル溶液を液滴とした水分散液を得た。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)22.5重量部とレソルシノール(尿素樹脂の架橋剤)2.0重量部と水16.0重量部を混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液60.0重量部を酢酸でpH4.2に調整し、上記カプセル膜剤40.5重量部を添加し、液温60℃にてマグネチックスターラーで3時間撹拌して、1,3−ジフェニル−1,3プロパンジオンの酢酸ヘキシル溶液の芯物質液滴表面上にて尿素樹脂を重合させた平均粒径3.0μmのマイクロカプセル分散液を得た。
この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質が尿素樹脂であるマイクロカプセル12を得た。Microcapsule 12 (in situ polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.0 parts by weight of water 32.0 parts by weight The above components were mixed and stirred with a magnetic stirrer for 1 hour to obtain a styrene-maleic acid resin aqueous solution.
Hexyl acetate (liquid having ester group, boiling point 170 ° C.) 18.0 parts by weight 1,3-diphenyl-1,3-propanedione (solid having ketone group (crystalline))
2.0 parts by weight The above components were dissolved with a magnetic stirrer for 1 hour to obtain a hexyl acetate solution of 1,3-diphenyl-1,3-propanedione.
To 40.0 parts by weight of the styrene-maleic acid resin aqueous solution, 20.0 parts by weight of a hexyl acetate solution of 1,3-diphenyl-1,3-propanedione is added and stirred at 13500 rpm for 10 minutes with a homogenizer. An aqueous dispersion having droplets of a hexyl acetate solution of 3-diphenyl-1,3-propanedione was obtained.
(Adjustment of capsule film)
Becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation) 22.5 parts by weight, resorcinol (urea resin crosslinking agent) 2.0 parts by weight and water 16.0 parts by weight, magnetic The capsule membrane agent was obtained by stirring with a stirrer.
(Microencapsulation)
60.0 parts by weight of the core material emulsion is adjusted to pH 4.2 with acetic acid, 40.5 parts by weight of the capsule membrane agent is added, and stirred at a liquid temperature of 60 ° C. with a magnetic stirrer for 3 hours. A microcapsule dispersion having an average particle size of 3.0 μm was obtained by polymerizing urea resin on the surface of the core material droplet of a hexyl acetate solution of 1,3-diphenyl-1,3-propanedione.
After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 12 whose film material was urea resin.
マイクロカプセル13(in situ重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.0重量部
水 32.0重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸樹脂水溶液を得た。
酢酸ヘキシル(エステル基を有する液体、沸点170℃) 18.0重量部
セタノール(脂肪族水酸基を有する固体(結晶質)) 2.0重量部
上記各成分をマグネチックスターラーで1時間溶解し、セタノールの酢酸ヘキシル溶液を得た。
上記スチレン−マレイン酸樹脂水溶液40.0重量部に、セタノールの酢酸ヘキシル溶液20.0重量部を添加し、ホモジナイザーにて6500rpmで10分間撹拌し、セタノールの酢酸ヘキシル溶液を液滴とした水分散液を得た。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)22.5重量部とレソルシノール(尿素樹脂の架橋剤)2.0重量部と水16.0重量部を混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液60重量部を酢酸でpH4.2に調整し、上記カプセル膜剤40.5重量部を添加し、液温60℃にてマグネチックスターラーで3時間撹拌して、セタノールの酢酸ヘキシル溶液の芯物質液滴表面上にて尿素樹脂を重合させた平均粒径7.0μmのマイクロカプセル分散液を得た。この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質が尿素樹脂であるマイクロカプセル13を得た。Microcapsule 13 (in situ polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.0 parts by weight of water 32.0 parts by weight The above components were mixed and stirred with a magnetic stirrer for 1 hour to obtain a styrene-maleic acid resin aqueous solution.
Hexyl acetate (liquid having an ester group, boiling point 170 ° C.) 18.0 parts by weight cetanol (solid having an aliphatic hydroxyl group (crystalline)) 2.0 parts by weight The above components are dissolved with a magnetic stirrer for 1 hour, and cetanol Of hexyl acetate was obtained.
20.0 parts by weight of cetanol acetate hexyl acetate solution is added to 40.0 parts by weight of the above styrene-maleic acid resin aqueous solution, and the mixture is stirred with a homogenizer at 6500 rpm for 10 minutes, and dispersed in water with cetanol acetate hexyl acetate as droplets. A liquid was obtained.
(Adjustment of capsule film)
Becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation) 22.5 parts by weight, resorcinol (urea resin crosslinking agent) 2.0 parts by weight and water 16.0 parts by weight, magnetic The capsule membrane agent was obtained by stirring with a stirrer.
(Microencapsulation)
60 parts by weight of the above core substance emulsion was adjusted to pH 4.2 with acetic acid, 40.5 parts by weight of the above capsule membrane agent was added, and the mixture was stirred with a magnetic stirrer at 60 ° C. for 3 hours. A microcapsule dispersion having an average particle size of 7.0 μm obtained by polymerizing urea resin on the surface of the core material droplet of the hexyl solution was obtained. After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 13 whose film material was urea resin.
マイクロカプセル14(in situ重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.0重量部
水 32.0重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸樹脂水溶液を得た。
酢酸ヘキシル(エステル基を有する液体、沸点170℃) 18.0重量部
4−メトキシベンゾフェノン(ケトン基、エーテル基を有する固体(結晶質))
2.0重量部
上記各成分をマグネチックスターラーで1時間溶解し、4−メトキシベンゾフェノンの酢酸ヘキシル溶液を得た。
上記スチレン−マレイン酸樹脂水溶液40.0重量部に、4−メトキシベンゾフェノンの酢酸ヘキシル溶液20.0重量部を添加し、ホモジナイザーにて17500rpmで10分間撹拌し、4−メトキシベンゾフェノンの酢酸ヘキシル溶液を液滴とした水分散液を得た。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)22.5重量部とレソルシノール(尿素樹脂の架橋剤)2.0重量部と水16.0重量部を混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液60重量部を酢酸でpH4.2に調整し、上記カプセル膜剤40.5重量部を添加し、液温60℃にてマグネチックスターラーで3時間撹拌して、4−メトキシベンゾフェノンの酢酸ヘキシル溶液の芯物質液滴表面上にて尿素樹脂を重合させた平均粒径2.0μmのマイクロカプセル分散液を得た。この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質が尿素樹脂であるマイクロカプセル14を得た。Microcapsule 14 (in situ polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.0 parts by weight of water 32.0 parts by weight The above components were mixed and stirred with a magnetic stirrer for 1 hour to obtain a styrene-maleic acid resin aqueous solution.
Hexyl acetate (liquid having an ester group, boiling point: 170 ° C.) 18.0 parts by weight 4-methoxybenzophenone (solid having a ketone group and an ether group (crystalline))
2.0 parts by weight The above components were dissolved with a magnetic stirrer for 1 hour to obtain a hexyl acetate solution of 4-methoxybenzophenone.
To 40.0 parts by weight of the aqueous styrene-maleic acid resin solution, 20.0 parts by weight of hexyl acetate solution of 4-methoxybenzophenone is added and stirred for 10 minutes at 17500 rpm with a homogenizer, and hexyl acetate solution of 4-methoxybenzophenone is added. An aqueous dispersion was obtained as droplets.
(Adjustment of capsule film)
Becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation) 22.5 parts by weight, resorcinol (urea resin crosslinking agent) 2.0 parts by weight and water 16.0 parts by weight, magnetic The capsule membrane agent was obtained by stirring with a stirrer.
(Microencapsulation)
60 parts by weight of the core material emulsion is adjusted to pH 4.2 with acetic acid, 40.5 parts by weight of the capsule membrane agent is added, and the mixture is stirred at a liquid temperature of 60 ° C. with a magnetic stirrer for 3 hours. A microcapsule dispersion having an average particle size of 2.0 μm was obtained by polymerizing urea resin on the surface of the core material droplet of hexyl acetate solution of benzophenone. After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 14 whose film material was urea resin.
マイクロカプセル15(in situ重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.0重量部
水 32.0重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸樹脂水溶液を得た。
酢酸ヘキシル(エステル基を有する液体、沸点170℃) 18.0重量部
3,4,5−トリメトキシ安息香酸メチル(エステル基、エーテル基を有する固体(結晶質))
2.0重量部
上記各成分をマグネチックスターラーで1時間溶解し、3,4,5−トリメトキシ安息香酸メチルの酢酸ヘキシル溶液を得た。
上記スチレン−マレイン酸樹脂水溶液40.0重量部に、3,4,5−トリメトキシ安息香酸メチルの酢酸ヘキシル溶液20.0重量部を添加し、ホモジナイザーにて13500rpmで10分間撹拌し、3,4,5−トリメトキシ安息香酸メチルの酢酸ヘキシル溶液を液滴とした水分散液を得た。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)27.6重量部とレソルシノール(尿素樹脂の架橋剤)2.5重量部と水16.0重量部を混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液60重量部を酢酸でpH4.2に調整し、上記カプセル膜剤46.1重量部を添加し、液温60℃にてマグネチックスターラーで3時間撹拌して、3,4,5−トリメトキシ安息香酸メチルの酢酸ヘキシル溶液の芯物質液滴表面上にて尿素樹脂を重合させた平均粒径3.0μmのマイクロカプセル分散液を得た。この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質が尿素樹脂であるマイクロカプセル15を得た。Microcapsule 15 (in situ polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.0 parts by weight of water 32.0 parts by weight The above components were mixed and stirred with a magnetic stirrer for 1 hour to obtain a styrene-maleic acid resin aqueous solution.
Hexyl acetate (liquid having an ester group, boiling point 170 ° C.) 18.0 parts by weight methyl 3,4,5-trimethoxybenzoate (solid having an ester group and an ether group (crystalline))
2.0 parts by weight Each of the above components was dissolved with a magnetic stirrer for 1 hour to obtain a hexyl acetate solution of methyl 3,4,5-trimethoxybenzoate.
20.0 parts by weight of a hexyl acetate solution of methyl 3,4,5-trimethoxybenzoate is added to 40.0 parts by weight of the styrene-maleic acid resin aqueous solution, and the mixture is stirred with a homogenizer at 13500 rpm for 10 minutes. An aqueous dispersion having droplets of hexyl acetate solution of methyl, 5-trimethoxybenzoate was obtained.
(Adjustment of capsule film)
Becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation) 27.6 parts by weight, resorcinol (urea resin cross-linking agent) 2.5 parts by weight and water 16.0 parts by weight, magnetic The capsule film was obtained by stirring with a stirrer.
(Microencapsulation)
60 parts by weight of the core material emulsion is adjusted to pH 4.2 with acetic acid, 46.1 parts by weight of the capsule membrane agent is added, and the mixture is stirred at a liquid temperature of 60 ° C. with a magnetic stirrer for 3 hours. A microcapsule dispersion having an average particle size of 3.0 μm was obtained by polymerizing urea resin on the surface of the core material droplet of a hexyl acetate solution of methyl 5-trimethoxybenzoate. After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 15 whose film material was urea resin.
マイクロカプセル16(in situ重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.0重量部
水 32.0重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸樹脂水溶液を得た。
酢酸2−エチルヘキシル(エステル基を有する液体、沸点198.6℃)
19.8重量部
リン酸トリフェニル(エーテル基を有する固体) 0.2重量部
上記各成分をマグネチックスターラーで1時間溶解し、リン酸トリフェニルの酢酸2−エチルヘキシル溶液を得た。
上記スチレン−マレイン酸樹脂水溶液40.0重量部に、リン酸トリフェニルの酢酸2−エチルヘキシル溶液20.0重量部を添加し、ホモジナイザーにて13500rpmで10分間撹拌し、リン酸トリフェニルの酢酸2−エチルヘキシル溶液を液滴とした水分散液を得る。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)20.0重量部とレソルシノール(尿素樹脂の架橋剤)1.8重量部と水16.0重量部を混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液60重量部を酢酸でpH4.2に調整し、上記カプセル膜剤37.8重量部を添加し、液温60℃にてマグネチックスターラーで3時間撹拌して、リン酸トリフェニルの酢酸2−エチルヘキシル溶液の芯物質液滴表面上にて尿素樹脂を重合させた平均粒径1.0μmのマイクロカプセル分散液を得た。この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質が尿素樹脂であるマイクロカプセル16を得た。Microcapsule 16 (in situ polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.0 parts by weight of water 32.0 parts by weight The above components were mixed and stirred with a magnetic stirrer for 1 hour to obtain a styrene-maleic acid resin aqueous solution.
2-ethylhexyl acetate (liquid having an ester group, boiling point 198.6 ° C.)
19.8 parts by weight Triphenyl phosphate (solid having an ether group) 0.2 part by weight The above components were dissolved with a magnetic stirrer for 1 hour to obtain a 2-ethylhexyl acetate solution of triphenyl phosphate.
20.0 parts by weight of a triethyl phosphate 2-ethylhexyl acetate solution is added to 40.0 parts by weight of the styrene-maleic acid resin aqueous solution, and the mixture is stirred with a homogenizer at 13500 rpm for 10 minutes. -Obtain an aqueous dispersion in which ethylhexyl solution is used as droplets.
(Adjustment of capsule film)
Becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation) 20.0 parts by weight, resorcinol (urea resin cross-linking agent) 1.8 parts by weight and water 16.0 parts by weight, magnetic The capsule membrane agent was obtained by stirring with a stirrer.
(Microencapsulation)
60 parts by weight of the core material emulsion is adjusted to pH 4.2 with acetic acid, 37.8 parts by weight of the capsule membrane agent is added, and the mixture is stirred at a liquid temperature of 60 ° C. for 3 hours with a magnetic stirrer. A microcapsule dispersion having an average particle size of 1.0 μm was obtained by polymerizing urea resin on the surface of the core material droplet of phenyl 2-ethylhexyl acetate solution. After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 16 whose film material was urea resin.
マイクロカプセル17(in situ重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.0重量部
水 32.0重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸樹脂水溶液を得た。
酢酸アミル(エステル基を有する液体、沸点149.2℃)
19.0重量部
4−アセトキシ安息香酸メチル(エステル基を有する固体(結晶質))
1.0重量部
上記各成分をマグネチックスターラーで1時間溶解し、4−アセトキシ安息香酸メチルの酢酸アミル溶液を得た。
上記スチレン−マレイン酸樹脂水溶液40.0重量部に、4−アセトキシ安息香酸メチルの酢酸アミル溶液20.0重量部を添加し、ホモジナイザーにて13500rpmで10分間撹拌し、4−アセトキシ安息香酸メチルの酢酸アミル溶液を液滴とした水分散液を得た。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)20.0重量部とレソルシノール(尿素樹脂の架橋剤)1.8重量部と水16.0重量部を混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液60.0重量部を酢酸でpH4.2に調整し、上記カプセル膜剤37.8重量部を添加し、液温60℃にてマグネチックスターラーで3時間撹拌して、4−アセトキシ安息香酸メチルの酢酸アミル溶液の芯物質液滴表面上にて尿素樹脂を重合させた平均粒径5.0μmのマイクロカプセル分散液を得た。この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質が尿素樹脂であるマイクロカプセル17を得た。Microcapsule 17 (in situ polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.0 parts by weight of water 32.0 parts by weight The above components were mixed and stirred with a magnetic stirrer for 1 hour to obtain a styrene-maleic acid resin aqueous solution.
Amyl acetate (liquid with ester group, boiling point 149.2 ° C)
19.0 parts by weight methyl 4-acetoxybenzoate (solid having an ester group (crystalline))
1.0 part by weight Each of the above components was dissolved with a magnetic stirrer for 1 hour to obtain an amyl acetate solution of methyl 4-acetoxybenzoate.
To 40.0 parts by weight of the aqueous styrene-maleic acid resin solution, 20.0 parts by weight of an amyl acetate solution of methyl 4-acetoxybenzoate was added and stirred for 10 minutes at 13500 rpm with a homogenizer. An aqueous dispersion having droplets of amyl acetate solution was obtained.
(Adjustment of capsule film)
Becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation) 20.0 parts by weight, resorcinol (urea resin cross-linking agent) 1.8 parts by weight and water 16.0 parts by weight, magnetic The capsule membrane agent was obtained by stirring with a stirrer.
(Microencapsulation)
60.0 parts by weight of the core material emulsion is adjusted to pH 4.2 with acetic acid, 37.8 parts by weight of the capsule membrane agent is added, and the mixture is stirred at a liquid temperature of 60 ° C. for 3 hours with a magnetic stirrer. -A microcapsule dispersion having an average particle diameter of 5.0 µm was obtained by polymerizing urea resin on the surface of the core material droplet of an amyl acetate solution of methyl acetoxybenzoate. After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 17 whose film material was urea resin.
マイクロカプセル18(in situ重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.0重量部
水 32.0重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸樹脂水溶液を得た。
ジイソノニルフタレート(エステル基を有する沸点403℃の液体)
18.0重量部
フェニル酢酸p−トリル(エステル基を有する固体(結晶質))
2.0重量部
上記各成分をマグネチックスターラーで1時間溶解し、フェニル酢酸p−トリルのジイソノニルフタレート溶液を得た。
上記スチレン−マレイン酸樹脂水溶液40.0重量部に、フェニル酢酸p−トリルのジイソノニルフタレート溶液20.0重量部を添加し、ホモジナイザーにて9500rpmで10分間撹拌し、フェニル酢酸p−トリルのジイソノニルフタレート溶液を液滴とした水分散液を得た。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)22.5重量部とレソルシノール(尿素樹脂の架橋剤)2.0重量部と水16.0重量部を混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液60重量部を酢酸でpH4.2に調整し、上記カプセル膜剤40.5重量部を添加し、液温60℃にてマグネチックスターラーで3時間撹拌して、フェニル酢酸p−トリルのジイソノニルフタレート溶液の芯物質液滴表面上にて尿素樹脂を重合させた平均粒径5.0μmのマイクロカプセル分散液を得た。この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質が尿素樹脂であるマイクロカプセル18を得た。Microcapsule 18 (in situ polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.0 parts by weight of water 32.0 parts by weight The above components were mixed and stirred with a magnetic stirrer for 1 hour to obtain a styrene-maleic acid resin aqueous solution.
Diisononyl phthalate (liquid having an ester group and a boiling point of 403 ° C.)
18.0 parts by weight p-tolyl phenylacetate (solid having an ester group (crystalline))
2.0 parts by weight The above components were dissolved with a magnetic stirrer for 1 hour to obtain a diisononyl phthalate solution of phenylacetic acid p-tolyl.
To 40.0 parts by weight of the above aqueous styrene-maleic acid resin solution, 20.0 parts by weight of a diisononyl phthalate solution of p-tolyl phenylacetate was added and stirred at 9500 rpm for 10 minutes with a homogenizer. An aqueous dispersion having the solution as droplets was obtained.
(Adjustment of capsule film)
Becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation) 22.5 parts by weight, resorcinol (urea resin crosslinking agent) 2.0 parts by weight and water 16.0 parts by weight, magnetic The capsule membrane agent was obtained by stirring with a stirrer.
(Microencapsulation)
60 parts by weight of the core material emulsion is adjusted to pH 4.2 with acetic acid, 40.5 parts by weight of the capsule membrane agent is added, and the mixture is stirred at a liquid temperature of 60 ° C. with a magnetic stirrer for 3 hours. -A microcapsule dispersion liquid having an average particle size of 5.0 µm obtained by polymerizing urea resin on the surface of the core material droplet of diisononyl phthalate solution of tolyl was obtained. After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 18 whose film material was urea resin.
マイクロカプセル19(in situ重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.0重量部
水 32.0重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸樹脂水溶液を得た。
エチルシクロヘキサン(沸点132℃) 18.0重量部
NIKKOL Hexaglyn3−S(エステル基、エーテル基を有する固体(非晶質)、トリステアリン酸ヘキサグリセリル、日光ケミカルズ(株)製)
2.0重量部
上記各成分をマグネチックスターラーで1時間溶解し、トリステアリン酸ヘキサグリセリルのエチルシクロヘキサン溶液を得た。
上記スチレン−マレイン酸樹脂水溶液40.0重量部に、トリステアリン酸ヘキサグリセリルのエチルシクロヘキサン溶液20.0重量部を添加し、ホモジナイザーにて6500rpmで10分間撹拌し、トリステアリン酸ヘキサグリセリルのエチルシクロヘキサン溶液を液滴とした水分散液を得た。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)18.0重量部とレソルシノール(尿素樹脂の架橋剤)1.6重量部と水16.0重量部を混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液60重量部を酢酸でpH4.2に調整し、上記カプセル膜剤35.6重量部を添加し、液温60℃にてマグネチックスターラーで3時間撹拌して、トリステアリン酸ヘキサグリセリルのエチルシクロヘキサン溶液の芯物質液滴表面上にて尿素樹脂を重合させた平均粒径7.0μmのマイクロカプセル分散液を得た。この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質が尿素樹脂であるマイクロカプセル19を得た。Microcapsule 19 (in situ polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.0 parts by weight of water 32.0 parts by weight The above components were mixed and stirred with a magnetic stirrer for 1 hour to obtain a styrene-maleic acid resin aqueous solution.
Ethylcyclohexane (boiling point 132 ° C.) 18.0 parts by weight NIKKOL Hexaglyn 3-S (Ester group, solid having ether group (amorphous), hexaglyceryl tristearate, manufactured by Nikko Chemicals Co., Ltd.)
2.0 parts by weight Each of the above components was dissolved with a magnetic stirrer for 1 hour to obtain an ethylcyclohexane solution of hexaglyceryl tristearate.
To 40.0 parts by weight of the styrene-maleic acid resin aqueous solution, 20.0 parts by weight of hexaglyceryl tristearate solution in ethylcyclohexane was added and stirred at 6500 rpm for 10 minutes with a homogenizer. An aqueous dispersion having the solution as droplets was obtained.
(Adjustment of capsule film)
Becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation) 18.0 parts by weight, resorcinol (urea resin cross-linking agent) 1.6 parts by weight and water 16.0 parts by weight, magnetic The capsule membrane agent was obtained by stirring with a stirrer.
(Microencapsulation)
Tristearic acid was prepared by adjusting 60 parts by weight of the above core substance emulsion to pH 4.2 with acetic acid, adding 35.6 parts by weight of the above capsule membrane agent, and stirring with a magnetic stirrer at 60 ° C. for 3 hours. A microcapsule dispersion liquid having an average particle diameter of 7.0 μm obtained by polymerizing urea resin on the surface of the core material droplet of an ethylcyclohexane solution of hexaglyceryl was obtained. After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 19 whose film material was urea resin.
マイクロカプセル20(界面重合法)
(芯物質乳化液の作成)
水 93.0重量部
ポバール117(ポリビニルアルコール、クラレ(株)製) 7.0重量部
上記各成分を混合してマグネチックスターラーで60℃にて5時間撹拌し、ポリビニルアルコール水溶液を得た。
酢酸イソアミル(エステル基を有する液体、沸点142.1℃)
88.4重量部
BS−2(ポリオキシエチレンステアリルエーテル、日光ケミカルズ(株))
4.7重量部
テレフタル酸クロリド(カプセル膜剤、大陽日酸(株)製) 6.9重量部
上記各成分をマグネチックスターラーで1時間溶解し、ポリオキシエチレンステアリルエーテルとテレフタル酸クロリドとの酢酸イソアミル溶液を得た。
上記ポリビニルアルコール水溶液48.4重量部に、ポリオキシエチレンステアリルエーテルとテレフタル酸クロリドとの酢酸イソアミル溶液42.0重量部を添加し、ホモジナイザーにて13500rpmで10分間撹拌し、ポリオキシエチレンステアリルエーテルとテレフタル酸クロリドとの酢酸イソアミル溶液を液滴とした水分散液を得た。
(硬化剤の調整)
ジエチレントリアミン(カプセル膜剤の硬化剤)15.0重量部と水85.0重量部を混合、マグネチックスターラーで攪拌して、ジエチレントリアミン水溶液を得た。
(マイクロカプセル化)
上記芯物質乳化液90.4重量部とジエチレントリアミン水溶液9.6重量部を添加し、マグネチックスターラーで3時間撹拌して、ポリオキシエチレンステアリルエーテルとテレフタル酸クロリドとの酢酸イソアミル溶液の芯物質液滴表面上にてテレフタル酸クロリドとジエチレントリアミンとの反応によるポリアミドを重合させた平均粒径10.0μmのマイクロカプセル分散液を得た。これを自然乾燥し、皮膜材質がポリアミド樹脂であるマイクロカプセル20を得た。Microcapsule 20 (interfacial polymerization method)
(Creation of core material emulsion)
Water 93.0 parts by weight POVAL 117 (polyvinyl alcohol, manufactured by Kuraray Co., Ltd.) 7.0 parts by weight The above components were mixed and stirred with a magnetic stirrer at 60 ° C. for 5 hours to obtain an aqueous polyvinyl alcohol solution.
Isoamyl acetate (liquid with ester group, boiling point 142.1 ° C)
88.4 parts by weight BS-2 (polyoxyethylene stearyl ether, Nikko Chemicals)
4.7 parts by weight terephthalic acid chloride (capsule film agent, manufactured by Taiyo Nippon Sanso Co., Ltd.) 6.9 parts by weight The above components were dissolved with a magnetic stirrer for 1 hour, and polyoxyethylene stearyl ether, terephthalic acid chloride and An isoamyl acetate solution was obtained.
To 48.4 parts by weight of the above-mentioned aqueous polyvinyl alcohol solution, 42.0 parts by weight of an isoamyl acetate solution of polyoxyethylene stearyl ether and terephthalic acid chloride is added and stirred at 13500 rpm for 10 minutes with a homogenizer. An aqueous dispersion having droplets of isoamyl acetate solution with terephthalic acid chloride was obtained.
(Adjustment of curing agent)
15.0 parts by weight of diethylenetriamine (curing agent for capsule film agent) and 85.0 parts by weight of water were mixed and stirred with a magnetic stirrer to obtain a diethylenetriamine aqueous solution.
(Microencapsulation)
Add 90.4 parts by weight of the above core substance emulsion and 9.6 parts by weight of diethylenetriamine aqueous solution and stir with a magnetic stirrer for 3 hours to obtain a core substance solution of an isoamyl acetate solution of polyoxyethylene stearyl ether and terephthalic acid chloride. A microcapsule dispersion liquid having an average particle size of 10.0 μm was obtained by polymerizing polyamide on the surface of the droplet by reaction of terephthalic acid chloride with diethylenetriamine. This was naturally dried to obtain a microcapsule 20 whose film material was a polyamide resin.
マイクロカプセル21(in situ重合法)
(芯物質乳化液の作成)
NIKKOL MYS−55V(モノステアリン酸ポリエチレングリコール、日光ケミカルズ(株)製)
0.4重量部
水 20.0重量部
上記各成分をマグネチックスターラーで1時間攪拌して、溶解させモノステアリン酸ポリエチレングリコール水溶液を得た。
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
6.5重量部
水 15.0重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸樹脂水溶液を得た。
酢酸2−エチルヘキシル(エステル基を有する液体、沸点198.6℃)
19.0重量部
ハロン110H(ケトン樹脂、本州化学(株)製) 1.0重量部
上記各成分をマグネチックスターラーで1時間溶解し、ケトン樹脂の酢酸2−エチルヘキシル溶液を得た。
上記モノステアリン酸ポリエチレングリコール水溶液20.4重量部に、ケトン樹脂の酢酸2−エチルヘキシル溶液20.0重量部を添加し、ホモジナイザー(Star Burst Mini、スギノマシン(株)製)にて圧力80MPaで、1パスする。ここにスチレン−マレイン酸樹脂水溶液21.5重量部を添加し、更にマグネチックスターラーで3時間撹拌乳化させ、ケトン樹脂の酢酸2−エチルヘキシル溶液を液滴とした水分散液を得た。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)20.0重量部とレソルシノール(尿素樹脂の架橋剤)1.8重量部と水16.0重量部を混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液61.9重量部を酢酸でpH4.2に調整し、上記カプセル膜剤37.8重量部を添加し、液温60℃にてマグネチックスターラーで3時間撹拌して、ケトン樹脂の酢酸2−エチルヘキシル溶液の芯物質液滴表面上にて尿素樹脂を重合させ平均粒径1.0μmのマイクロカプセル分散液を得た。この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質が尿素樹脂であるマイクロカプセル21を得た。Microcapsule 21 (in situ polymerization method)
(Creation of core material emulsion)
NIKKOL MYS-55V (polyethylene glycol monostearate, manufactured by Nikko Chemicals Corporation)
0.4 parts by weight of water 20.0 parts by weight The above components were stirred for 1 hour with a magnetic stirrer and dissolved to obtain a polyethylene glycol monostearate aqueous solution.
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
6.5 weight part water 15.0 weight part The said each component was mixed and it stirred with the magnetic stirrer for 1 hour, and obtained styrene- maleic acid resin aqueous solution.
2-ethylhexyl acetate (liquid having an ester group, boiling point 198.6 ° C.)
19.0 parts by weight Halon 110H (ketone resin, manufactured by Honshu Chemical Co., Ltd.) 1.0 part by weight The above components were dissolved with a magnetic stirrer for 1 hour to obtain a 2-ethylhexyl acetate solution of the ketone resin.
To 20.4 parts by weight of the aqueous polyethylene glycol monostearate solution, 20.0 parts by weight of a 2-ethylhexyl acetate solution of a ketone resin is added, and the pressure is 80 MPa with a homogenizer (Star Burst Mini, manufactured by Sugino Machine Co., Ltd.) Take one pass. 21.5 parts by weight of a styrene-maleic acid resin aqueous solution was added thereto, and the mixture was further stirred and emulsified with a magnetic stirrer for 3 hours to obtain an aqueous dispersion having a 2-ethylhexyl acetate solution of a ketone resin as droplets.
(Adjustment of capsule film)
Becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation) 20.0 parts by weight, resorcinol (urea resin cross-linking agent) 1.8 parts by weight and water 16.0 parts by weight, magnetic The capsule membrane agent was obtained by stirring with a stirrer.
(Microencapsulation)
61.9 parts by weight of the core material emulsion is adjusted to pH 4.2 with acetic acid, 37.8 parts by weight of the capsule membrane agent is added, and the mixture is stirred at a liquid temperature of 60 ° C. with a magnetic stirrer for 3 hours. The urea resin was polymerized on the surface of the core material droplet of a 2-ethylhexyl acetate solution of the resin to obtain a microcapsule dispersion having an average particle size of 1.0 μm. After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 21 whose film material was urea resin.
マイクロカプセル22の作成(in situ重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.0重量部
水 32.0重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸樹脂水溶液を得た。
酢酸フェニル(エステル基を有する液体、沸点195℃) 18.0重量部
ベヘニルアルコール(脂肪族水酸基を有する固体(非晶質))
2.0重量部
上記各成分をマグネチックスターラーで1時間溶解し、ベヘニルアルコールの酢酸フェニル溶液を得た。
上記スチレン−マレイン酸樹脂水溶液40.0重量部に、ベヘニルアルコールの酢酸フェニル溶液20.0重量部を添加し、ホモジナイザーにて17500rpmで10分間撹拌し、ベヘニルアルコールの酢酸フェニル溶液を液滴とした水分散液を得た。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)22.5重量部とレソルシノール(尿素樹脂の架橋剤)2.0重量部と水16.0重量部を混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液60重量部を酢酸でpH4.2に調整し、上記カプセル膜剤40.5重量部を添加し、液温60℃にてマグネチックスターラーで3時間撹拌して、ベヘニルアルコールの酢酸フェニル溶液の芯物質液滴表面上にて尿素樹脂を重合させた平均粒径1.0μmのマイクロカプセル分散液を得た。この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質が尿素樹脂であるマイクロカプセル22を得た。Preparation of microcapsules 22 (in situ polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.0 parts by weight of water 32.0 parts by weight The above components were mixed and stirred with a magnetic stirrer for 1 hour to obtain a styrene-maleic acid resin aqueous solution.
Phenyl acetate (liquid having ester group, boiling point 195 ° C.) 18.0 parts by weight behenyl alcohol (solid having aliphatic hydroxyl group (amorphous))
2.0 parts by weight The above components were dissolved with a magnetic stirrer for 1 hour to obtain a phenyl acetate solution of behenyl alcohol.
20.0 parts by weight of a phenyl acetate solution of behenyl alcohol was added to 40.0 parts by weight of the aqueous styrene-maleic acid resin solution, stirred for 10 minutes at 17500 rpm with a homogenizer, and dispersed in water with the phenyl acetate solution of behenyl alcohol as droplets. A liquid was obtained.
(Adjustment of capsule film)
Becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation) 22.5 parts by weight, resorcinol (urea resin crosslinking agent) 2.0 parts by weight and water 16.0 parts by weight, magnetic The capsule membrane agent was obtained by stirring with a stirrer.
(Microencapsulation)
60 parts by weight of the above core substance emulsion was adjusted to pH 4.2 with acetic acid, 40.5 parts by weight of the above capsule membrane agent was added, and the mixture was stirred for 3 hours with a magnetic stirrer at a liquid temperature of 60 ° C. to be acetic acid of behenyl alcohol. A microcapsule dispersion liquid having an average particle size of 1.0 μm obtained by polymerizing urea resin on the surface of the core material droplet of the phenyl solution was obtained. After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 22 whose film material was urea resin.
マイクロカプセル23の作成(in situ重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.0重量部
水 32.0重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸樹脂水溶液を得た。
酢酸フェニル(沸点195℃) 18.0重量部
NIKKOL MYS−10(エステル基、エーテル基を有するモノステアリン酸ポリエチレングリコール、日光ケミカルズ(株)製)
2.0重量部
上記各成分をマグネチックスターラーで1時間溶解し、モノステアリン酸ポリエチレングリコールの酢酸フェニル溶液を得た。
上記スチレン−マレイン酸樹脂水溶液40.0重量部に、モノステアリン酸ポリエチレングリコールの酢酸フェニル溶液20.0重量部を添加し、ホモジナイザーにて17500rpmで10分間撹拌し、モノステアリン酸ポリエチレングリコールの酢酸フェニル溶液を液滴とした水分散液を得た。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)22.5重量部とレソルシノール(尿素樹脂の架橋剤)2.0重量部と水16.0重量部とを混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液60重量部を酢酸でpH4.2に調整し、上記カプセル膜剤40.5重量部を添加し、液温60℃にてマグネチックスターラーで3時間撹拌して、モノステアリン酸ポリエチレングリコールの酢酸フェニル溶液の芯物質液滴表面上にて尿素樹脂を重合させた平均粒径1.0μmのマイクロカプセル分散液を得た。この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質が尿素樹脂であるマイクロカプセル23を得た。Production of microcapsule 23 (in situ polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.0 parts by weight of water 32.0 parts by weight The above components were mixed and stirred with a magnetic stirrer for 1 hour to obtain a styrene-maleic acid resin aqueous solution.
Phenyl acetate (boiling point 195 ° C.) 18.0 parts by weight NIKKOL MYS-10 (polyester glycol monostearate having an ester group and an ether group, manufactured by Nikko Chemicals Co., Ltd.)
2.0 parts by weight The above components were dissolved with a magnetic stirrer for 1 hour to obtain a phenyl acetate solution of polyethylene glycol monostearate.
20.0 parts by weight of a polyethylene glycol monostearate solution is added to 40.0 parts by weight of the aqueous styrene-maleic acid resin solution, and the mixture is stirred with a homogenizer at 17500 rpm for 10 minutes. An aqueous dispersion having the solution as droplets was obtained.
(Adjustment of capsule film)
22.5 parts by weight of becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation), 2.0 parts by weight of resorcinol (urea resin cross-linking agent) and 16.0 parts by weight of water were mixed. The capsule membrane agent was obtained by stirring with a tic stirrer.
(Microencapsulation)
60 parts by weight of the above core substance emulsion was adjusted to pH 4.2 with acetic acid, 40.5 parts by weight of the above capsule membrane agent was added, and the mixture was stirred for 3 hours with a magnetic stirrer at a liquid temperature of 60 ° C. A microcapsule dispersion having an average particle size of 1.0 μm was obtained by polymerizing urea resin on the core material droplet surface of a phenyl acetate solution of polyethylene glycol. After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 23 whose film material was urea resin.
マイクロカプセル24の作成(in situ重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.0重量部
水 32.0重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸樹脂水溶液を得た。
酢酸フェニル(沸点195℃) 18.0重量部
NIKKOL MGS−F20(エステル基、脂肪族水酸基を有するモノステアリン酸グリセリル、日光ケミカルズ(株)製)
2.0重量部
上記各成分をマグネチックスターラーで1時間溶解し、モノステアリン酸グリセリルの酢酸フェニル溶液を得た。
上記スチレン−マレイン酸樹脂水溶液40.0重量部に、モノステアリン酸グリセリルの酢酸フェニル溶液20.0重量部を添加し、ホモジナイザーにて17500rpmで10分間撹拌し、モノステアリン酸グリセリルの酢酸フェニル溶液を液滴とした水分散液を得る。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)22.5重量部とレソルシノール(尿素樹脂の架橋剤)2.0重量部と水16.0重量部を混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液60重量部を酢酸でpH4.2に調整し、上記カプセル膜剤40.5重量部を添加し、液温60℃にてマグネチックスターラーで3時間撹拌して、モノステアリン酸グリセリルの酢酸フェニル溶液の芯物質液滴表面上にて尿素樹脂を重合させた平均粒径1.0μmのマイクロカプセル分散液を得た。この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質が尿素樹脂であるマイクロカプセル24を得た。Preparation of microcapsules 24 (in situ polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.0 parts by weight of water 32.0 parts by weight The above components were mixed and stirred with a magnetic stirrer for 1 hour to obtain a styrene-maleic acid resin aqueous solution.
Phenyl acetate (boiling point 195 ° C.) 18.0 parts by weight NIKKOL MGS-F20 (glyceryl monostearate having an ester group and an aliphatic hydroxyl group, manufactured by Nikko Chemicals Co., Ltd.)
2.0 parts by weight Each of the above components was dissolved with a magnetic stirrer for 1 hour to obtain a phenyl acetate solution of glyceryl monostearate.
20.0 parts by weight of a glyceryl monostearate solution is added to 40.0 parts by weight of the styrene-maleic acid resin aqueous solution, and the mixture is stirred for 10 minutes at 17500 rpm with a homogenizer. A phenyl acetate solution of glyceryl monostearate is added. An aqueous dispersion is obtained as droplets.
(Adjustment of capsule film)
Becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation) 22.5 parts by weight, resorcinol (urea resin crosslinking agent) 2.0 parts by weight and water 16.0 parts by weight, magnetic The capsule membrane agent was obtained by stirring with a stirrer.
(Microencapsulation)
60 parts by weight of the above core substance emulsion was adjusted to pH 4.2 with acetic acid, 40.5 parts by weight of the above capsule membrane agent was added, and the mixture was stirred for 3 hours with a magnetic stirrer at a liquid temperature of 60 ° C. A microcapsule dispersion having an average particle size of 1.0 μm was obtained by polymerizing urea resin on the surface of the core material droplet of a phenyl acetate solution of glyceryl. After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 24 whose film material was urea resin.
マイクロカプセル25の作成(界面重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.6重量部
水 16.8重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸樹脂水溶液を得た。
酢酸ヘキシル(エステル基を有する液体、沸点170℃) 18.0重量部
ハロン110H(ケトン樹脂、本州化学(株)製) 2.0重量部
コロネート HXLV(カプセル膜剤、ポリイソシアネート、日本ポリウレタン工業(株)製)
7.6重量部
上記各成分をマグネチックスターラーで1時間溶解し、ケトン樹脂とポリイソシアネートとの酢酸ヘキシル溶液を得た。
上記スチレン−マレイン酸樹脂水溶液25.4重量部に、ケトン樹脂とポリイソシアネートとの酢酸ヘキシル溶液27.6重量部を添加し、ホモジナイザーにて21500rpmで10分間撹拌し、ケトン樹脂とポリイソシアネートとの酢酸ヘキシル溶液を液滴とした水分散液を得た。
(硬化剤の調整)
ジエチレントリアミン(カプセル膜剤の硬化剤)0.3重量部と水2.2重量部を混合、マグネチックスターラーで攪拌して、ジエチレントリアミン水溶液を得た。
(マイクロカプセル化)
上記芯物質乳化液53.0重量部とジエチレントリアミン水溶液2.5重量部を添加し、マグネチックスターラーで3時間撹拌して、ケトン樹脂とポリイソシアネートとの酢酸ヘキシル溶液の芯物質液滴表面上にてポリイソシアネートとジエチレントリアミンとの反応によるポリウレタンを重合させた平均粒径2.0μmのマイクロカプセル分散液25を得た。Preparation of microcapsule 25 (interfacial polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.6 parts by weight of water 16.8 parts by weight The above components were mixed and stirred for 1 hour with a magnetic stirrer to obtain a styrene-maleic acid resin aqueous solution.
Hexyl acetate (liquid having ester group, boiling point 170 ° C.) 18.0 parts by weight Halon 110H (ketone resin, manufactured by Honshu Chemical Co., Ltd.) 2.0 parts by weight Coronate HXLV (capsule film agent, polyisocyanate, Nippon Polyurethane Industry ( Made by Co., Ltd.)
7.6 parts by weight Each of the above components was dissolved with a magnetic stirrer for 1 hour to obtain a hexyl acetate solution of a ketone resin and a polyisocyanate.
27.6 parts by weight of a hexyl acetate solution of a ketone resin and a polyisocyanate is added to 25.4 parts by weight of the aqueous styrene-maleic acid resin solution, and the mixture is stirred for 10 minutes at 21500 rpm with a homogenizer. An aqueous dispersion having droplets of hexyl acetate solution was obtained.
(Adjustment of curing agent)
0.3 parts by weight of diethylenetriamine (curing agent for capsule film agent) and 2.2 parts by weight of water were mixed and stirred with a magnetic stirrer to obtain a diethylenetriamine aqueous solution.
(Microencapsulation)
Add 53.0 parts by weight of the above core substance emulsion and 2.5 parts by weight of diethylenetriamine aqueous solution and stir with a magnetic stirrer for 3 hours to form a hexyl acetate solution of ketone resin and polyisocyanate on the core substance droplet surface. Thus, a microcapsule dispersion 25 having an average particle size of 2.0 μm was obtained by polymerizing polyurethane by the reaction of polyisocyanate and diethylenetriamine.
マイクロカプセル26(in situ重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.0重量部
水 32.0重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸樹脂水溶液を得た。
酢酸フェニル(沸点195℃) 18.0重量部
Synthetic resin AP(ケトン樹脂(非晶質)、ヒュルス社製(独国))
2.0重量部
上記各成分をマグネチックスターラーで1時間溶解し、ケトン樹脂の酢酸フェニル溶液を得た。
上記スチレン−マレイン酸樹脂水溶液40.0重量部に、ケトン樹脂の酢酸フェニル溶液20.0重量部を添加し、ホモジナイザーにて17500rpmで10分間撹拌し、ケトン樹脂の酢酸フェニル溶液を液滴とした水分散液を得た。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)22.5重量部とレソルシノール(尿素樹脂の架橋剤)2.0重量部と水16.0重量部とを混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液60重量部を酢酸でpH4.2に調整し、上記カプセル膜剤40.5重量部を添加し、液温60℃にてマグネチックスターラーで3時間撹拌して、ケトン樹脂の酢酸フェニル溶液の芯物質液滴表面上にて尿素樹脂を重合させた平均粒径1.0μmのマイクロカプセル分散液を得た。この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質が尿素樹脂であるマイクロカプセル26を得た。Microcapsule 26 (in situ polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.0 parts by weight of water 32.0 parts by weight The above components were mixed and stirred with a magnetic stirrer for 1 hour to obtain a styrene-maleic acid resin aqueous solution.
Phenyl acetate (boiling point 195 ° C.) 18.0 parts by weight Synthetic resin AP (ketone resin (amorphous), manufactured by Huls (Germany))
2.0 parts by weight Each of the above components was dissolved with a magnetic stirrer for 1 hour to obtain a phenyl acetate solution of a ketone resin.
20.0 parts by weight of a ketone resin phenyl acetate solution was added to 40.0 parts by weight of the styrene-maleic acid resin aqueous solution, and the mixture was stirred with a homogenizer at 17500 rpm for 10 minutes. An aqueous dispersion was obtained.
(Adjustment of capsule film)
22.5 parts by weight of becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation), 2.0 parts by weight of resorcinol (urea resin cross-linking agent) and 16.0 parts by weight of water were mixed. The capsule membrane agent was obtained by stirring with a tic stirrer.
(Microencapsulation)
60 parts by weight of the core material emulsion is adjusted to pH 4.2 with acetic acid, 40.5 parts by weight of the capsule membrane agent is added, and the mixture is stirred at a liquid temperature of 60 ° C. with a magnetic stirrer for 3 hours. A microcapsule dispersion having an average particle size of 1.0 μm obtained by polymerizing urea resin on the surface of the core material droplet of the phenyl acetate solution was obtained. After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 26 whose film material was urea resin.
マイクロカプセル27(in situ重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.0重量部
水 32.0重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸樹脂水溶液を得た。
ジイソノニルフタレート(エステル基を有する沸点403℃の液体)
19.0重量部
NIKKOL BS−2(エーテル基を有する固体(非晶質)、ポリオキシエチレンアルキルエーテル、日光ケミカルズ(株)製)
1.0重量部
上記各成分をマグネチックスターラーで1時間溶解し、ポリオキシエチレンアルキルエーテルのジイソノニルフタレート溶液を得た。
上記スチレン−マレイン酸樹脂水溶液40.0重量部に、ポリオキシエチレンアルキルエーテルのジイソノニルフタレート溶液20.0重量部を添加し、マグネチックスターラーで20分間撹拌し、ポリオキシエチレンアルキルエーテルのジイソノニルフタレート溶液を液滴とした水分散液を得た。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)22.5重量部とレソルシノール(尿素樹脂の架橋剤)2.0重量部と水16.0重量部とを混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液60重量部を酢酸でpH4.2に調整し、上記カプセル膜剤40.5重量部を添加し、液温60℃にてマグネチックスターラーで3時間撹拌して、ポリオキシエチレンアルキルエーテルのジイソノニルフタレート溶液の芯物質液滴表面上にて尿素樹脂を重合させた平均粒径9.0μmのマイクロカプセル分散液を得た。この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質が尿素樹脂であるマイクロカプセル27を得た。Microcapsule 27 (in situ polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.0 parts by weight of water 32.0 parts by weight The above components were mixed and stirred with a magnetic stirrer for 1 hour to obtain a styrene-maleic acid resin aqueous solution.
Diisononyl phthalate (liquid having an ester group and a boiling point of 403 ° C.)
19.0 parts by weight NIKKOL BS-2 (solid having an ether group (amorphous), polyoxyethylene alkyl ether, manufactured by Nikko Chemicals Co., Ltd.)
1.0 part by weight The above components were dissolved with a magnetic stirrer for 1 hour to obtain a diisononyl phthalate solution of polyoxyethylene alkyl ether.
20.0 parts by weight of a polyoxyethylene alkyl ether diisononyl phthalate solution is added to 40.0 parts by weight of the styrene-maleic acid resin aqueous solution, and the mixture is stirred with a magnetic stirrer for 20 minutes, and the polyoxyethylene alkyl ether diisononyl phthalate solution is added. A water dispersion was obtained in the form of droplets.
(Adjustment of capsule film)
22.5 parts by weight of becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation), 2.0 parts by weight of resorcinol (urea resin cross-linking agent) and 16.0 parts by weight of water were mixed. The capsule membrane agent was obtained by stirring with a tic stirrer.
(Microencapsulation)
60 parts by weight of the core material emulsion is adjusted to pH 4.2 with acetic acid, 40.5 parts by weight of the capsule membrane agent is added, and the mixture is stirred at a liquid temperature of 60 ° C. for 3 hours with a magnetic stirrer. A microcapsule dispersion having an average particle size of 9.0 μm was obtained by polymerizing urea resin on the surface of the core material droplet of a diisononyl phthalate solution of alkyl ether. After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 27 whose film material was urea resin.
マイクロカプセル28(in situ重合法)
(芯物質乳化液の作成)
Sumirez Resin 402K(スチレン−マレイン酸樹脂の35%水溶液、田岡化学(株)製)
8.0重量部
水 32.0重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、スチレン−マレイン酸樹脂水溶液を得た。
上記スチレン−マレイン酸樹脂水溶液40.0重量部に、4−tert−ブチルシクロヘキサノン(ケトン基を有する固体(結晶質)、融点50℃)20.0重量部を添加し、60℃にてホモジナイザー6500rpmで10分間撹拌し、4−tert−ブチルシクロヘキサノンの水分散液を得る。
(カプセル膜剤の調整)
ベッカミン J300S(尿素樹脂プレポリマー、不揮発分70%、DIC(株)製)22.5重量部とレソルシノール(尿素樹脂の架橋剤)2.0重量部と水16.0重量部を混合、マグネチックスターラーで攪拌して、カプセル膜剤を得た。
(マイクロカプセル化)
上記芯物質乳化液60重量部を酢酸でpH4.2に調整し、上記カプセル膜剤40.5重量部を添加し、液温60℃にてマグネチックスターラーで3時間撹拌して、4−tert−ブチルシクロヘキサノンの芯物質液滴表面上にて尿素樹脂を重合させた平均粒径9.0μmのマイクロカプセル分散液を得た。この分散液にPVP K−15(ポリビニルピロリドン、ISPジャパン(株)製)を1.0重量部溶解後、これを自然乾燥し、皮膜材質が尿素樹脂であるマイクロカプセル28を得た。Microcapsule 28 (in situ polymerization method)
(Creation of core material emulsion)
Sumirez Resin 402K (35% aqueous solution of styrene-maleic acid resin, manufactured by Taoka Chemical Co., Ltd.)
8.0 parts by weight of water 32.0 parts by weight The above components were mixed and stirred with a magnetic stirrer for 1 hour to obtain a styrene-maleic acid resin aqueous solution.
To 40.0 parts by weight of the styrene-maleic acid resin aqueous solution, 20.0 parts by weight of 4-tert-butylcyclohexanone (solid (crystalline) having a ketone group (melting point: 50 ° C.)) is added, and the homogenizer is 6500 rpm at 60 ° C. At 10 minutes to obtain an aqueous dispersion of 4-tert-butylcyclohexanone.
(Adjustment of capsule film)
Becamine J300S (urea resin prepolymer, non-volatile content 70%, manufactured by DIC Corporation) 22.5 parts by weight, resorcinol (urea resin crosslinking agent) 2.0 parts by weight and water 16.0 parts by weight, magnetic The capsule membrane agent was obtained by stirring with a stirrer.
(Microencapsulation)
60 parts by weight of the core material emulsion is adjusted to pH 4.2 with acetic acid, 40.5 parts by weight of the capsule membrane agent is added, and the mixture is stirred at a liquid temperature of 60 ° C. with a magnetic stirrer for 3 hours. -A microcapsule dispersion liquid having an average particle size of 9.0 µm obtained by polymerizing urea resin on the surface of the core material droplet of butylcyclohexanone was obtained. After 1.0 part by weight of PVP K-15 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.) was dissolved in this dispersion, this was naturally dried to obtain microcapsules 28 whose film material was urea resin.
(ベースインキ組成物1)
S−205(黒色ロイコ染料、2’−アニリノ−6’−(N−エチル−N−イソペンチルアミノ)−3’−メチルスピロ〔フタリド−3,9’〔9H〕キサンテン〕、山田化学(株)製)
18.85重量部
タマノルPA(顕色剤、フェノール樹脂、荒川化学工業(株)製)
17.65重量部
2,2−ビス(4−ヒドロキシフェニル)プロパン(顕色剤)
6.36重量部
レソルシノール 12.61重量部
ベンジルアルコール(インキ液媒体) 37.65重量部
PVP−K90(ポリビニルピロリドン、ISPジャパン(株)製)
0.05重量部
PVB−4000−1(ポリビニルブチラール、電気化学工業(株)製)
0.48重量部
NIKKOL MGO(オレイン酸グリセリル、日光ケミカルズ(株)製)
6.36重量部
上記各成分をマグネチックスターラーで50℃にて1時間撹拌し、ベースインキを得た。(Base ink composition 1)
S-205 (black leuco dye, 2′-anilino-6 ′-(N-ethyl-N-isopentylamino) -3′-methylspiro [phthalide-3,9 ′ [9H] xanthene], Yamada Chemical Co., Ltd. Made)
18.85 parts by weight Tamanol PA (Developer, phenol resin, manufactured by Arakawa Chemical Industries, Ltd.)
17.65 parts by weight 2,2-bis (4-hydroxyphenyl) propane (developer)
6.36 parts by weight Resorcinol 12.61 parts by weight benzyl alcohol (ink liquid medium) 37.65 parts by weight PVP-K90 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.)
0.05 parts by weight PVB-4000-1 (polyvinyl butyral, manufactured by Denki Kagaku Kogyo Co., Ltd.)
0.48 parts by weight NIKKOL MGO (glyceryl oleate, manufactured by Nikko Chemicals)
6.36 parts by weight The above components were stirred with a magnetic stirrer at 50 ° C. for 1 hour to obtain a base ink.
(ベースインキ組成物2)
S−205(黒色ロイコ染料、2’−アニリノ−6’−(N−エチル−N−イソペンチルアミノ)−3’−メチルスピロ[フタリド−3,9’[9H]キサンテン]、山田化学(株)製)
4.00重量部
ベンジルアルコール 45.40重量部
PVP−K90(ポリビニルピロリドン、ISPジャパン(株)製)
0.10重量部
エスレックBM−2(ポリビニルブチラール、積水化学工業(株)製)
0.50重量部
没食子酸プロピル 10.00重量部
2,2−ビス(4−ヒドロキシフェニル)プロパン 3.00重量部
タマノル758(ノボラック型フェノール樹脂、荒川化学工業(株)製)
7.00重量部
上記各成分をマグネチックスターラーで50℃にて1時間撹拌し、ベースインキ2を得た。(Base ink composition 2)
S-205 (black leuco dye, 2′-anilino-6 ′-(N-ethyl-N-isopentylamino) -3′-methylspiro [phthalide-3,9 ′ [9H] xanthene], Yamada Chemical Co., Ltd. Made)
4.00 parts by weight benzyl alcohol 45.40 parts by weight PVP-K90 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.)
0.10 parts by weight ESREC BM-2 (polyvinyl butyral, manufactured by Sekisui Chemical Co., Ltd.)
0.50 parts by weight Propyl gallate 10.00 parts by weight 2,2-bis (4-hydroxyphenyl) propane 3.00 parts by weight Tamanol 758 (Novolac type phenolic resin, manufactured by Arakawa Chemical Co., Ltd.)
7.00 parts by weight The above components were stirred with a magnetic stirrer at 50 ° C. for 1 hour to obtain a base ink 2.
実施例1
ベースインキ組成物1を85重量部とマイクロカプセル1を15重量部とをロールミルで分散し、黒色のインキ組成物を得た。Example 1
85 parts by weight of the base ink composition 1 and 15 parts by weight of the microcapsules 1 were dispersed by a roll mill to obtain a black ink composition.
実施例2
ベースインキ組成物1を80重量部とマイクロカプセル2を20重量部とをロールミルで分散し、黒色のインキ組成物を得た。Example 2
80 parts by weight of the base ink composition 1 and 20 parts by weight of the microcapsules 2 were dispersed by a roll mill to obtain a black ink composition.
実施例3
ベースインキ組成物1を80重量部とマイクロカプセル3を20重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 3
80 parts by weight of the base ink composition 1 and 20 parts by weight of the microcapsules 3 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例4
ベースインキ組成物1を80重量部とマイクロカプセル4を20重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 4
80 parts by weight of the base ink composition 1 and 20 parts by weight of the microcapsules 4 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例5
ベースインキ組成物1を80重量部とマイクロカプセル5を20重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 5
80 parts by weight of the base ink composition 1 and 20 parts by weight of the microcapsules 5 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例6
ベースインキ組成物1を85重量部とマイクロカプセル6を15重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 6
85 parts by weight of the base ink composition 1 and 15 parts by weight of the microcapsules 6 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例7
ベースインキ組成物1を80重量部とマイクロカプセル7を20重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 7
80 parts by weight of the base ink composition 1 and 20 parts by weight of the microcapsules 7 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例8
ベースインキ組成物1を75重量部とマイクロカプセル8を25重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 8
75 parts by weight of the base ink composition 1 and 25 parts by weight of the microcapsules 8 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例9
ベースインキ組成物1を70重量部とマイクロカプセル9を30重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 9
70 parts by weight of the base ink composition 1 and 30 parts by weight of the microcapsules 9 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例10
ベースインキ組成物1を85重量部とマイクロカプセル10を15重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 10
85 parts by weight of the base ink composition 1 and 15 parts by weight of the microcapsules 10 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例11
ベースインキ組成物1を85重量部とマイクロカプセル11を15重量部とをロールミルで分散し、黒色のインキ組成物を得た。Example 11
85 parts by weight of the base ink composition 1 and 15 parts by weight of the microcapsules 11 were dispersed with a roll mill to obtain a black ink composition.
実施例12
ベースインキ組成物1を80重量部とマイクロカプセル12を20重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 12
80 parts by weight of the base ink composition 1 and 20 parts by weight of the microcapsules 12 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例13
ベースインキ組成物1を80重量部とマイクロカプセル13を20重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 13
80 parts by weight of the base ink composition 1 and 20 parts by weight of the microcapsules 13 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例14
ベースインキ組成物1を80重量部とマイクロカプセル14を20重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 14
80 parts by weight of the base ink composition 1 and 20 parts by weight of the microcapsules 14 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例15
ベースインキ組成物1を80重量部とマイクロカプセル15を20重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 15
80 parts by weight of the base ink composition 1 and 20 parts by weight of the microcapsules 15 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例16
ベースインキ組成物1を80重量部とマイクロカプセル16を20重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 16
80 parts by weight of the base ink composition 1 and 20 parts by weight of the microcapsules 16 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例17
ベースインキ組成物1を80重量部とマイクロカプセル17を20重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 17
80 parts by weight of the base ink composition 1 and 20 parts by weight of the microcapsules 17 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例18
ベースインキ組成物1を80重量部とマイクロカプセル18を20重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 18
80 parts by weight of the base ink composition 1 and 20 parts by weight of the microcapsules 18 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例19
ベースインキ組成物1を80重量部とマイクロカプセル19を20重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 19
80 parts by weight of the base ink composition 1 and 20 parts by weight of the microcapsules 19 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例20
ベースインキ組成物1を85重量部とマイクロカプセル20を15重量部とをロールミルで分散し、黒色のインキ組成物を得た。Example 20
85 parts by weight of the base ink composition 1 and 15 parts by weight of the microcapsules 20 were dispersed by a roll mill to obtain a black ink composition.
実施例21
ベースインキ組成物1を85重量部とマイクロカプセル21を15重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 21
85 parts by weight of the base ink composition 1 and 15 parts by weight of the microcapsules 21 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例22
ベースインキ組成物2を70重量部とマイクロカプセル22を30重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 22
70 parts by weight of the base ink composition 2 and 30 parts by weight of the microcapsules 22 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例23
ベースインキ組成物2を70重量部とマイクロカプセル23を30重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 23
70 parts by weight of the base ink composition 2 and 30 parts by weight of the microcapsules 23 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例24
ベースインキ組成物2を70重量部とマイクロカプセル24を30重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 24
70 parts by weight of the base ink composition 2 and 30 parts by weight of the microcapsules 24 were dispersed with a magnetic stirrer to obtain a black ink composition.
実施例25
(ロイコ染料−顕色剤の顔料1)
S−205(黒色ロイコ染料、2’−アニリノ−6’−(N−エチル−N−イソペンチルアミノ)−3’−メチルスピロ〔フタリド−3,9’〔9H〕キサンテン〕、山田化学(株)製)
15重量部
2,2−ビス(4−ヒドロキシフェニル)プロパン(顕色剤)
45重量部
アセトン 40重量部
上記各成分をマグネチックスターラーで1時間撹拌後、室温3日放置しアセトンを蒸発させる。その後乳鉢で粉砕しロイコ染料−顕色剤の顔料1を得た。
(インキ化)
ロイコ染料−顕色剤の顔料1 20.0重量部
水 21.5重量部
エチレングリコール 10.0重量部
マイクロカプセル分散液25 40.0重量部
ケルザンAR6%水溶液(キサンタンガム、三晶(株)製) 7.0重量部
デモールEP(ポリカルボン酸型高分子界面活性剤、花王(株)製)
1.5重量部
マイクロカプセル分散液25、ケルザンAR6%水溶液を除く上記各成分をボールミルで24時間分散処理した後、マイクロカプセル分散液25を添加し更に1時間分散処理した。その後ケルザンAR6%水溶液を添加し、マグネチックスターラーで3時間撹拌し黒色のインキ組成物を得た。Example 25
(Leuco dye-Developer pigment 1)
S-205 (black leuco dye, 2′-anilino-6 ′-(N-ethyl-N-isopentylamino) -3′-methylspiro [phthalide-3,9 ′ [9H] xanthene], Yamada Chemical Co., Ltd. Made)
15 parts by weight 2,2-bis (4-hydroxyphenyl) propane (developer)
45 parts by weight Acetone 40 parts by weight Each of the above components is stirred with a magnetic stirrer for 1 hour and then allowed to stand at room temperature for 3 days to evaporate acetone. Thereafter, the mixture was pulverized in a mortar to obtain pigment 1 of leuco dye-developer.
(Ink)
Leuco dye-developer pigment 1 20.0 parts by weight water 21.5 parts by weight ethylene glycol 10.0 parts by weight Microcapsule dispersion 25 40.0 parts by weight Kelzan AR 6% aqueous solution (xanthan gum, manufactured by Sanki Co., Ltd.) 7.0 parts by weight Demol EP (polycarboxylic acid type polymer surfactant, manufactured by Kao Corporation)
1.5 parts by weight The above components except for the microcapsule dispersion 25 and the Kelzan AR 6% aqueous solution were dispersed for 24 hours with a ball mill, and then the microcapsule dispersion 25 was added and further dispersed for 1 hour. Thereafter, a 6% aqueous solution of Kelzan AR was added and stirred with a magnetic stirrer for 3 hours to obtain a black ink composition.
実施例26
(ロイコ染料−顕色剤の顔料2)
S−205(黒色ロイコ染料、2’−アニリノ−6’−(N−エチル−N−イソペンチルアミノ)−3’−メチルスピロ〔フタリド−3,9’〔9H〕キサンテン〕、山田化学(株)製)
4.0重量部
ミズカエース#400(顕色剤、酸性白土、水澤化学工業(株)製)
12.0重量部
アセトン 30.0重量部
上記各成分をボールミルで24時間処理後、アセトンを蒸発させて発色した黒色顔料を得た。
(インキ化)
ロイコ染料−顕色剤の顔料2 16.0重量部
ベンジルアルコール 48.4重量部
PVP−K90(ポリビニルピロリドン、ISPジャパン(株)製)
0.1重量部
エスレックBM−2(ポリビニルブチラール、積水化学工業(株)製)
0.5重量部
YSポリスターS145(テルペンフェノール、ヤスハラケミカル(株)製)
7.0重量部
上記各成分をマグネチックスターラーで70℃、1時間撹拌後、マイクロカプセル26を30重量部加えホモジナイザーで30分間攪拌し、5A濾紙を用いて加圧濾過を行い黒色の油性インキ組成物を得た。Example 26
(Leuco dye-Developer pigment 2)
S-205 (black leuco dye, 2′-anilino-6 ′-(N-ethyl-N-isopentylamino) -3′-methylspiro [phthalide-3,9 ′ [9H] xanthene], Yamada Chemical Co., Ltd. Made)
4.0 parts by weight Mizuka Ace # 400 (Developer, acid clay, manufactured by Mizusawa Chemical Co., Ltd.)
12.0 parts by weight Acetone 30.0 parts by weight Each of the above components was treated with a ball mill for 24 hours, and then the acetone was evaporated to obtain a black pigment.
(Ink)
Leuco dye—Developer pigment 2 16.0 parts by weight benzyl alcohol 48.4 parts by weight PVP-K90 (polyvinylpyrrolidone, manufactured by ISP Japan Co., Ltd.)
0.1 parts by weight ESREC BM-2 (polyvinyl butyral, manufactured by Sekisui Chemical Co., Ltd.)
0.5 parts by weight YS Polystar S145 (terpene phenol, manufactured by Yasuhara Chemical Co., Ltd.)
7.0 parts by weight The above components were stirred with a magnetic stirrer at 70 ° C. for 1 hour, then 30 parts by weight of microcapsules 26 were added, stirred with a homogenizer for 30 minutes, filtered under pressure using 5A filter paper, and black oil-based ink A composition was obtained.
実施例27
ベースインキ組成物1を80重量部とマイクロカプセル27を20重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Example 27
80 parts by weight of the base ink composition 1 and 20 parts by weight of the microcapsules 27 were dispersed with a magnetic stirrer to obtain a black ink composition.
比較例1
熱変色性マイクロカプセル顔料(界面重合法)
(芯物質乳化液の作成)
2−(2−クロロアニリノ)−6−ジ−n−ブチルアミノフルオラン(黒色ロイコ染料)
4.5重量部
1,1−ビス(4’−ヒドロキシフェニル)n−デカン(顕色剤)
4.5重量部
1,1−ビス(4’−ヒドロキシフェニル)ヘキサフルオロプロパン(顕色剤)
7.5重量部
カプリン酸4−ベンジルオキシフェニルエチル(消色剤) 50.0重量部
上記各成分をマグネチックスターラーで50℃1時間撹拌し、熱変色性化合物1を得た。
熱変色性化合物1 56.5重量部
コロネートHX(ポリイソシアネート、日本ポリウレタン工業(株)製)
30.0重量部
酢酸イソブチル 40.0重量部
上記各成分をマグネチックスターラーで1時間撹拌し、熱変色性化合物とポリイソシアネートの酢酸イソブチル溶液を得た。
水 92.0重量部
PVA205(ポリビニルアルコール、クラレ(株)製) 8.0重量部
上記各成分を混合してマグネチックスターラーで1時間撹拌し、ポリビニルアルコール水溶液を得た。
ポリビニルアルコール水溶液66.5重量部に、熱変色性化合物とポリイソシアネートの酢酸イソブチル溶液70.0重量部を添加し、ホモジナイザーにて13500rpmで20分間撹拌し、熱変色性化合物とポリイソシアネートの酢酸イソブチル溶液を液滴とした水分散液を得た。
(硬化剤の調整)
ジエチレントリアミン(カプセル膜剤の硬化剤)3.0重量部と水27.0重量部を混合、マグネチックスターラーで攪拌して、ジエチルトリアミン水溶液を得た。
(マイクロカプセル化)
上記芯物質乳化液136.5重量部とジエチレントリアミン水溶液30.0重量部を添加し、マグネチックスターラーで3時間撹拌して、変色性化合物とポリイソシアネートの酢酸イソブチル溶液の芯物質液滴表面上にてポリイソシアネートとジエチレントリアミンとの反応によるポリウレタンを重合させた平均粒径3.0μmマイクロカプセル分散液を得た。
(インキ化)
マイクロカプセル分散液 25.70重量部
サクシノグルカン(剪断減粘性付与剤、三晶(株)製) 0.20重量部
尿素 5.50重量部
グリセリン 7.50重量部
ノプコSW−WET−366(非イオン系界面活性剤、サンノプコ(株)製)
0.03重量部
FSアンチフォーム013A(シリコーン消泡剤、東レ・ダウコーニング(株)製)
0.15重量部
プロクセルXL−2(ベンゾイソチアゾリン−3−オン、ICIジャパン(株)製)
0.10重量部
プライサーフA212C(ポリオキシアルキレンアルキルエーテルリン酸塩、第一工業製薬(株)製)
0.50重量部
トリエタノールアミン 0.50重量部
水 59.82重量部
サクシノグルカンを除く上記各成分をマグネチックスターラーで分散後、サクシノグルカンを添加しマグネチックスターラーで2時間撹拌する。その後、−20℃に24時間放置し黒色のインキ組成物を得た。Comparative Example 1
Thermochromic microcapsule pigment (interfacial polymerization method)
(Creation of core material emulsion)
2- (2-Chloroanilino) -6-di-n-butylaminofluorane (black leuco dye)
4.5 parts by weight 1,1-bis (4′-hydroxyphenyl) n-decane (developer)
4.5 parts by weight 1,1-bis (4′-hydroxyphenyl) hexafluoropropane (developer)
7.5 parts by weight 4-benzyloxyphenylethyl caprate (decolorant) 50.0 parts by weight The above components were stirred with a magnetic stirrer at 50 ° C. for 1 hour to obtain thermochromic compound 1.
Thermochromic compound 1 56.5 parts by weight Coronate HX (polyisocyanate, manufactured by Nippon Polyurethane Industry Co., Ltd.)
30.0 parts by weight Isobutyl acetate 40.0 parts by weight Each of the above components was stirred with a magnetic stirrer for 1 hour to obtain a thermochromic compound and an isobutyl acetate solution of polyisocyanate.
Water 92.0 parts by weight PVA205 (polyvinyl alcohol, manufactured by Kuraray Co., Ltd.) 8.0 parts by weight The above components were mixed and stirred with a magnetic stirrer for 1 hour to obtain an aqueous polyvinyl alcohol solution.
70.0 parts by weight of a thermochromic compound and a polyisocyanate isobutyl acetate solution are added to 66.5 parts by weight of a polyvinyl alcohol aqueous solution, and the mixture is stirred for 20 minutes at 13500 rpm with a homogenizer, and the thermochromic compound and isobutyl acetate of a polyisocyanate are mixed. An aqueous dispersion having the solution as droplets was obtained.
(Adjustment of curing agent)
A mixture of 3.0 parts by weight of diethylenetriamine (curing agent for capsule film) and 27.0 parts by weight of water was stirred with a magnetic stirrer to obtain a diethyltriamine aqueous solution.
(Microencapsulation)
Add 136.5 parts by weight of the above core substance emulsion and 30.0 parts by weight of diethylenetriamine aqueous solution and stir with a magnetic stirrer for 3 hours on the core substance droplet surface of the isobutyl acetate solution of the discolorable compound and polyisocyanate. Thus, a microcapsule dispersion having an average particle size of 3.0 μm was obtained by polymerizing polyurethane by the reaction of polyisocyanate and diethylenetriamine.
(Ink)
Microcapsule dispersion 25.70 parts by weight Succinoglucan (shear thinning agent, manufactured by Sanki Co., Ltd.) 0.20 parts by weight urea 5.50 parts by weight glycerin 7.50 parts by weight Nopco SW-WET-366 ( Non-ionic surfactant, manufactured by San Nopco)
0.03 parts by weight FS Antifoam 013A (silicone defoaming agent, manufactured by Toray Dow Corning Co., Ltd.)
0.15 parts by weight Proxel XL-2 (benzoisothiazolin-3-one, manufactured by ICI Japan Ltd.)
0.10 parts by weight Plysurf A212C (polyoxyalkylene alkyl ether phosphate, manufactured by Daiichi Kogyo Seiyaku Co., Ltd.)
0.50 parts by weight Triethanolamine 0.50 parts by weight Water 59.82 parts by weight The above components except for succinoglucan are dispersed with a magnetic stirrer, succinoglucan is added, and the mixture is stirred with a magnetic stirrer for 2 hours. Then, it was left to stand at −20 ° C. for 24 hours to obtain a black ink composition.
比較例2
比較例1の熱変色性化合物1を下記熱変色性化合物2にした他は、比較例1と同様に成し、黒色インキ組成物を得た。
(熱変色性化合物2)
2−(2−クロロアニリノ)−6−ジ−n−ブチルアミノフルオラン(黒色ロイコ染料)
6.8重量部
1,1−ビス(4’−ヒドロキシフェニル)n−デカン(顕色剤)
6.8重量部
1,1−ビス(4’−ヒドロキシフェニル)ヘキサフルオロプロパン(顕色剤)
11.3重量部
カプリン酸4−ベンジルオキシフェニルエチル(消色剤) 41.6重量部
上記各成分をマグネチックスターラーで50℃1時間撹拌し、熱変色性化合物2を得た。Comparative Example 2
A black ink composition was obtained in the same manner as in Comparative Example 1 except that the thermochromic compound 1 of Comparative Example 1 was changed to the following thermochromic compound 2.
(Thermochromic compound 2)
2- (2-Chloroanilino) -6-di-n-butylaminofluorane (black leuco dye)
6.8 parts by weight of 1,1-bis (4′-hydroxyphenyl) n-decane (developer)
6.8 parts by weight 1,1-bis (4′-hydroxyphenyl) hexafluoropropane (developer)
11.3 parts by weight 4-benzyloxyphenylethyl caprate (decolorant) 41.6 parts by weight The above components were stirred with a magnetic stirrer at 50 ° C. for 1 hour to obtain thermochromic compound 2.
比較例3
比較例1の熱変色性化合物1を下記熱変色性化合物3にした他は、比較例1と同様に成し、黒色インキ組成物を得た。
(熱変色性化合物3)
2−(2−クロロアニリノ)−6−ジ−n−ブチルアミノフルオラン(黒色ロイコ染料)
9.0重量部
1,1−ビス(4’−ヒドロキシフェニル)n−デカン(顕色剤)
9.0重量部
1,1−ビス(4’−ヒドロキシフェニル)ヘキサフルオロプロパン(顕色剤)
15.0重量部
カプリン酸4−ベンジルオキシフェニルエチル(消色剤) 33.5重量部
上記各成分をマグネチックスターラーで50℃1時間撹拌し、熱変色性化合物3を得た。Comparative Example 3
A black ink composition was obtained in the same manner as in Comparative Example 1 except that the thermochromic compound 1 of Comparative Example 1 was changed to the following thermochromic compound 3.
(Thermochromic compound 3)
2- (2-Chloroanilino) -6-di-n-butylaminofluorane (black leuco dye)
9.0 parts by weight 1,1-bis (4′-hydroxyphenyl) n-decane (developer)
9.0 parts by weight 1,1-bis (4′-hydroxyphenyl) hexafluoropropane (developer)
15.0 parts by weight 4-benzyloxyphenylethyl caprate (decolorant) 33.5 parts by weight The above components were stirred with a magnetic stirrer at 50 ° C. for 1 hour to obtain thermochromic compound 3.
比較例4
ベースインキ組成物1を80重量部とマイクロカプセル28を20重量部とをマグネチックスターラーで分散し、黒色のインキ組成物を得た。Comparative Example 4
80 parts by weight of the base ink composition 1 and 20 parts by weight of the microcapsules 28 were dispersed with a magnetic stirrer to obtain a black ink composition.
これら各実施例、比較例のインキ組成物について、次の各試験を行った。結果は表1に示す。
筆跡濃度測定
実施例、比較例で得られたインキ組成物を筆記具(ぺんてる(株)製の水性ゲルボールペンBLN25(ボール径0.5mm)、製品名:エナージェル)に充填し、上質紙(JIS P3201筆記用紙A)に5cmの直線を1.5cmの幅内に並列して直線と直線の間が隙間なく筆記し、カラーコンピューターでY値を測定した。The following tests were performed on the ink compositions of these Examples and Comparative Examples. The results are shown in Table 1.
Measurement of handwriting density The ink compositions obtained in Examples and Comparative Examples were filled in writing instruments (water gel ballpoint pen BLN25 (ball diameter 0.5 mm), product name: Engel) manufactured by Pentel Co., Ltd.), and fine paper (JIS P3201) On a writing paper A), a straight line of 5 cm was juxtaposed within a width of 1.5 cm, and a straight line was written with no gap, and the Y value was measured with a color computer.
消去性試験
上記、筆記濃度測定で使用した各検体に対し、筆記面を、ぺんてるローリーBPC47A後端の頭冠部で荷重2kg、角度90°で10往復させて擦過し、直後(1分以内)に当該擦過部分をカラーコンピューターでYを測定した。尚、上質紙のY値は83.4%だった。Erasability test For each specimen used in the above-mentioned writing concentration measurement, the writing surface is rubbed by reciprocating 10 kg at a 90 ° angle with a load of 2 kg at the crown of the rear end of the Pentel Lorry BPC47A, immediately after (within 1 minute) Then, Y was measured on the rubbing portion with a color computer. The Y value of fine paper was 83.4%.
消色維持状態確認試験
上記消去性試験を行った各検体について、消去性試験後24時間経過した後の擦過部分をカラーコンピューターでYを測定した。Decoloration maintenance state confirmation test For each specimen subjected to the erasability test, Y was measured with a color computer at the rubbing portion after 24 hours had elapsed after the erasability test.
実施例1〜27のインキ組成物は、感熱消去性マイクロカプセルを使用した比較例1と比べ、筆跡濃度が高く良好なものである。
実施例2〜27のインキ組成物は、蒸発しにくい沸点250℃以上の物質、又はエステル基、ケトン基、エーテル基、脂肪族水酸基を有する固体を使用しているので消色してから24時間後の筆跡は、再発色が抑えられる。
また、エステル基、ケトン基、エーテル基、脂肪族水酸基を有する固体が非晶質である実施例4〜5、7,9〜27は再発色防止効果がアップしている。
マイクロカプセルの平均粒径1〜10μmである実施例6,8,12〜27はマイクロカプセルが壊れやすく消色効果が高い。また、ボールペン形態で吐出時マイクロカプセルは壊れにくく、筆跡濃度の低下もない。The ink compositions of Examples 1 to 27 have a high handwriting density and are good compared to Comparative Example 1 using heat-erasable microcapsules.
The ink compositions of Examples 2 to 27 use a substance that does not easily evaporate and has a boiling point of 250 ° C. or higher, or a solid having an ester group, a ketone group, an ether group, or an aliphatic hydroxyl group. Later handwriting has reduced recurrence color.
Further, Examples 4-5, 7, 9-27, in which the solid having an ester group, a ketone group, an ether group, and an aliphatic hydroxyl group is amorphous, have an improved recurrence color prevention effect.
In Examples 6, 8, and 12 to 27, in which the average particle diameter of the microcapsules is 1 to 10 μm, the microcapsules are easily broken and the decoloring effect is high. In addition, the microcapsules at the time of ejection in the form of a ballpoint pen are not easily broken, and the handwriting density does not decrease.
本発明を詳細にまた特定の実施態様を参照して説明したが、本発明の精神と範囲を逸脱することなく様々な変更や修正を加えることができることは当業者にとって明らかである。
本出願は、2011年10月31日出願の日本国特許出願(特願2011−239827)、2012年8月29日出願の日本国特許出願(特願2012−189322)及び2012年9月28日出願の日本国特許出願(特願2012−217192)に基づくものであり、その内容はここに参照として取り込まれる。Although the present invention has been described in detail and with reference to specific embodiments, it will be apparent to those skilled in the art that various changes and modifications can be made without departing from the spirit and scope of the invention.
The present application includes a Japanese patent application filed on October 31, 2011 (Japanese Patent Application No. 2011-239827), a Japanese patent application filed on August 29, 2012 (Japanese Patent Application No. 2012-189322), and September 28, 2012. It is based on the Japanese patent application (Japanese Patent Application No. 2012-217192) of the application, and the content is taken in here as a reference.
本発明のインキ組成物は、これにより筆記した筆跡が十分濃く、また該筆跡を擦過により消去可能であり、またその消去した筆跡の再発色もなく、ボールペン等にインキ等に使用することができる。 The ink composition of the present invention has a sufficiently thick handwriting written thereby, and can be erased by rubbing, and there is no reappearance of the erased handwriting, and it can be used for ink etc. in a ballpoint pen or the like. .
Claims (5)
The erasable ink composition according to any one of claims 1 to 4, wherein the average particle size of the microcapsules is 1 to 10 µm.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011239827 | 2011-10-31 | ||
JP2011239827 | 2011-10-31 | ||
JP2012189322 | 2012-08-29 | ||
JP2012189322 | 2012-08-29 | ||
JP2012217192 | 2012-09-28 | ||
JP2012217192 | 2012-09-28 | ||
PCT/JP2012/077924 WO2013065653A1 (en) | 2011-10-31 | 2012-10-29 | Ink composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2013065653A1 JPWO2013065653A1 (en) | 2015-04-02 |
JP6024667B2 true JP6024667B2 (en) | 2016-11-16 |
Family
ID=48192000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013541772A Expired - Fee Related JP6024667B2 (en) | 2011-10-31 | 2012-10-29 | Ink composition |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP6024667B2 (en) |
WO (1) | WO2013065653A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6049064B2 (en) * | 2012-12-19 | 2016-12-21 | 株式会社パイロットコーポレーション | Glossy ink composition for ballpoint pen and ballpoint pen incorporating the same |
CN103265847B (en) * | 2013-05-30 | 2014-12-03 | 华东理工大学 | Aromatic erasable blue gel ink and preparation method thereof |
JP6168412B2 (en) * | 2014-01-20 | 2017-07-26 | 荒川化学工業株式会社 | Heat transfer oil |
KR101785616B1 (en) * | 2015-05-22 | 2017-10-17 | 주식회사 동화아이엔디 | High heat resistant thermal paper |
US20220064464A1 (en) * | 2018-12-14 | 2022-03-03 | Sanford L.P. | Dry Erase Inks, and Associated Methods and Writing Instruments |
JP7504710B2 (en) | 2020-08-14 | 2024-06-24 | 東芝テック株式会社 | Coloring materials |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3472144B2 (en) * | 1998-06-30 | 2003-12-02 | 株式会社東芝 | Erasable image forming material |
JP2001342415A (en) * | 2000-05-31 | 2001-12-14 | Zebra Pen Corp | Water-based ink composition for ball-point pen, capable of being achromatized by solvent and heating |
JP3878504B2 (en) * | 2002-03-19 | 2007-02-07 | ゼブラ株式会社 | Suspension polymer particles containing a color developing compound and ink and toner using the same |
JP5201919B2 (en) * | 2007-09-12 | 2013-06-05 | パイロットインキ株式会社 | Water-based ink composition for writing instruments, writing instrument containing the same, and writing instrument set |
JP5186225B2 (en) * | 2008-01-30 | 2013-04-17 | パイロットインキ株式会社 | Discoloring writing instrument |
-
2012
- 2012-10-29 JP JP2013541772A patent/JP6024667B2/en not_active Expired - Fee Related
- 2012-10-29 WO PCT/JP2012/077924 patent/WO2013065653A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2013065653A1 (en) | 2013-05-10 |
JPWO2013065653A1 (en) | 2015-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6024667B2 (en) | Ink composition | |
WO1997035935A1 (en) | Water base ink having metallic luster for ball-point pen and aqueous pigment ink | |
JP6231351B2 (en) | Microcapsule coloring material and ink composition for writing instrument | |
JP4093940B2 (en) | Temperature-sensitive color-changing color memory liquid composition | |
JP5506224B2 (en) | Thermal decolorizable ink composition | |
WO2014142014A1 (en) | Color-fadable water-based ink composition | |
JP2021031679A (en) | Aqueous ink composition for writing instrument and writing instrument containing the same | |
JP2009270033A (en) | Reversible thermochromic marking pen oil-based ink | |
JP5686502B2 (en) | Thermal decolorizable ink composition | |
JP2001207101A (en) | Reversible thermal color changing water-based ink composition and writing material using the same | |
JP2016160327A (en) | Discharge or discoloration ink composition | |
JP2002265843A (en) | Color-changeable writing ink composition and writing utensil including the same | |
JP2001220530A (en) | Aqueous marker ink composition using decoloring composition with solvent or heating | |
JP6817151B2 (en) | Water-based ink composition for writing instruments | |
JP4093968B2 (en) | Temperature-sensitive color change color memory ink composition for writing instruments | |
JP2005298746A (en) | Temperature-sensitively color-changing color-memorizing ink composition for writing utensil | |
JP2017082142A (en) | Pressure-sensitive decolorable and discolorable ink composition | |
JP2015091941A (en) | Decoloring and color-changing ink composition | |
JP7007241B2 (en) | Aqueous ink composition for reversible thermochromic writing tools, and writing tools using it | |
JP6622073B2 (en) | Ink composition for writing instruments | |
JP6896403B2 (en) | Erasing writing tool | |
JP2013213080A (en) | Ink composition | |
JP5118277B2 (en) | Decolorizable water-based ink composition | |
JP6811562B2 (en) | Stationery with a clip | |
JP2014148593A (en) | Ink composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AA64 | Notification of invalidation of claim of internal priority (with term) |
Free format text: JAPANESE INTERMEDIATE CODE: A241764 Effective date: 20140701 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140710 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150831 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150831 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160607 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160802 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160913 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160926 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6024667 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |